
<html lang="en"     class="pb-page"  data-request-id="45cc7c51-6a24-4b4a-bf9c-2ed6942781c3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-6;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b00089;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series" /></meta><meta name="dc.Creator" content="Scott H.  Watterson" /></meta><meta name="dc.Creator" content="Junqing  Guo" /></meta><meta name="dc.Creator" content="Steve H.  Spergel" /></meta><meta name="dc.Creator" content="Charles M.  Langevine" /></meta><meta name="dc.Creator" content="Robert V.  Moquin" /></meta><meta name="dc.Creator" content="Ding Ren  Shen" /></meta><meta name="dc.Creator" content="Melissa  Yarde" /></meta><meta name="dc.Creator" content="Mary Ellen  Cvijic" /></meta><meta name="dc.Creator" content="Dana  Banas" /></meta><meta name="dc.Creator" content="Richard  Liu" /></meta><meta name="dc.Creator" content="Suzanne J.  Suchard" /></meta><meta name="dc.Creator" content="Kathleen  Gillooly" /></meta><meta name="dc.Creator" content="Tracy  Taylor" /></meta><meta name="dc.Creator" content="Sandra  Rex-Rabe" /></meta><meta name="dc.Creator" content="David J.  Shuster" /></meta><meta name="dc.Creator" content="Kim W.  McIntyre" /></meta><meta name="dc.Creator" content="Georgia  Cornelius" /></meta><meta name="dc.Creator" content="Celia  D’Arienzo" /></meta><meta name="dc.Creator" content="Anthony  Marino" /></meta><meta name="dc.Creator" content="Praveen  Balimane" /></meta><meta name="dc.Creator" content="Bethanne  Warrack" /></meta><meta name="dc.Creator" content="Luisa  Salter-Cid" /></meta><meta name="dc.Creator" content="Murray  McKinnon" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="Percy H.  Carter" /></meta><meta name="dc.Creator" content="William J.  Pitts" /></meta><meta name="dc.Creator" content="Jenny  Xie" /></meta><meta name="dc.Creator" content="Alaric J.  Dyckman" /></meta><meta name="dc.Description" content="Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1–5) and evokes a variety of cellular responses through their stimulation. The interaction of S1..." /></meta><meta name="Description" content="Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1–5) and evokes a variety of cellular responses through their stimulation. The interaction of S1..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 10, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00089" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00089" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00089" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00089" /></link>
        
    
    

<title>Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00089" /></meta><meta property="og:title" content="Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0020.jpeg" /></meta><meta property="og:description" content="Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1–5) and evokes a variety of cellular responses through their stimulation. The interaction of S1P with the S1P receptors plays a fundamental physiological role in a number of processes including vascular development and stabilization, lymphocyte migration, and proliferation. Agonism of S1P1, in particular, has been shown to play a significant role in lymphocyte trafficking from the thymus and secondary lymphoid organs, resulting in immunosuppression. This article will detail the discovery and SAR of a potent and selective series of isoxazole based full agonists of S1P1. Isoxazole 6d demonstrated impressive efficacy when administered orally in a rat model of arthritis and in a mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00089"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00089">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00089&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00089&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00089&amp;href=/doi/10.1021/acs.jmedchem.6b00089" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2820-2840</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00062" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01962" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P<sub>1</sub>): Discovery and SAR of a Novel Isoxazole Based Series</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+H.++Watterson">Scott H. Watterson</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junqing++Guo">Junqing Guo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steve+H.++Spergel">Steve H. Spergel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+M.++Langevine">Charles M. Langevine</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+V.++Moquin">Robert V. Moquin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ding+Ren++Shen">Ding Ren Shen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Yarde">Melissa Yarde</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ellen++Cvijic">Mary Ellen Cvijic</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dana++Banas">Dana Banas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Liu">Richard Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+J.++Suchard">Suzanne J. Suchard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathleen++Gillooly">Kathleen Gillooly</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tracy++Taylor">Tracy Taylor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Rex-Rabe">Sandra Rex-Rabe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Shuster">David J. Shuster</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim+W.++McIntyre">Kim W. McIntyre</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georgia++Cornelius">Georgia Cornelius</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++D%E2%80%99Arienzo">Celia D’Arienzo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Marino">Anthony Marino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Praveen++Balimane">Praveen Balimane</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bethanne++Warrack">Bethanne Warrack</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luisa++Salter-Cid">Luisa Salter-Cid</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murray++McKinnon">Murray McKinnon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Percy+H.++Carter">Percy H. Carter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+J.++Pitts">William J. Pitts</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Xie">Jenny Xie</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alaric+J.++Dyckman">Alaric J. Dyckman</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 609-252-6778. E-mail: <a href="/cdn-cgi/l/email-protection#3546565a41411b425441415047465a5b755758461b565a58"><span class="__cf_email__" data-cfemail="384b5b574c4c164f594c4c5d4a4b5756785a554b165b5755">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00089&amp;href=/doi/10.1021%2Facs.jmedchem.6b00089" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2820–2840</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 28, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 January 2016</li><li><span class="item_label"><b>Published</b> online</span>10 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 March 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00089" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00089</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2820%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DScott%2BH.%2BWatterson%252C%2BJunqing%2BGuo%252C%2BSteve%2BH.%2BSpergel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D6%26contentID%3Dacs.jmedchem.6b00089%26title%3DPotent%2Band%2BSelective%2BAgonists%2Bof%2BSphingosine%2B1-Phosphate%2B1%2B%2528S1P1%2529%253A%2BDiscovery%2Band%2BSAR%2Bof%2Ba%2BNovel%2BIsoxazole%2BBased%2BSeries%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2840%26publicationDate%3DMarch%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00089"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2310</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00089" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;H. Watterson&quot;},{&quot;first_name&quot;:&quot;Junqing&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;H. Spergel&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;M. Langevine&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;V. Moquin&quot;},{&quot;first_name&quot;:&quot;Ding&quot;,&quot;last_name&quot;:&quot;Ren Shen&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Yarde&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ellen Cvijic&quot;},{&quot;first_name&quot;:&quot;Dana&quot;,&quot;last_name&quot;:&quot;Banas&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;J. Suchard&quot;},{&quot;first_name&quot;:&quot;Kathleen&quot;,&quot;last_name&quot;:&quot;Gillooly&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Rex-Rabe&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Shuster&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;W. McIntyre&quot;},{&quot;first_name&quot;:&quot;Georgia&quot;,&quot;last_name&quot;:&quot;Cornelius&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;D’Arienzo&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Marino&quot;},{&quot;first_name&quot;:&quot;Praveen&quot;,&quot;last_name&quot;:&quot;Balimane&quot;},{&quot;first_name&quot;:&quot;Bethanne&quot;,&quot;last_name&quot;:&quot;Warrack&quot;},{&quot;first_name&quot;:&quot;Luisa&quot;,&quot;last_name&quot;:&quot;Salter-Cid&quot;},{&quot;first_name&quot;:&quot;Murray&quot;,&quot;last_name&quot;:&quot;McKinnon&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Percy&quot;,&quot;last_name&quot;:&quot;H. Carter&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;J. Pitts&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Alaric&quot;,&quot;last_name&quot;:&quot;J. Dyckman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2820-2840&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00089&quot;},&quot;abstract&quot;:&quot;Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P1–5) and evokes a variety of cellular responses through their stimulation. The interaction of S1P with the S1P receptors plays a fundamental physiological role in a number of processes including vascular development and stabilization, lymphocyte migration, and proliferation. Agonism of S1P1, in particular, has been shown to play a significant role in lymphocyte trafficking from the thymus and secondary lymphoid organs, resulting in immunosuppression. This article will detail the discovery and SAR of a potent and selective series of isoxazole based full agonists of S1P1. Isoxazole 6d demonstrated impressive efficacy when administered orally in a rat model of arthritis and in a mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00089&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00089" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00089&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00089" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00089&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00089" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00089&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00089&amp;href=/doi/10.1021/acs.jmedchem.6b00089" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00089" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00089" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00089%26sid%3Dliteratum%253Aachs%26pmid%3D26924461%26genre%3Darticle%26aulast%3DWatterson%26date%3D2016%26atitle%3DPotent%2Band%2BSelective%2BAgonists%2Bof%2BSphingosine%2B1-Phosphate%2B1%2B%2528S1P1%2529%253A%2BDiscovery%2Band%2BSAR%2Bof%2Ba%2BNovel%2BIsoxazole%2BBased%2BSeries%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D6%26spage%3D2820%26epage%3D2840%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=290860" title="Solution chemistry">Solution chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/jmcmar.2016.59.issue-6/20160324/jmcmar.2016.59.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Sphingosine 1-phosphate (S1P) is the endogenous ligand for the sphingosine 1-phosphate receptors (S1P<sub>1–5</sub>) and evokes a variety of cellular responses through their stimulation. The interaction of S1P with the S1P receptors plays a fundamental physiological role in a number of processes including vascular development and stabilization, lymphocyte migration, and proliferation. Agonism of S1P<sub>1</sub>, in particular, has been shown to play a significant role in lymphocyte trafficking from the thymus and secondary lymphoid organs, resulting in immunosuppression. This article will detail the discovery and SAR of a potent and selective series of isoxazole based full agonists of S1P<sub>1</sub>. Isoxazole <b>6d</b> demonstrated impressive efficacy when administered orally in a rat model of arthritis and in a mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine 1-phosphate (S1P) is a lysophopholipid, endogenous mediator that functions as a high-affinity ligand for five members of the endothelial differentiation gene class of G-protein-coupled receptors, S1P<sub>1–5</sub>. The interaction of S1P with the S1P receptors plays a fundamental physiological role in a number of processes including vascular development and stabilization, lymphocyte migration, and proliferation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Levels of S1P in various tissues are regulated through the coordinated activities of biosynthetic kinases and biodegradative phosphatases and lyases.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Specifically, S1P is derived from the phosphorylation of sphingosine by two kinases, S1Pkinase-1 and S1Pkinase-2 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Conversely, S1P is degraded by S1P lyase and lysophospholipid phosphatases.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of sphingosine and sphingosine 1-phospate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The S1P<sub>1</sub> receptor is the predominant receptor expressed on lymphocytes and plays a crucial role in lymphocyte egress from the thymus and lymph nodes to systemic circulation and ultimately to sites of tissue inflammation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The S1P concentration gradient differential between blood plasma and tissue is sensed by the lymphocytes through the interaction of the S1P<sub>1</sub> receptor with circulating S1P, resulting in egress.<a onclick="showRef(event, 'ref2 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref4">(2, 4)</a> In support of this, conditional deletion of the S1P<sub>1</sub> receptors expressed on lymphocytes in mice resulted in sequestration of the lymphocytes in the thymus and lymph nodes.<a onclick="showRef(event, 'ref3 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref6">(3, 5, 6)</a> This was further supported in studies with conditional S1Pkinase-deficient mice in which the lack of S1P in the plasma and lymph nodes resulted in a significant reduction in circulating lymphocytes.<a onclick="showRef(event, 'ref2 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref6">(2, 6)</a></div><div class="NLM_p">Fingolimod (<b>1</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was shown in vivo to induce a significant, but reversible, reduction in circulating lymphocytes,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and as a result, <b>1</b> was found to be efficacious in several animal models of inflammation. Although <b>1</b> is inactive toward the S1P<sub>1–5</sub> receptors, a phosphorylated metabolic derivative <b>2</b> (fingolimod-P) generated through the stereospecific action of S1Pkinase-2, analogous to S1P, was found to act as a potent, full agonist of the S1P<sub>1,3,4,5</sub> receptors with no activity toward S1P<sub>2</sub>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Additionally, unlike S1P, fingolimod-P (<b>2</b>) agonism of S1P<sub>1</sub> resulted in prolonged internalization and degradation of the receptor, thus acting as a “functional antagonist.”<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> With this mechanism of action, lymphocytes are no longer able to recognize and respond to changes in the S1P gradient, thus preventing their migration into circulation and tissue. With positive phase III clinical results, fingolimod (<b>1</b>) was approved in 2010 as the first oral, disease-modifying treatment for relapsing-remitting multiple sclerosis (RRMS).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of fingolimod (<b>1</b>) and fingolimod-P (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although fingolimod (<b>1</b>) has proven to be very effective in the treatment of RRMS, several concerns emerged during clinical trials including cardiovascular effects (bradycardia and blood pressure elevation), macular edema, decline in pulmonary function, and an extended half-life resulting in a prolonged pharmacologic effect after drug discontinuation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Initially, the cardiovascular effects were linked to the agonism of S1P<sub>3</sub>, as supported by rodent studies,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> but more recent clinical data suggest that there is no solid correlation between rodent and human. In particular, clinical studies with S1P<sub>3</sub> sparing agonists have revealed that the cardiovascular effects seen in humans are independent of S1P<sub>3</sub> receptor agonism.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In fact, recent evidence suggests that the bradycardia in humans may be triggered by S1P<sub>1</sub> receptor activation.<a onclick="showRef(event, 'ref10 ref11 cit13d'); return false;" href="javascript:void(0);" class="ref ref10 ref11 cit13d">(10, 11, 13d)</a></div><div class="NLM_p">With fingolimod’s clinical success, there has been an enormous effort to identify direct-acting, full agonists of the S1P<sub>1</sub> receptor that do not require phosphorylation for pharmacological activity.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Additionally, most research efforts have focused on improving both the pharmacokinetic profile and the receptor selectivity of fingolimod (<b>1</b>), including the work discussed in this article. Identification of a compound with a shorter pharmacokinetic half-life would reduce concerns over the prolonged recovery from lymphocyte suppression observed with <b>1</b> upon drug discontinuation, which could potentially hinder recovery from an infection. Selectivity for the S1P<sub>1</sub> receptor over the S1P<sub>3</sub> receptor was originally anticipated to improve the cardiovascular profile, but with a better understanding of the cardiovascular effects in humans, this is no longer expected to have a significant benefit. With that being said, S1P<sub>3</sub> receptor agonism does not appear to contribute to the efficacy, so a desire for selectivity has remained a primary emphasis of most research efforts, including our own.</div><div class="NLM_p">The key structural features of <b>2</b>, and other typical S1P<sub>1</sub> receptor agonists, include a polar headgroup, a rigid linker, and a lipophilic tail group. Merck was the first to report on results aimed at identifying direct-acting agonists of the S1P receptors, ultimately leading to the identification of compounds with an azetidine-3-carboxylic polar group utilized in conjunction with a 3,5-diaryl-1,2,4-oxadiazole linker, as exemplified by compound <b>3</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In our efforts to identify novel lipophilic fragments, the azetidine-3-carboxylic acid substituted linker <b>4</b>, derived from <b>3</b>, provided a valuable combination for identifying agonists of the S1P<sub>1</sub> receptor when combined with our fragments.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> This effort ultimately led to the identification of two highly potent, selective isoxazole-based full agonists of the S1P<sub>1</sub> receptor, as depicted in structures <b>5</b> and <b>6</b> shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. As discussed in this article, further optimization led to the identification of isoxazole <b>6d</b> (BMS-520).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Discovery of isoxazole based agonists of S1P<sub>1</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic pathways utilized in the preparation of the isoxazole analogs presented in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> are provided in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> – <a class="ref internalNav" href="#sch9" aria-label="9">9</a>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> outlines isoxazole derivatives appended to the linker at C3 with substitution at C4 and C5. <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> outlines derivatives appended to the linker at C5 with substitution at C3 and C4. Compounds presented in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were prepared as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Intermediate <b>9</b> was prepared through a reductive amination reaction between 4-cyanobenzaldehyde and the <i>tert</i>-butyl ester protected azetidine-3-carboxylic acid. Subsequent treatment with hydroxylamine afforded the amidoxime intermediate <b>10</b>. Intermediate <b>10</b> was then coupled with the substituted isoxazole-3-carboxylic acids <b>13a</b>–<b>n</b> or isoxazole-5-carboxylic acids <b>22a</b>–<b>c</b>, utilizing EDCI and HOBt in dimethylformamide, followed by deprotection of the azetidine carboxylic acid with trifluoroacetic acid to provide the desired analogs <b>5a</b>–<b>n</b> or <b>6a</b>–<b>c</b> in good yield.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Isoxazoles <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuOH, DMAP, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 81%; (b) 10% Pd/C, EtOAc, 92%; (c) 4-cyanobenzaldehyde, Na(CN)BH<sub>3</sub>; MeOH, 89%; (d) HONH<sub>2</sub>–HCl; NaHCO<sub>3</sub>, <i>t</i>-BuOH, 55%; (e) <b>13</b>, <b>25</b>, or <b>29</b>, EDCI, HOBt, DMF, 53–86%; (f) TFA.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro and in Vivo Potency of C3-Linked Isoxazoles (<b>5</b>)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="6" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub>, nM<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub>, nM<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction 4 h (1.0 mpk), %</th><th class="colsep0 rowsep0" align="center">plasma concn (nM)</th><th class="colsep0 rowsep0" align="center">reduction 24 h (1.0 mpk), %</th><th class="colsep0 rowsep0" align="center">plasma concn (nM)</th><th class="colsep0 rowsep0" align="center">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">44<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6300<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">150×</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5.0<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>31<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>6300×</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.05</td><td class="colsep0 rowsep0" align="left">12000<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">7500×</td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="left">0.44 ± 0.16</td><td class="colsep0 rowsep0" align="left">1300 ± 410</td><td class="colsep0 rowsep0" align="left">2900×</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Bu</td><td class="colsep0 rowsep0" align="left">0.27 ± 0.03</td><td class="colsep0 rowsep0" align="left">680 ± 20</td><td class="colsep0 rowsep0" align="left">250×</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">0.56 ± 0.12</td><td class="colsep0 rowsep0" align="left">730 ± 450</td><td class="colsep0 rowsep0" align="left">1300×</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.60</td><td class="colsep0 rowsep0" align="left">5100 ± 3900</td><td class="colsep0 rowsep0" align="left">4000×</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">cyc-Pr</td><td class="colsep0 rowsep0" align="left">3.2 ± 2.2</td><td class="colsep0 rowsep0" align="left">1800 ± 280</td><td class="colsep0 rowsep0" align="left">540×</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">5.3 ± 1.7</td><td class="colsep0 rowsep0" align="left">2600 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">500×</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">520</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">0.99 ± 0.41</td><td class="colsep0 rowsep0" align="left">130 ± 34</td><td class="colsep0 rowsep0" align="left">130×</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.98 ± 0.05</td><td class="colsep0 rowsep0" align="left">4100 ± 710</td><td class="colsep0 rowsep0" align="left">4100×</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">CF<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.25</td><td class="colsep0 rowsep0" align="left">1900 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">3500×</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.08</td><td class="colsep0 rowsep0" align="left">850 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">2900×</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">1300</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5n</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.39 ± 0.21</td><td class="colsep0 rowsep0" align="left">6200 ± 1400</td><td class="colsep0 rowsep0" align="left">16000×</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">1600</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">280</td><td class="colsep0 rowsep0" align="left">6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">EC<sub>50</sub> values are shown as a single determination.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro and in Vivo Potency of C5-Linked Isoxazoles (<b>6</b>)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0018.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro activity</th><th class="rowsep1 colsep0" colspan="5" align="center">rat blood lymphocyte reduction assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>1</sub> GTPγS EC<sub>50</sub>, nM<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>h</i>S1P<sub>3</sub> GTPγS EC<sub>50</sub>, nM<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub>/S1P<sub>1</sub> sel</th><th class="colsep0 rowsep0" align="center">reduction 4 h (1.0 mpk), %</th><th class="colsep0 rowsep0" align="center">plasma concn (nM)</th><th class="colsep0 rowsep0" align="center">reduction 24 h (1.0 mpk), %</th><th class="colsep0 rowsep0" align="center">plasma concn (nM)</th><th class="colsep0 rowsep0" align="center">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">25<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">1.7 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">9200 ± 6200</td><td class="colsep0 rowsep0" align="left">5500×</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="left">0.44 (<i>n</i> = 2)</td><td class="colsep0 rowsep0" align="left">1000 ± 440</td><td class="colsep0 rowsep0" align="left">2300×</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.47 ± 0.25</td><td class="colsep0 rowsep0" align="left">1600 ± 320</td><td class="colsep0 rowsep0" align="left">3400×</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">2100</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">700</td><td class="colsep0 rowsep0" align="left">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">EC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last">EC<sub>50</sub> values are shown as a single determination. </p></div></div></div><div class="NLM_p">Isoxazole-3-carboxylic acids used for the preparation of <b>5a</b>–<b>j</b> and <b>5l</b>–<b>m</b> were either commercially available or were prepared as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. A mixture of the appropriately substituted alkyne and dimethyl nitromalonate was either heated in mesitylene in a sealed tube at 150 °C overnight or heated in acetonitrile under microwave conditions at 170 °C in the presence of an ionic liquid, 1-butyl-3-methylimidazolium hexafluorophosphate, to give ethers <b>12b</b>–<b>j</b> and <b>12l</b>–<b>m</b>. Subsequent hydrolysis with either lithium hydroxide or sodium hydroxide afforded the desired isoxazole-3-carboxylic acids <b>13b</b>–<b>j</b> and <b>13l</b>,<b>m</b> in good yield. The C4 trifluoromethylisoxazoles acids <b>5k</b> and <b>5n</b> were prepared in high yield as outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Isoxazole ester <b>14</b> was iodinated at C4 with <i>N</i>-iodosuccinimide and trifluoroacectic acid to give intermediate <b>15</b> in 97% yield. Trifluoromethylation at C4 was carried out with methyl 2,2-difluoro-2-(fluorosulfonyl)acetate in the presence of copper iodide and HMPA to give isoxazole ester <b>16</b> in 94% yield. Subsequent hydrolysis with lithium hydroxide provided isoxazole acid <b>17</b> in near quantitative yield. The related 5-isobutyl-4-(trifluoromethyl)isoxazole-3-carboxylic acid <b>21</b> was prepared in an analogous manner in high yield. The C4-difluoroethylisoxazole <b>5l</b> was prepared as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Isoxazole-3-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-butyl-3-methyl-1<i>H</i>-imidazol-3-ium hexafluorophosphate, toluene, microwave, 170 °C; (b) mesitylene, 150 °C; (c) LiOH–H<sub>2</sub>O, MeOH/H<sub>2</sub>O; (d) 1 N aqueous NaOH, MeOH, microwave, 100 °C.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 4-Trifluoromethylisoxazole-3-carboxylic Acids</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Isoxazole-3-carboxylic Acid <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, 5% fuming HNO<sub>3</sub> in AcOH; (b) tributyl(1-ethoxyvinyl)tin, dioxane, 100 °C; (c) deoxofluor, ethanol, 85 °C; (d) 1 N aq NaOH, methanol.</p></p></figure><div class="NLM_p">The synthetic routes used to prepare the C5 linked isoxazoles <b>6a</b>–<b>d</b> are outlined in <a class="ref internalNav" href="#sch5" aria-label="Schemes 5">Schemes 5</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a>. Isoxazole-5-carboxylic acids <b>29a</b>–<b>c</b> were either commercially available or prepared as outlined in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. A mixture of the <i>N</i>-hydroxybenzimidoyl chloride <b>26</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and substituted ethyl bromoenoates <b>27b</b> and <b>27c</b> in dichloromethane was stirred at room temperature in the presence of triethylamine to give esters <b>28b</b> and <b>28c</b>. Subsequent hydrolysis with lithium hydroxide afforded the desired acids <b>29b</b> and <b>29c</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Isoxazole-5-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, <10%; (b) LiOH, MeOH/H<sub>2</sub>O, 95–100%.</p></p></figure><div class="NLM_p">Preparation of C4 trifluoromethylisoxazole acid <b>35</b> proved to be a challenge. An initial survey of the literature revealed that the only reported method for the preparation of ester <b>30</b> occurred through a 1,3-dipolar cycloaddition reaction between ethyl trifluorobut-2-ynoate and a dipole generated in situ from <i>N</i>-hydroxybenzimidoyl chloride favoring the formation of the undesired isomer <b>31</b> in a ratio of 85:15.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In our hands, the reaction provided <b>30</b>, with a ratio consistent with that reported in the literature, in ∼7% yield after chromatographic separation (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). To optimize the [3 + 2]-cycloaddition reaction, the electronic pairing of the dipolarophile was inverted by replacing ethyl trifluorobut-2-ynoate with the trifluorobut-2-yn-1-ol, prepared as shown in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As expected, slow addition of triethylamine to the mixture of <i>N</i>-hydroxybenzimidoyl chloride <b>26</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and trifluorobutyne alcohol <b>32</b> at 70 °C resulted in a mixture of isomers <b>33</b> and <b>34</b>, but in a ratio of 9:1 favoring the desired isomer <b>33</b>, with a typical isolated yield of ∼65% after chromatographic separation (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). The desired alcohol isomer <b>33</b> was oxidized with either Jones’ reagent or TEMPO/bleach to give 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid <b>35</b> in >90% yield.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of 3-Phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic Acid <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of 4,4,4-Trifluorobut-2-yn-1-ol<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>-BuLi, DIPA, Et<sub>2</sub>O; (b) <i>n</i>-BuLi, Et<sub>2</sub>O; (c) paraformaldehyde, 70%.</p></p></figure><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0016.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. An Improved Synthesis of Isoxazole <b>6d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) cyanuric fluoride, >95%; (b) Hunig’s base, MeCN, 80%; (c) TFA, neutralization, >90%.</p></p></figure><div class="NLM_p">An optimized, high yielding procedure for the preparation of isoxazole <b>6d</b> is outlined in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>. This approach relies on the coupling of acid fluoride <b>36</b>, derived from the treatment of acid <b>35</b> with cyanuric fluoride, with amidoxime intermediate <b>10</b> in the presence of Hunig’s base to generate oxadiazole <b>37</b> in 80% yield. Subsequent deprotection of the azetidine carboxylic acid with trifluoroacetic acid afforded <b>6d</b> in >90% yield. This improved sequence was applicable for the preparation of the other analogs described in this article, especially <b>5k</b> and <b>5n</b>.</div><div class="NLM_p last">Isoxazole agonists presented in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were evaluated in a functional GTPγS assay looking at both human S1P<sub>1</sub> and S1P<sub>3</sub> receptor agonism. While it is important to maintain selectivity against the S1P<sub>2</sub> and S1P<sub>3</sub> receptors, activity against the S1P<sub>4</sub> and S1P<sub>5</sub> receptors was less of a concern and was only monitored periodically. In parallel with the functional assays, liability profiling was utilized to facilitate the progression of compounds into a rat blood lymphocyte reduction (BLR) pharmacodynamic/pharmacokinetic (PD/PK) assay. In this assay, healthy rats were dosed orally with a 1.0 mg/kg dose of each compound. Blood samples were drawn at 4 and 24 h time points to assess the reduction in circulating lymphocytes relative to control and to evaluate plasma concentration for each compound. Selected compounds with appropriate in vivo activity were further evaluated in full PK studies and ultimately animal efficacy models of rheumatoid arthritis and multiple sclerosis.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> highlights the structure–activity relationship (SAR) for agonists <b>5</b> derived from isoxazole-3-carboxylic acids. The more facile synthesis of these examples allowed for a broader exploration of SAR, with a particular focus on exploring substitution at R<sup>2</sup> while maintaining R<sup>1</sup> as a phenyl substituent (<b>5a</b>–<b>l</b>). Isoxazole <b>5a</b>, with no C4 substitution, provided modest agonist activity against the S1P<sub>1</sub> receptor with an EC<sub>50</sub> of 44 nM. The addition of a methyl group (<b>5b</b>) provided a 9-fold improvement in potency, as well as enhanced selectivity for the S1P<sub>1</sub> receptor relative to the S1P<sub>3</sub> receptor. In general, increasing the length of the alkyl chain (<b>5c</b>–<b>f</b>) resulted in improvements in activity, with butyl and isobutyl substitution providing potent agonist activity against the S1P<sub>1</sub> receptor with EC<sub>50</sub> values of 0.27 nM and 0.56 nM, respectively. On the other hand, shorter, branched alkyl groups (<b>5g</b>–<b>i</b>) were less potent compared with the longer, linear side chains (e.g., <b>5i</b>, EC<sub>50</sub> = 5.3 nM vs <b>5d</b>, EC<sub>50</sub> = 0.27 nM). In the BLR PD/PK assay, the lymphocyte reduction at 4 and 24 h time points with an oral dose of 1 mg/kg was consistent with the agonist activity trends observed for the C4 alkyl isoxazoles <b>5b</b>–<b>f</b> and <b>5i</b>, with the longer alkyl substituents <b>5d</b>–<b>f</b> providing a higher level of lymphopenia at 4 h with a sustained PD effect out to 24 h. When the C5 phenyl in <b>5d</b> was replaced with an isobutyl group (<b>5m</b>), activity and selectivity were both maintained, but significantly higher plasma concentrations were observed in the BLR assay. Interestingly, phenyl substitution at C4 (<b>5j</b>) retained potency against the S1P<sub>1</sub> receptor but selectivity against the S1P<sub>3</sub> receptor was reduced relative to <b>5b</b>–<b>i</b>. Although the C4 substitution outlined in compounds <b>5b</b>–<b>j</b>,<b>m</b> provided improvements in both activity and selectivity relative to <b>5a</b>, these modifications introduced hERG, sodium, and calcium channel concerns, based on in vitro liability profiling (data not shown).</div><div class="NLM_p">Substitution of C4 with a trifluoromethyl group (<b>5k</b>), on the other hand, provided a very clean liability profile while maintaining potent agonist activity and selectivity (ED<sub>50</sub> of 0.98 nM; S1P<sub>3</sub>/S1P<sub>1</sub> selectivity of 4000-fold). In the BLR PD/PK assay, a 1 mg/kg oral dose of <b>5k</b> resulted in an 84% reduction in lymphocyte counts at 4 h with a sustained PD effect providing an 85% reduction at 24 h. Compound plasma concentrations at both time points for <b>5k</b> were considerably higher when compared to those observed for <b>5a</b>–<b>j</b>. Additionally, <b>5k</b> had a 4 h/24 h peak-to-trough ratio of 6, suggesting that this compound has a low rate of clearance. Other fluorinated variations <b>5l</b> and <b>5n</b> were also promising, with <b>5n</b> providing significant enhancements in selectivity while demonstrating a similar PD/PK effect as <b>5k</b> but with higher overall compound plasma levels.</div><div class="NLM_p">The SAR of agonists (<b>6a</b>–<b>d</b>) derived from isoxazole-5-carloxylic acids highlighted in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> followed the same trends observed with the C3-linked isoxazoles (<b>5</b>). The more synthetically challenging nature of this series resulted in comparably limited exploration of substitution. Consistent with the data presented in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, C4 trifluoromethyl substitution (<b>6d</b>) provided a highly desirable activity and selectivity profile. In the rat BLR PD/PK assay, <b>6d</b> showed robust lymphopenia at a 1 mg/kg oral dose at both 4 h and 24 h time points, 78% and 91%, respectively. Additionally, the plasma concentrations of <b>6d</b> were higher than those observed for <b>5k</b> (∼1.9× at 4 h and ∼3.9× at 24 h) with a 4 h/24 h peak-to-trough ratio of only 3.</div><div class="NLM_p">The ability of <b>6d</b> to drive receptor internalization was investigated using CHO cells transfected with human S1P<sub>1</sub> fused with GFP. In this assay, <b>6d</b> induced S1P<sub>1</sub> internalization with an EC<sub>50</sub> of 0.27 ± 0.04 nM (<i>n</i> = 3), similar to fingolimod-P (<b>2</b>, EC<sub>50</sub> = 0.28 ± 0.10 nM). The maximal signal of S1P<sub>1</sub> receptor internalization was similar between <b>6d</b> and S1P treatment. As seen in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, S1P resulted in >90% receptor internalization. Following a washout period, S1P<sub>1</sub> receptors reappeared on the cell surface by 4 and 16 h time points with levels of 60% and 100%, respectively. However, <b>6d</b> which demonstrated a similar level of receptor internalization showed receptor recycling levels of only 20% at 4 h and 40% at 16 h, compared with baseline levels prior to stimulation. It is worth noting that newly synthesized protein may have contributed to the total receptor count, since protein synthesis inhibitors were not used in this assay. As a result, <b>6d</b> is likely to induce S1P<sub>1</sub> receptor degradation similar to that reported for fingolimod-P (<b>2</b>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Quantification of S1P<sub>1</sub> on the cell membrane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a highly desirable activity and selectivity profile and a very clean liability profile (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), <b>6d</b> was further evaluated in vivo. As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, <b>6d</b> demonstrated dose dependent lymphopenia in the rat BLR assay, demonstrating a significant reduction in circulating lymphocytes at 24 h with an oral dose of only 0.03 mg/kg with compound plasma concentrations of 4 nM at the 24 h time point. In pharmacokinetic (PK) studies in mice, rat, cyno, and dog (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), bioavailabilities were around 50% or higher across all species with low clearance and desirable half-lives in the range of 7.4–10 h in mouse, rat, and dog. Interestingly, cyno proved to be an outlier with a more moderate rate of clearance resulting in a shorter half-life of only 3 h, consequently leading to a larger peak-to-trough ratio. With an excellent dose response in the rat BLR PD/PK assay, an overall acceptable liability profile, and a desirable PK profile differentiated from that of fingolimod (<b>1)</b>, <b>6d</b> was advanced into animal models of human autoimmune disease.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Partial in Vitro Profiling Data for Compound <b>6d</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0019.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>2</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">>10000×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>4</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">5.2×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</td><td class="colsep0 rowsep0" align="left">2.7×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein binding (bound)</td><td class="colsep0 rowsep0" align="left">99.7% human</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.9% mounse</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.4% rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.0% dog</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">99.3% monkey</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mutagenicity</td><td class="colsep0 rowsep0" align="left">Ames negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG (patch clamp)</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 18 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sup>+</sup> (patch clamp)</td><td class="colsep0 rowsep0" align="left"><5% at 10 μM (1 and 4 Hz)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ca<sup>+</sup> (patch clamp)</td><td class="colsep0 rowsep0" align="left">12% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> inhibition (IC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">>40 μM 1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 3A4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAMPA permeability</td><td class="colsep0 rowsep0" align="left">1032 nm/s at pH 7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 permeability<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">104 nm/s</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">3.7 and 7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i> (pH 6.5)</td><td class="colsep0 rowsep0" align="left">2.68</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">CYP = cytochrome P450.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Apical to basolateral.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vivo Potency of Isoxazole <b>6d</b> in the Rat Blood Lymphocyte Reduction Assay</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">reduction 4 h (%)</th><th class="colsep0 rowsep0" align="center">plasma concn (nM)</th><th class="colsep0 rowsep0" align="center">reduction 24 h (%)</th><th class="colsep0 rowsep0" align="center">plasma concn (nM)</th><th class="colsep0 rowsep0" align="center">4 h/24 h ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">2100</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">700</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters for Compound <b>6d</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cyno<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">10<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM), po</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (μM), po</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μM·h), po</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h), iv</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h), iv</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL min<sup>–1</sup> kg<sup>–1</sup>), iv</td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (% HBF)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg), iv</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> (%)</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peak/trough ratio</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Average of three animals.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Cynomologus monkey.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">% hepatic blood flow.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Average of two animals.</p></div></div></div><div class="NLM_p">In a rat adjuvant arthritis study, a preclinical model of human rheumatoid arthritis,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> arthritis was induced by the subcutaneous injection of Complete Freund’s adjuvant (CFA) containing heat-killed <i>Mycobacterium butyricum</i> into the base of the tail of male Lewis rats. Isoxazole <b>6d</b> was administered at doses of 0.03. 0.1, 0.5, and 3 mg/kg po/q.d., along with fingolimod (<b>1</b>) at 1 mg/kg po/q.d., for 21 days starting at day 0 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). Baseline measurements of hind paw volume were obtained by water displacement plethysmometry. Additional paw volume measurements were performed over the next 3 weeks, and the increases in paw volume above baseline were calculated. Although a dose of 0.03 mg/kg had little impact on disease development, a dose of 0.1 mg/kg provided >50% suppression of paw swelling, and the higher doses of 0.5 and 3.0 mg/kg resulted in robust inhibition. On the basis of the paw swelling observed in this study, the ED<sub>50</sub> was determined to be 0.05 mg/kg. At the end of the study, histological analysis of the paws confirmed that <b>6d</b> provided inhibition of inflammation and bone resorption in a dose dependent fashion, as depicted in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B.</div><figure id="fig5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0006.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Paw swelling of <b>6d</b> (0.03, 0.1, 0.5, and 3.0 mg/kg) and <b>1</b> (0.3 mg/kg) vs vehicle in a rat adjuvant arthritis model. (B) Paw histology of <b>6d</b> (0.03, 0.1, 0.5, and 3.0 mg/kg) and <b>1</b> (0.3 mg/kg) vs vehicle in a rat adjuvant arthritis model: rats (<i>n</i> = 8–10/group) were administered <b>6d</b> and <b>1</b> po/q.d. starting on day 0 at the time of immunization; vehicle, PEG300; (∗) <i>p</i> < 0.05 compared to vehicle treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With success in the rat adjuvant arthritis model, <b>6d</b> was evaluated in a mouse experimental autoimmune encephalomyelitis study (EAE), a preclinical model of multiple sclerosis. Disease was induced by subcutaneous immunization with MOG (myelin oligodendrocyte glycoprotein)/CFA and two doses of pertussis toxin in C57BL/6 mice (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details). Mice were dosed orally, q.d. with <b>6d</b> beginning on the day of immunization. <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A presents the mean clinical scores of groups of mice treated with vehicle or varying dose levels of <b>6d</b>. Isoxazole <b>6d</b> treatment provided a dose-dependent delay in disease onset and a dose-dependent reduction in the overall severity of disease compared with the vehicle treatment group. In this study, <b>6d</b> at a dose of 0.2 mg/kg q.d. provided a degree of efficacy comparable to that of fingolimod (<b>1</b>) at a 1.0 mg/kg dose q.d. On the basis of the efficacy observed in this study, the ED<sub>50</sub> for <b>6d</b> was determined to be 0.02 mg/kg. At the end of the study, histological analysis of the spinal cords confirmed that <b>6d</b> provided inhibition of inflammation and demyelination in a dose dependent fashion, as shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B.</div><figure id="fig6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0007.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Efficacy of <b>6d</b> (0.0, 0.2, and 2.0 mg/kg) and <b>1</b> (1.0 mg/kg) vs vehicle in a mouse experimental autoimmune encephalomyelitis model (EAE). (B) Spinal cord histology of <b>6d</b> (0.0, 0.2, and 2.0 mg/kg) and <b>1</b> (1.0 mg/kg) vs vehicle in a mouse experimental autoimmune encephalomyelitis model (EAE): mice (<i>n</i> = 10/group) were administered <b>6d</b> and <b>1</b> po/q.d. starting on day 0 at the time of immunization with MOG-peptide (myelin oligodendrocyte glycoprotein); vehicle, PEG300; (∗) <i>p</i> < 0.05 compared to vehicle treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56766" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56766" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a novel series of isoxazole based full agonists of the S1P<sub>1</sub> receptor with selectivity over the S1P<sub>2</sub> and S1P<sub>3</sub> receptors has been identified. Through this effort, we identified isoxazole <b>6d</b> (BMS-520) as our lead compound. With a potent and selective in vitro activity profile, an acceptable PK profile, robust potency in the rat BLR assay, and a clean liability profile, <b>6d</b> was advanced into rodent models of human autoimmune disease. In a rat adjuvant arthritis study, a preclinical model of human rheumatoid arthritis, <b>6d</b> demonstrated robust efficacy with an ED<sub>50</sub> of 0.05 mg/kg. In a mouse EAE study, a preclinical model of multiple sclerosis, treatment with <b>6d</b> resulted in significant reduction of disease with an ED<sub>50</sub> of 0.02 mg/kg. As a result, <b>6d</b> was selected as a development candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proton magnetic resonance (<sup>1</sup>H) spectra were recorded on either a Bruker Avance 400 or a JEOL Eclipse 500 spectrometer and are reported in ppm relative to the reference solvent of the sample in which they were run. HPLC and LCMS analyses were conducted using a Shimadzu SCL-10A liquid chromatograph and a SPD UV–vis detector at 220 or 254 nm with the MS detection performed on a Waters Micromass ZQ spectrometer. Preparative reverse-phase HPLC purifications were performed using the following conditions: YMC S5 ODS 20 mm × 100 mm column with a binary solvent system where solvent A is 10% methanol, 90% water, 0.1% trifluoroacetic acid and solvent B is 90% methanol, 10% water, and 0.1% trifluoroacetic acid; flow rate, 20 mL/min; linear gradient time,10 min; start % B = 20, final % B = 100. Fractions containing the product were concentrated in vacuo to remove the methanol and neutralized with aqueous sodium bicarbonate. The pH was adjusted to ∼4.5–5.0, and the aqueous layer was extracted with organic solvents. The organic layer was collected, dried over anhydrous sodium sulfate or magnesium sulfate, and concentrated under reduced pressure. All flash column chromatography was performed on EM Science silica gel 60 (particle size of 40–60 μm). All reagents were purchased from commercial sources and used without further purification unless otherwise noted. All reactions were performed under an inert atmosphere.</div><div class="NLM_p">HPLC analyses were performed using the following conditions. All final compounds had an HPLC purity of ≥95%.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Method A</h3><div class="NLM_p last">A linear gradient using 5% acetonitrile, 95% water, and 0.05% TFA (solvent A) and 95% acetonitrile, 5% water, and 0.05% TFA (solvent B), <i>t</i> = 0 min, 10% B, <i>t</i> = 15 min, 100% B (20 min) was employed on a SunFire C18 3.5u 4.6 mm × 150 mm column. Flow rate was 1.0 mL/min, and UV detection was set to 220/254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Method B</h3><div class="NLM_p last">A linear gradient using 5% acetonitrile, 95% water, and 0.05% TFA (solvent A) and 95% acetonitrile, 5% water, and 0.05% TFA (solvent B), <i>t</i> = 0 min, 10% B, <i>t</i> = 15 min, 100% B (20 min) was employed on a XBridge Ph 3.5u 4.6 mm × 150 mm column. Flow rate was 1.0 mL/min, and UV detection was set to 220/254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Method C</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B), <i>t</i> = 0 min, 0% B, <i>t</i> = 4 min, 100% B (5 min) was employed on a Chromolith SpeedROD 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Method D</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B), <i>t</i> = 0 min, 0% B, <i>t</i> = 4 min, 100% B (5 min) was employed on a YMC S5 CombiScreen 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min, and UV detection was set to 220 or 254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(4-(5-(5-Phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5a</b>)</h3><div class="NLM_p">To a homogeneous mixture of 5-phenylisoxazole-3-carboxylic acid (0.200 g, 1.057 mmol) and pyridine (0.103 mL, 1.269 mmol) in dichloromethane (10 mL) at room temperature was added 2,4,6-trifluoro-1,3,5-triazine (0.107 mL, 1.269 mmol). The reaction mixture was stirred at room temperature for 2 h. The heterogeneous reaction mixture was diluted with dichloromethane (25 mL), washed with an ice-cold solution of 0.5 N aqueous hydrochloric acid (2 × 10 mL), and the organic layer was collected. The aqueous layer was back-extracted with dichloromethane (25 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated to afford 5-phenylisoxazole-3-carbonyl fluoride (0.201 g, 1.05 mmol, 99%) as a white solid. HPLC <i>t</i><sub>R</sub> = 1.97 min, corresponding to the methyl ester (method C).</div><div class="NLM_p">A mixture of 5-phenylisoxazole-3-carbonyl fluoride (0.201 g, 1.05 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 0.321 g, 1.05 mmol), and Hunig’s base (0.239 mL, 1.37 mmol) in acetonitrile (2.0 mL) was stirred at room temperature over the weekend. The reaction mixture was heated at 50 °C for 4 h. The solidified reaction mixture was diluted with dichloromethane (30 mL) and washed with a saturated aqueous solution of sodium bicarbonate (10 mL). The aqueous layer was extracted with dichloromethane (30 mL), and the organic layers were combined and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded a tan solid which was triturated with methanol with sonication and filtered under reduced pressure to give <i>tert</i>-butyl 1-(4-(5-(5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.253 g, 0.552 mmol, 53%) as a tan solid (two crops which were combined). HPLC <i>t</i><sub>R</sub> = 2.69 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 459.2. Found: 459.3.</div><div class="NLM_p last">A mixture of <i>tert</i>-butyl 1-(4-(5-(5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.253 g, 0.552 mmol) and trifluoroacetic acid (3.02 mL, 39.2 mmol) was stirred at room temperature for 2.0 h. The trifluoroacetic acid was removed under reduced pressure, and the oily residue was suspended in water with sonication. To the resulting white suspension was added a 1 N aqueous solution of sodium hydroxide portionwise until the pH was ∼5 (∼2.9 mL of 1 N NaOH). The suspension was stirred overnight at room temperature. Several drops of 1 N aqueous hydrochloric acid were needed to readjust the pH to 5. The solid was collected by vacuum filtration, washed with water several times, and dried under reduced pressure for 5 h. The solid was then suspended in methanol with sonication and collected by vacuum filtration, washed with methanol, and dried under reduced pressure to give 1-(4-(5-(5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5a</b>, 0.150 g, 0.369 mmol, 67%) as a white solid. HPLC purity 99.6%; <i>t</i><sub>R</sub> = 6.80 min (method A); 99.1%; <i>t</i><sub>R</sub> = 8.05 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 417.2. Found: 403.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.06 (4H, d, <i>J</i> = 8.05 Hz), 7.92 (1H, s), 7.59–7.62 (3H, m), 7.53 (2H, s), 6.96–6.98 (1H, m), 3.66 (2H, s), 3.44 (2H, s), and 3.23–3.26 (3H, m).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-(4-(5-(4-Methyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5b</b>)</h3><div class="NLM_p">A mixture of prop-1-ynylbenzene (1.08 mL, 8.61 mmol) and dimethyl 2-nitromalonate (1.06 mL, 7.83 mmol) in mesitylene (10.0 mL, 72.0 mmol) in a sealed tube was heated in an oil bath at 150 °C overnight. The reaction mixture was concentrated under reduced pressure to give 1.52 g of the product mixture as an orange, viscous oil. Approximately 200 mg of the product mixture was purified by flash silica gel chromatography (2–5% ethyl acetate in hexane) to give methyl 4-methyl-5-phenylisoxazole-3-carboxylate (47 mg, 0.216 mmol, 28%) as a white solid. HPLC <i>t</i><sub>R</sub> = 2.42 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 218.1. Found: 218.1.</div><div class="NLM_p">A mixture of methyl 4-methyl-5-phenylisoxazole-3-carboxylate (0.047 g, 0.216 mmol) and lithium hydroxide hydrate (9.08 mg, 0.216 mmol) in methanol (1.0 mL) and water (0.5 mL) was stirred at room temperature overnight. The reaction mixture was concentrated to dryness to give 4-methyl-5-phenylisoxazole-3-carboxylic acid, lithium salt (0.045 g, 0.214 mmol, 99%) as a white solid. HPLC <i>t</i><sub>R</sub> = 2.08 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 204.1. Found: 204.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.25 (s, 3H), 7.44–7.49 (m, 1H), 7.53 (t, <i>J</i> = 7.70 Hz, 2H), and 7.69 (d, <i>J</i> = 7.70 Hz, 2H).</div><div class="NLM_p last">A mixture of 4-methyl-5-phenylisoxazole-3-carboxylic acid, lithium salt (0.021 g, 0.100 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 0.031 g, 0.100 mmol), <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (0.019 g, 0.100 mmol), and HOBt (0.015 g, 0.100 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1.0 mL) was shaken on a shaker block for 60 min. The homogeneous reaction mixture was then shaken at 50 °C overnight. The solvent was removed under reduced pressure. Trifluoroacetic acid (0.501 mL, 6.50 mmol) was added, and the homogeneous reaction mixture was shaken at room temperature for 30 min, concentrated under reduced pressure, and purified by reverse-phase preparative HPLC to give 1-(4-(5-(4-methyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid, TFA (<b>5b</b>, 0.026 g, 0.048 mmol, 48%) as a white solid. HPLC purity 97.0%; <i>t</i><sub>R</sub> = 7.16 min (method A); 97.0%; <i>t</i><sub>R</sub> = 8.35 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 417.2. Found: 417.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.60 (s, 3H), 3.58–3.67 (m, 1H), 4.19 (br s, 4H), 4.47 (br s, 2H), 7.61–7.68 (m, 3H), 7.71 (d, <i>J</i> = 7.70 Hz, 2H), 7.87 (d, <i>J</i> = 7.15 Hz, 2H), 8.21 (d, <i>J</i> = 8.25 Hz, 2H), 10.51 (br s, 1H), and 13.13 (br s, 1H).</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-(4-(5-(4-Ethyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5c</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">A solution of but-1-ynylbenzene (404 mg, 3.11 mmol) and dimethyl nitromalonate (0.381 mL, 2.82 mmol) in mesitylene (5 mL) was heated to 150 °C overnight. The reaction mixture was concentrated, and the residue purified by flash silica gel chromatography (hexane/ethyl acetate, 10:1) to afford methyl 4-ethyl-5-phenylisoxazole-3-carboxylate (194 mg, 0.791 mmol, 28%). HPLC <i>t</i><sub>R</sub> = 3.25 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>13</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 232.1. Found: 232<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 4-ethyl-5-phenylisoxazole-3-carboxylate (194 mg, 0.839 mmol) and 1 N aqueous sodium hydroxide (1.26 mL, 1.26 mmol) in methanol (3 mL) was heated to 100 °C for 10 min via microwave. The reaction mixture was acidified with acetic acid until the pH was about 4. The mixture was concentrated, and the residue was suspended in water (2 mL) and stirred for 20 min. The solid was collected by vacuum filtration and dried to give 4-ethyl-5-phenylisoxazole-3-carboxylic acid (148 mg, 0.735 mmol, 87%). HPLC <i>t</i><sub>R</sub> = 2.93 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 218.1. Found: 218<sup>+</sup>.</div><div class="NLM_p">To a solution of 4-ethyl-5-phenylisoxazole-3-carboxylic acid (22 mg, 0.101 mmol), HOBt (27.9 mg, 0.182 mmol), and diisopropylethylamine (0.071 mL, 0.405 mmol) in acetonitrile (1 mL) was added <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (45.6 mg, 0.238 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 30.9 mg, 0.101 mmol). The reaction mixture was stirred at 80 °C for 2 h and then concentrated. The residue was diluted with ethyl acetate (3 mL), washed a saturated aqueous solution of sodium bicarbonate (1 mL), washed with water (1 mL), washed with brine (1 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by flash silica gel chromatography (hexanes/ethyl acetate, 1:1) provided <i>tert</i>-butyl 1-(4-(5-(4-ethyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4-ethyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate in dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL) was stirred at room temperature for 30 min. Concentration followed by drying under reduced pressure afforded 1-(4-(5-(4-ethyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5c</b>, 32 mg, 0.074 mmol, 73% over two steps). HPLC purity 99.1%; <i>t</i><sub>R</sub> = 7.46 min (method A); 99.5%; <i>t</i><sub>R</sub> = 8.83 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 431.2. Found: 431<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 1.39 (t, <i>J</i> = 7.40 Hz, 3H), 3.07–3.15 (m, 2H), 3.71 (qd, <i>J</i> = 8.32, 8.16 Hz, 1H), 4.35–4.41 (m, 4H), 4.53 (s, 2 H), 7.56–7.65 (m, 3H), 7.70 (d, <i>J</i> = 8.28 Hz, 2H), 7.81–7.85 (m, 2H), and 8.30 (d, <i>J</i> = 8.53 Hz, 2H).</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(4-(5-(5-Phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5d</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">A solution of pent-1-ynylbenzene (0.221 mL, 1.39 mmol) and dimethyl nitromalonate (0.374 mL, 2.77 mmol) in mesitylene (3 mL) was heated to 150 °C for 16 h. The reaction mixture was concentrated, and the residue was purified by flash silica gel chromatography (hexanes/ethyl acetate, 10:1) to yield methyl 5-phenyl-4-propylisoxazole-3-carboxylate (138 mg, 0.564 mmol, 41%).</div><div class="NLM_p">A solution of methyl 5-phenyl-4-propylisoxazole-3-carboxylate (138 mg, 0.564 mmol) and 1 N aqueous sodium hydroxide (0.846 mL, 0.846 mmol) in methanol (2.5 mL) was heated to 100 °C for 10 min under microwave conditions. The reaction mixture was concentrated, and the crude product was suspended in water (2 mL), acidified with acetic acid until the pH was ∼4, and stirred for 20 min. The solid was collected by vacuum filtration to give 5-phenyl-4-propylisoxazole-3-carboxylic acid (56 mg, 0.260 mmol, 46%). HPLC <i>t</i><sub>R</sub> = 2.88 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>13</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 232.1. Found: 232<sup>+</sup>.</div><div class="NLM_p">To a solution of 5-phenyl-4-propylisoxazole-3-carboxylic acid (23 mg, 0.099 mmol), HOBt (27.4 mg, 0.179 mmol), and diisopropylethylamine (0.069 mL, 0.398 mmol) in acetonitrile (1 mL) was added <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (44.8 mg, 0.234 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 30.4 mg, 0.099 mmol). The reaction mixture was stirred at 80 °C for 2 h. The reaction mixture was concentrated to yield a crude product which was diluted with ethyl acetate (3 mL), washed with a saturated aqueous solution of sodium bircarbonate (1 mL), washed with water (1 mL), washed with brine (1 mL), and dried over anhydrous sodium sulfate. Concentration under reduced pressure provided <i>tert</i>-butyl 1-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylatein dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL) was stirred at room temperature for 30 min. Concentration followed by purification by preparative HPLC afforded 1-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5d</b>, 33 mg, 0.074 mmol, 75% over two steps). HPLC purity 95.7%; <i>t</i><sub>R</sub> = 7.72 min (method A); 95.3%; <i>t</i><sub>R</sub> = 8.91 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 445.2. Found: 445<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 1.05 (t, 3H), 1.72–1.84 (m, 2H), 3.03–3.11 (m, 2H), 3.71 (t, <i>J</i> = 8.28 Hz, 1H), 4.34–4.42 (m, 4H), 4.53 (s, 2H), 7.56–7.65 (m, 3H), 7.70 (d, <i>J</i> = 8.28 Hz, 2H), 7.80–7.85 (m, 2H), and 8.30 (d, <i>J</i> = 8.28 Hz, 2H).</div></div><div id="secy" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-(4-(5-(4-Butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5e</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">A solution of hex-1-ynylbenzene (0.274 mL, 1.56 mmol), dimethyl 2-nitromalonate (0.421 mL, 3.12 mmol), 1-butyl-3-methylimidazolium hexafluorophosphate (0.032 mL, 0.156 mmol) in toluene (6 mL) was subjected to microwave conditions at 170 °C for 150 min. The reaction mixture was concentrated under reduced pressure, and the residue was purified by flash silica gel chromatography using 5% ethyl acetate in hexane to give methyl 4-butyl-5-phenylisoxazole-3-carboxylate (0.142 g, 0.531 mmol, 34%) as a clear, colorless oil. HPLC purity 97%; <i>t</i><sub>R</sub> = 3.11 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 260.1. Found: 260<sup>+</sup>.</div><div class="NLM_p">A mixture of methyl 4-butyl-5-phenylisoxazole-3-carboxylate (0.142 g, 0.548 mmol) and lithium hydroxide hydrate (0.023 g, 0.548 mmol) in methanol (3.0 mL) and water (1.5 mL) was stirred at room temperature overnight. The reaction mixture was concentrated to dryness to give 4-butyl-5-phenylisoxazole-3-carboxylic acid, lithium salt (0.134 g, 0.531 mmol, 97%) as a white solid. HPLC <i>t</i><sub>R</sub> = 2.82 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>15</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 246.1. Found: 246.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.84 (t, <i>J</i> = 7.42 Hz, 3H), 1.23–1.32 (m, 2H), 1.44–1.53 (m, 2H), 2.66–2.72 (m, 2H), 7.44–7.49 (m, 1H), 7.53 (t, <i>J</i> = 7.42 Hz, 2H), and 7.64 (d, <i>J</i> = 7.15 Hz, 2H).</div><div class="NLM_p">A mixture of 4-butyl-5-phenylisoxazole-3-carboxylic acid, lithium salt (0.132 g, 0.523 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 0.160 g, 0.523 mmol), <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (0.100 g, 0.523 mmol), and HOBt (0.080 g, 0.523 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (4 mL) was stirred at room temperature for 60 min and then heated at 60 °C overnight. The solvent was removed under reduced pressure, and the residue was purified by flash silica gel chromatography, eluting with 1% methanol in dichloromethane to give <i>tert</i>-butyl 1-(4-(5-(4-butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.156 g, 0.303 mmol, 58%) as a pale yellow solid. HPLC purity >99%; <i>t</i><sub>R</sub> = 3.40 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 515.3. Found: 515.0<sup>+</sup>.</div><div class="NLM_p last">The <i>tert</i>-butyl 1-(4-(5-(4-butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate intermediate (0.156 g, 0.303 mmol) was stirred in trifluoroacetic acid (4.03 mL, 52.3 mmol) for 30 min and concentrated under reduced pressure to give the desired product as a yellow, viscous oil. The oil was dissolved in dichloromethane and washed with a saturated aqueous solution of sodium bicarbonate. The organic layer, which contained the product (presumably as the sodium salt), was concentrated under reduced pressure. The white, solid residue was dissolved in water (pH ≈ 9), and the pH was adjusted to ∼4.5 with concentrated hydrochloric acid. The resulting white precipitate was collected by vacuum filtration and dried. The solid was suspended in methanol with sonication, and the solid was collected by vacuum filtration, washed with methanol, and dried under reduced pressure to give 1-(4-(5-(4-butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5e</b>, 0.102 g, 0.222 mmol, 74%) as a white solid. 99.0%; <i>t</i><sub>R</sub> = 8.75 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 459.2. Found: 459.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.91 (t, <i>J</i> = 7.42 Hz, 3H), 1.37–1.46 (m, 2H), 1.62–1.70 (m, 2H), 3.00–3.06 (m, 2H), 3.23 (br s, 3H), 3.43 (br s, 2H), 3.65 (s, 2H), 7.52 (d, <i>J</i> = 8.25 Hz, 2H), 7.59–7.68 (m, 3H), 7.83 (d, <i>J</i> = 7.15 Hz, 2H), 8.06 (d, <i>J</i> = 8.25 Hz, 2H), and 12.27 (s, 1H).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-(5-(4-Isobutyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5f</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">A solution of (4-methylpent-1-ynyl)benzene (0.247 g, 1.56 mmol), dimethyl 2-nitromalonate (0.421 mL, 3.12 mmol), 1-butyl-3-methylimidazolium hexafluorophosphate (0.032 mL, 0.156 mmol) in toluene (5 mL) was subjected to the microwave conditions at 170 °C for 500 min. The toluene was decanted off leaving a dark gum which was triturated several times with ethyl acetate. The combined organic layers were concentrated under reduced pressure. The residue was purified by flash silica gel chromatography using 5% ethyl acetate in hexane to give methyl 4-isobutyl-5-phenylisoxazole-3-carboxylate (0.122 g, 0.470 mmol, 30% yield) as a clear, colorless oil. HPLC <i>t</i><sub>R</sub> = 2.96 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 260.1. Found: 259.9. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 0.88 (s, 3H), 0.89 (s, 3H), 1.89 (dt, <i>J</i> = 13.75, 6.87 Hz, 1H), 2.80 (d, <i>J</i> = 7.15 Hz, 2 H), 4.00 (s, 3H), 7.45–7.53 (m, 3H), 7.73 (d, <i>J</i> = 6.60 Hz, 2H).</div><div class="NLM_p">A mixture of methyl 4-isobutyl-5-phenylisoxazole-3-carboxylate (0.122 g, 0.470 mmol) and lithium hydroxide hydrate (0.020 g, 0.470 mmol) in methanol (2.5 mL) and water (1.25 mL) was stirred at room temperature overnight. The reaction mixture was concentrated to dryness to give 4-isobutyl-5-phenylisoxazole-3-carboxylic acid, lithium salt (0.119 g, 0.472 mmol, 100% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 2.68 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>15</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 245.1. Found: 245.8.</div><div class="NLM_p">A mixture of 4-isobutyl-5-phenylisoxazole-3-carboxylic acid, lithium salt (0.119 g, 0.472 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 0.144 g, 0.472 mmol), <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (0.090 g, 0.472 mmol), and HOBt (0.072 g, 0.472 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3.6 mL) was stirred at room temperature for 15 min and then heated at 60 °C overnight. The reaction mixture was diluted with ethyl acetate, washed with a saturated aqueous solution of sodium bicarbonate (2×), washed with a 10% aqueous solution of lithium chloride (2×), and dried over anhydrous sodium sulfate. The product mixture was concentrated under reduced pressure. The residue was purified by flash silica gel chromatography using a 1% mixture of methanol in dichloromethane to give <i>tert</i>-butyl 1-(4-(5-(4-isobutyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.179 g, 0.348 mmol, 74%) as a pale yellow solid. HPLC purity 98%; <i>t</i><sub>R</sub> = 3.27 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 515.3. Found: 515.4.</div><div class="NLM_p last">The <i>tert</i>-butyl 1-(4-(5-(4-isobutyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate intermediate was stirred in trifluoroacetic acid (3.64 mL, 47.2 mmol) for 30 min and concentrated under reduced pressure to give the desired product as a pale yellow solid. The solid was dispersed in water with sonication. The pH was adjusted to ∼4, and the resulting solid was collected by vacuum filtration, washed with water (3×), and dried. The white solid was triturated with methanol with sonication and filtered to give 1-(4-(5-(4-isobutyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5f</b>, 0.074 g, 0.161 mmol, 34% yield) as a white solid. HPLC purity 98.4%; <i>t</i><sub>R</sub> = 8.12 min (method A); 97.4%; <i>t</i><sub>R</sub> = 8.60 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 459.2. Found: 459.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.87 (d, <i>J</i> = 6.60 Hz, 6H), 1.93 (ddd, <i>J</i> = 13.61, 6.74, 6.60 Hz, 1H), 2.99 (d, <i>J</i> = 7.15 Hz, 2H), 3.24 (br s, 3H), 3.43 (s, 2 H), 3.66 (s, 2H), 7.53 (d, <i>J</i> = 7.70 Hz, 2H), 7.58–7.67 (m, 3H), 7.87 (d, <i>J</i> = 6.60 Hz, 2H), and 8.06 (d, 2H).</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(4-(5-(4-Isopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5g</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a degassed solution of iodobenzene (0.549 mL, 4.90 mmol), bis(triphenylphosphine)palladium(II) chloride (0.206 g, 0.294 mmol), copper(I) iodide (0.047 g, 0.245 mmol), and diisopropylamine (2.79 mL, 19.6 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (20 mL) was added 3-methylbut-1-yne (0.501 g, 7.35 mmol). The reaction mixture was heated to 75 °C for 1 h. The reaction mixture was then diluted with ethyl acetate (150 mL), washed with a 10% aqueous solution of lithium chloride (2 × 100 mL), washed with a 2 M aqueous solution of ammonium hydroxide (100 mL), washed with brine, (100 mL), and dried over anhydrous sodium sulfate. Concentration under reduce pressure followed by purification by silica gel chromatography with hexane/dichloromethane (10/1) afforded (3-methylbut-1-ynyl)benzene (225 mg). HPLC <i>t</i><sub>R</sub> = 3.58 min (method D).</div><div class="NLM_p">A solution of (3-methylbut-1-ynyl)benzene (225 mg, 1.56 mmol), dimethyl nitromalonate (0.527 mL, 3.90 mmol), and 1-butyl-3-methylimidazolium hexafluorophosphate (0.032 mL, 0.156 mmol) in toluene (6 mL) was heated to 170 °C for 160 min in a sealed tube. The reaction mixture was concentrated and purified by silica gel chromatography (hexanes/ethyl acetate, 10:1) to afford methyl 4-isopropyl-5-phenylisoxazole-3-carboxylate (136 mg, 0.554 mmol, 36%). HPLC <i>t</i><sub>R</sub> = 3.37 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>15</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 246.1. Found: 246<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 4-isopropyl-5-phenylisoxazole-3-carboxylate (25 mg, 0.108 mmol) and 1 N aqueous sodium hydroxide (150 μL, 0.150 mmol) in methanol (1 mL) was heated at 100 °C for 10 min under microwave conditions. The reaction mixture was concentrated to yield 4-isopropyl-5-phenylisoxazole-3-carboxylic acid (23 mg, 0.099 mmol, >99%). HPLC <i>t</i><sub>R</sub> = 3.01 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>13</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 232.1. Found: 232<sup>+</sup>.</div><div class="NLM_p">To a solution of 4-isopropyl-5-phenylisoxazole-3-carboxylic acid (23 mg, 0.099 mmol), HOBt (27.7 mg, 0.181 mmol), and diisopropylamine (0.070 mL, 0.401 mmol) in acetonitrile (1 mL) was added <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (45.2 mg, 0.236 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 31 mg, 0.099 mmol). The reaction mixture was stirred at 80 °C for 5 h. The reaction mixture was then concentrated, and the residue was diluted with ethyl acetate (3 mL), washed with a saturated aqueous solution of sodium bicarbonate (1 mL), washed with water (1 mL), washed with brine (1 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by preparative HPLC afforded <i>tert</i>-butyl 1-(4-(5-(4-isopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)-azetidine-3-carboxylate.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4-isopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate in dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL) was stirred at room temperature for 30 min. Concentration under reduce pressure afforded 1-(4-(5-(4-isopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5g</b>, 35.1 mg, 0.079 mmol, 80% over two steps). HPLC purity 97.2%; <i>t</i><sub>R</sub> = 7.88 min (method A); 98%; <i>t</i><sub>R</sub> = 8.40 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 445.2. Found: 445<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, MeOD) δ ppm 1.42 (s, 3H), 1.44 (s, 3H), 3.49–3.55 (m, 1H), 3.71 (s, 1H), 4.38 (d, <i>J</i> = 7.15 Hz, 4H), 4.53 (s, 2H), 7.59–7.63 (m, 3H), 7.66–7.72 (m, 4H), and 8.30 (d, <i>J</i> = 8.25 Hz, 2H).</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-(5-(4-Cyclopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5h</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a degassed solution of of iodobenzene (0.549 mL, 4.90 mmol), dichlorobis(triphenylphosphine)palladium(II) (0.206 g, 0.294 mmol), copper(I) iodide (0.047 g, 0.245 mmol), and diiopropylamine (3.49 mL, 24.5 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (20 mL) was added cyclopropylacetylene (0.622 mL, 7.35 mmol). The reaction mixture was heated at 75 °C for 45 min. The reaction mixture was then diluted with ethyl acetate (150 mL), washed with a 10% aqueous solution of lithium chloride (2 × 100 mL), washed with a 2 M aqueous solution of ammonium hydroxide (100 mL), washed with brine (100 mL), and dried over anhydrous sodium sulfate. Concentration afforded the crude product which was purified by flash silica gel chromatography with hexanes and dichloromethane (10/1) to give (cyclopropylethynyl)benzene (691 mg). HPLC <i>t</i><sub>R</sub> = 3.40 min (method D).</div><div class="NLM_p">A solution of (cyclopropylethynyl)benzene (300 mg, 2.11 mmol) and dimethyl nitromalonate (0.854 mL, 6.33 mmol) in mesitylene (4 mL) was heated to 150 °C for 16 h. The reaction mixture was concentrated to yield the crude product which was purified by silica gel chromatography (hexanes/ethyl acetate, 10:1) to give methyl 4-cyclopropyl-5-phenylisoxazole-3-carboxylate. The compound was repurified by reverse phase preparative HPLC to provide methyl 4-cyclopropyl-5-phenylisoxazole-3-carboxylate (170 mg, 0.699 mmol, 33%). HPLC <i>t</i><sub>R</sub> = 2.77 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>13</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 244.1. Found: 244<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 4-cyclopropyl-5-phenylisoxazole-3-carboxylate (170 mg, 0.699 mmol) and 1 N aqueous sodium hydroxide (1 mL, 1.05 mmol) in methanol (6 mL) was heated to 80 °C in a sealed tube for 1 h. The reaction mixture was acidified with acetic acid until the pH was ∼4. The mixture was concentrated, and the residue was purified by preparative HPLC to give 4-cyclopropyl-5-phenylisoxazole-3-carboxylic acid (124 mg, 0.541 mmol, 77%). HPLC <i>t</i><sub>R</sub> = 2.81 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 230.1. Found: 230<sup>+</sup>.</div><div class="NLM_p">To a solution of 4-cyclopropyl-5-phenylisoxazole-3-carboxylic acid (22 mg, 0.096 mmol), HOBt (26.5 mg, 0.173 mmol), and diisopropylethylamine (0.067 mL, 0.384 mmol) in acetonitrile (1 mL) were added <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (43.2 mg, 0.226 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 29.3 mg, 0.096 mmol). The reaction mixture was stirred at 80 °C for 2 h. The reaction mixture was concentrated, and the residue was purified by reverse phase preparative HPLC to give <i>tert</i>-butyl 1-(4-(5-(4-cyclopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4-cyclopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate in dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL) was stirred at room temperature for 30 min. Concentration under reduced pressure afforded 1-(4-(5-(4-cyclopropyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5h</b>, 26.2 mg, 0.059 mmol, 62% over two steps). HPLC purity 97%; <i>t</i><sub>R</sub> = 3.06 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 443.2. Found: 443<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 0.41–0.47 (m, 2H), 1.09–1.16 (m, 2H), 2.12 (tt, <i>J</i> = 8.31, 5.36 Hz, 1H), 3.66–3.77 (m, 1H), 4.35–4.41 (m, 4H), 4.53 (s, 2H), 7.56–7.64 (m, 3H), 7.70 (d, <i>J</i> = 8.53 Hz, 2H), 7.95–8.00 (m, 2H), and 8.32 (d, <i>J</i> = 8.28 Hz, 2H).</div></div><div id="sec5_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(4-(5-(4-<i>tert</i>-Butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)-azetidine-3-carboxylic Acid (<b>5i</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a degassed solution of iodobenzene (0.549 mL, 4.90 mmol), dichlorobis(triphenylphosphine)palladium(II) (0.206 g, 0.294 mmol), copper(I) iodide (0.047 g, 0.245 mmol), and diisopropylamine (3.49 mL, 24.5 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (20 mL) was added 3,3-dimethylbut-1-yne (0.896 mL, 7.35 mmol). The reaction mixture was heated to 75 °C for 45 min. The reaction mixture was then diluted with ethyl acetate (150 mL), washed with 10% aqueous solution of lithium chloride (2 × 100 mL), washed with a 2 M aqueous solution of ammonium hydroxide, washed with brine (100 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by flash silica gel chromatography (hexanes/dichloromethane, 10:1) afforded (3,3-dimethylbut-1-ynyl)benzene (740 mg). HPLC <i>t</i><sub>R</sub> = 3.78 min (method D).</div><div class="NLM_p">A solution of (3,3-dimethylbut-1-ynyl)benzene (400 mg, 2.53 mmol) and dimethyl nitromalonate (0.853 mL, 6.32 mmol) in mesitylene (5 mL) was heated at 150 °C for 48 h. The reaction mixture was concentrated, and the residue was purified by silica gel chromatography (hexanes/ethyl acetate, 10:1) to yield methyl 4-<i>tert</i>-butyl-5-phenylisoxazole-3-carboxylate (101 mg, 0.389 mmol, 15%). HPLC <i>t</i><sub>R</sub> = 3.39 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 260.1. Found: 260<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 4-<i>tert</i>-butyl-5-phenylisoxazole-3-carboxylate (26 mg, 0.100 mmol) and 1 N aqueous sodium hydroxide (150 μL, 0.150 mmol) in methanol (1 mL) was heated at 100 °C for 10 min under microwave conditions. The reaction mixture was concentrated to give 4-<i>tert</i>-butyl-5-phenylisoxazole-3-carboxylic acid, sodium salt (25 mg, 0.100 mmol, >99%). HPLC <i>t</i><sub>R</sub> = 2.97 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>15</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 246.1. Found: 246<sup>+</sup>.</div><div class="NLM_p">To a solution of 4-<i>tert</i>-butyl-5-phenylisoxazole-3-carboxylic acid (25 mg, 0.102 mmol), HOBt (28.1 mg, 0.183 mmol), and diisopropylethylamine (0.071 mL, 0.408 mmol) in acetonitrile (1 mL) was added <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (45.9 mg, 0.240 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 31.1 mg, 0.102 mmol). The reaction mixture was stirred at 80 °C for 5 h. The reaction mixture was concentrated, and the residue was diluted with ethyl acetate (3 mL), washed with a saturated aqueous solution of sodium bicarbonate (1 mL), washed with water (1 mL), washed with brine (1 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by reverse phase preparative HPLC afforded <i>tert</i>-butyl 1-(4-(5-(4-tert-butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4-<i>tert</i>-butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate in dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL) was stirred at room temperature for 30 min. Concentration under reduced pressure afforded 1-(4-(5-(4-<i>tert</i>-butyl-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid, 2,2,2-trifluoroacetic acid salt (<b>5i</b>, 31 mg, 0.068 mmol, 67% over two steps). HPLC purity 97.0%; <i>t</i><sub>R</sub> = 7.95 min (method A); 97.9%; <i>t</i><sub>R</sub> = 8.53 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 459.2. Found: 459<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 1.27 (s, 9H), 3.68–3.76 (m, 1H), 4.39 (d, <i>J</i> = 7.70 Hz, 4H), 4.54 (s, 2H), 7.53–7.57 (m, 4H), 7.57–7.63 (m, 1H), 7.70 (d, <i>J</i> = 8.25 Hz, 2H), and 8.29 (d, <i>J</i> = 8.25 Hz, 2H).</div></div><div id="sec5_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(4-(5-(4,5-Diphenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5j</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">A mixture of 1,2-diphenylethyne (1.53 g, 8.6 mmol) and dimethyl 2-nitromalonate (1.05 mL, 7.83 mmol) in mesitylene (11 mL) was heated to 150 °C for 18 h. Concentration under reduced pressure followed by purification by flash silica gel chromatography with a mixutre of ethyl acetate and hexane (0–10%) afforded methyl 4,5-diphenylisoxazole-3-carboxylate (307 mg, 1.1 mmol, 14%) as a light yellow solid. HPLC <i>t</i><sub>R</sub> = 1.85 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>13</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 280.1. Found: 280.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.87 (s, 3 H), 7.29–7.40 (m, 5 H), 7.43 (m, 3H), 7.47–7.53 (m, 2 H).</div><div class="NLM_p">To a thick suspension of methyl 4,5-diphenylisoxazole-3-carboxylate (306 mg, 1.09 mmol) in methanol (8 mL), tetrahydrofuran (2 mL), and water (2 mL) at room temperature was added lithium hydroxide, monohydrate (46.0 mg, 1.09 mmol), and the reaction mixture was allowed to stir at room temperature for 1 h. During this time, the reaction became homogeneous. The solvents were removed under reduced pressure, and the remaining aqueous mixture was acidified to pH ≈ 1 with 1 N aqueous hydrochloric acid. The mixture was then extracted with ethyl acetate (30 mL), and the organic layer was washed with brine (20 mL), dried over anhydrous magnesium sulfate, and concentrated to afford 4,5-diphenylisoxazole-3-carboxylic acid (290 mg, 1.09 mmol, 100% yield) as a yellow solid. HPLC <i>t</i><sub>R</sub> = 1.72 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 266.1. Found: 266.1.</div><div class="NLM_p">A mixture of 4,5-diphenylisoxazole-3-carboxylic acid (26.5 mg, 0.1 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate, <b>10</b> (30.5 mg, 0.100 mmol), HOBt (16.85 mg, 0.110 mmol), and <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (21.09 mg, 0.110 mmol) in dimethylformamide (1 mL) was stirred at room temperature for 18 h. The reaction mixture was heated at 60 °C for 2 h and 70 °C for 2 h. After cooling to room temperature overnight, the reaction mixture was partitioned between ethyl acetate (30 mL) and washed with a saturated sodium bicarbonate solution (30 mL). The organic layer was washed with water (2 × 30 mL), washed with brine (20 mL), and dried over anhydrous magnesium sulfate. The organic layer was concentrated to give a yellow solid which was purified by flash silica gel chromatography, eluting with a 0–60% mixture of ethyl acetate and hexane to afford <i>tert</i>-butyl 1-(4-(5-(4,5-diphenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (37 mg, 0.069 mmol, 69% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 1.90 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 535.2. Found: 535.2.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4,5-diphenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (37 mg, 0.069 mmol) in tetrahydrofuran (1 mL) was allowed to stand at room temperature for 1 h. The volatiles were removed under reduced pressure, and the residue was subjected to reverse phase preparative HPLC to afford 1-(4-(5-(4,5-diphenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid, trifluoroacetic acid salt (<b>5j</b>, 1 mg, 0.052 mmol, 76%) as a white solid. HPLC purity 95.9%; <i>t</i><sub>R</sub> = 9.17 min (method A); 95.0%; <i>t</i><sub>R</sub> = 9.94 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 479.2. Found: 479.1. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 3.70 (m, 1 H), 4.31–4.38 (m, 4 H), 4.48 (s, 2 H), 7.37–7.43 (m, 2 H), 7.43–7.53 (m, 6 H), 7.56–7.65 (m, 4 H), 8.09 (d, <i>J</i> = 8.3 Hz, 2 H).</div></div><div id="sec5_4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(4-(5-(5-Phenyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5k</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a mixture of (<i>Z</i>)-ethyl 2-chloro-2-(hydroxyimino)acetate (3.03 g, 20 mmol) and ethynylbenzene (4.39 mL, 40 mmol) in ether (80 mL) at room temperature was added a solution of triethylamine (5.58 mL, 40.0 mmol) in ether (20 mL) dropwise over 60 min. The reaction mixture was stirred for 2 h at room temperature. The reaction mixture was filtered, and the filtrate was concentrated to a yellow oil which was purified by flash silica gel chromatography using a mixture of ethyl acetate in hexane (0–12%) to afford ethyl 5-phenylisoxazole-3-carboxylate (<b>14</b>, 3.06 g, 14.1 mmol, 70%) as a white solid. HPLC <i>t</i><sub>R</sub> = 2.99 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 218.1. Found: 218.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.45 (t, <i>J</i> = 7.3 Hz, 3H), 4.48 (q, <i>J</i> = 7.3, 2H), 6.93 (s, 1H), 7.45–7.53 (m, 3H), and 7.77–7.85 (m, 2H).</div><div class="NLM_p">A mixture of ethyl 5-phenylisoxazole-3-carboxylate (<b>14</b>, 3.05 g, 14.0 mmol) and <i>N</i>-iodosuccinimide (3.79 g, 16.9 mmol) in trifluoroacetic acid (78 mL) was stirred at room temperature for 3.5 h. The volatiles were removed under reduced pressure, and the residue was partitioned between ethyl acetate (150 mL) and water (150 mL). The organic layer was washed with a 1 N aqueous solution of sodium hydroxide (150 mL), washed with a 3% aqueous solution of sodium bisulfite (2 × 150 mL), washed with brine (150 mL), and dried over anhydrous magnesium sulfate. Concentration under reduced pressure afforded ethyl 4-iodo-5-phenylisoxazole-3-carboxylate (<b>15</b>, 4.69 g, 13.7 mmol, 97%) as a light yellow oil. HPLC <i>t</i><sub>R</sub> = 3.36 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>10</sub>INO<sub>3</sub> [M + H]<sup>+</sup> 344.0. Found: 344.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.47 (t, <i>J</i> = 7.1 Hz, 3H), 4.50 (q, <i>J</i> = 7.0 Hz, 2H), 7.52–7.56 (m, 3H), and 8.05 (m, 2H).</div><div class="NLM_p">To a solution of ethyl 4-iodo-5-phenylisoxazole-3-carboxylate (4.62 g, 13.5 mmol) and copper(I) iodide (0.513 g, 2.69 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (59.8 mL) and HMPA (7.48 mL) at room temperature was added methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (6.86 mL, 53.9 mmol) at once. The reaction mixture was immediately immersed in an oil bath at 75–80 °C. Stirring was continued at this temperature for 3.5 h. After cooling to room temperature, the reaction mixture was cooled in an ice bath. A saturated aqueous solution of ammonium chloride (∼50 mL) was added <i>slowly</i> to quench the reaction. The mixture was partitioned between ethyl ether (400 mL) and a saturated aqueous solution of ammonium chloride (400 mL). The organic layer was washed with a saturated aqueous solution of ammonium chloride (200 mL), washed with water (2 × 200 mL), washed with brine (50 mL), and dried over anhydrous magnesium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using a mixture of ethyl acetate in hexane (0–10%) afforded ethyl 5-phenyl-4-(trifluoromethyl)isoxazole-3-carboxylate (<b>16</b>, 3.6 g, 12.6 mmol, 94% yield) as a colorless oil. HPLC <i>t</i><sub>R</sub> = 3.44 min (method D); LCMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>10</sub>INO<sub>3</sub> [M + H]<sup>+</sup> 286.1. Found: 286.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.45 (t, <i>J</i> = 7.2 Hz, 3H), 4.51 (q, <i>J</i> = 7.3 Hz, 2H), 7.52–7.62 (m, 3H), and 7.69 (d, <i>J</i> = 7.5 Hz, 2H).</div><div class="NLM_p">To a solution of ethyl 5-phenyl-4-(trifluoromethyl)isoxazole-3-carboxylate (<b>16</b>, 3.6 g, 12.6 mmol) in methanol (100 mL) and water (20 mL) at room temperature was added lithium hydroxide, monohydrate (0.583 g, 13.9 mmol). The reaction mixture was stirred at room temperature for 30 min. The methanol was removed under reduce pressure, and the residue was diluted with water (∼100 mL). Ethyl ether (200 mL) was added, and the pH of the aqueous layer was adjusted to <1 with a 1 N aqueous solution of hydrochloric acid. The mixture was transferred to a separatory funnel, and after agitation, the layers were separated. The organic layer was washed with brine (100 mL), dried over anhydrous magnesium sulfate, and concentrated to afford 5-phenyl-4-(trifluoromethyl)isoxazole-3-carboxylic acid (<b>17</b>, 3.12 g, 12.13 mmol, 96% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 2.58 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>6</sub>F<sub>3</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 258.0. Found: 258.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.53–7.64 (m, 3H), and 7.70 (d, <i>J</i> = 7.5 Hz, 2H).</div><div class="NLM_p">To a mixture of 5-phenyl-4-(trifluoromethyl)isoxazole-3-carboxylic acid (<b>17</b>, 197 mg, 0.766 mmol) and pyridine (0.074 mL, 0.919 mmol) in dichloromethane (5 mL) at room temperature was added cyanuric fluoride (0.078 mL, 0.919 mmol). The reaction mixture was stirred at room temperature for 18 h. The mixture was diluted with dichloromethane (40 mL) and washed with an ice-cold 0.5 N aqueous solution of hydrochloric acid (20 mL). The aqueous layer was extracted with dichloromethane (20 mL), and the combined organic layers were washed with ice-cold water (20 mL) and dried over anhydrous magnesium sulfate. Concentration under reduced pressure afforded 5-phenyl-4-(trifluoromethyl)isoxazole-3-carbonyl fluoride (199 mg, 0.768 mmol, 100%) as a pale yellow oil. HPLC <i>t</i><sub>R</sub> = 2.53 min, corresponding to the methyl ester (method D).</div><div class="NLM_p">To a mixture of 5-phenyl-4-(trifluoromethyl)isoxazole-3-carbonyl fluoride (100 mg, 0.386 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 118 mg, 0.386 mmol) in acetonitrile (2 mL) at room temperature was added Hunig’s base (0.081 mL, 0.463 mmol). The reaction mixture was stirred at room temperature for 3 days. The volatiles were removed under reduced pressure, and the residue was partitioned between dichloromethane (30 mL) and a saturated aqueous solution of sodium bicarbonate (30 mL). The aqueous layer was extracted with dichloromethane (2 × 20 mL), and the combined organic layers were dried over anhydrous magnesium sulfate and concentrated to afford a light yellow oil. The compound was purified by flash silica gel chromatography using a mixture of ethyl acetate/hexane (0–70%) to give <i>tert</i>-butyl 1-(4-(5-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (175 mg, 0.332 mmol, 86% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 3.34 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 527.2. Found: 527.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.47 (s, 9H), 3.26–3.33 (m, 3H), 3.54–3.59 (m, 2H), 3.70 (s, 2H), 7.46 (d, <i>J</i> = 8.28 Hz, 2H), 7.56–7.62 (m, 2H), 7.63–7.68 (m, 1H), 7.78 (d, <i>J</i> = 7.28 Hz, 2H), and 8.16 (d, 2H).</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (293 mg, 0.556 mmol) in trifluoroacetic acid (4 mL) was allowed to stand at room temperature for 1.5 h. The volatiles were removed under reduced pressure, and the residue was suspended in water (5 mL). The pH was adjusted to ∼4 with a 1 N aqueous solution of sodium hydroxide with stirring. The resulting thick suspension was stirred at room temperature for 1 h. The precipitate was collected by vacuum filtration and dried well under reduced pressure. The compound was suspended in methanol and stirred at room temperature for 18 h. The product was collected by vacuum filtration, washed with methanol, and dried well under reduced pressure to afford 1-(4-(5-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5k</b>, 194 mg, 0.412 mmol, 74%) as a white solid. HPLC purity 99.7%; <i>t</i><sub>R</sub> = 8.95 min (method A); 99.8%; <i>t</i><sub>R</sub> = 9.78 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 471.1. Found: 471.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.22–3.39 (m, 4H), 3.43 (br s, 2H) 3.66 (br s, 2H), 7.53 (d, <i>J</i> = 7.70 Hz, 2H), 7.69 (d, <i>J</i> = 7.15 Hz, 2H), 7.74 (d, <i>J</i> = 7.15 Hz, 1H), 7.82 (d, <i>J</i> = 7.15 Hz, 2H), 8.05 (d, <i>J</i> = 8.25 Hz, 2H). <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 3.45 (m, 1H), 4.19–4.22 (m, 4H), 4.43 (s, 2H), 7.64–7.75 (m, 5H), 7.83 (d, <i>J</i> = 7.5 Hz, 2H), and 8.28 (d, <i>J</i> = 8.3 Hz, 2H).</div></div><div id="sec5_4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(4-(5-(4-(1,1-Difluoroethyl)-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid, 2,2,2-Trifluoroacetic Acid Salt (<b>5l</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a solution of 5-phenylisoxazole-3-carboxylic acid (0.86 g, 4.55 mmol) in toluene (15.0 mL) and methanol (3 mL) was added a 2 M solution of TMS-diazomethane in hexanes (3.1 mL, 6.14 mmol) dropwise at room temperature. The reaction mixture was stirred for 30 min and concentrated. The residue was dispersed in methanol (3 mL), stirred for 5 min, and filtered to give methyl 5-phenylisoxazole-3-carboxylate (<b>22</b>, 897 mg). HPLC <i>t</i><sub>R</sub> = 2.67 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>9</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 204.1. Found: 204<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 5-phenylisoxazole-3-carboxylate (100 mg, 0.492 mmol) and <i>N</i>-bromosuccinimide (119 mg, 0.669 mmol) in 5% fuming nitric acid in acetic acid (2 mL) was heated to 150 °C for 10 min under microwave conditions. The reaction mixture was concentrated and purified by flash silica gel chromatography with hexanes/ethyl acetate (10/1) to afford methyl 4-bromo-5-phenylisoxazole-3-carboxylate (<b>23</b>, 108 mg). HPLC <i>t</i><sub>R</sub> = 3.21 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>BrNO<sub>3</sub> [M + H]<sup>+</sup> 282.0 and 284.0. Found: 282<sup>+</sup> and 284<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 4-bromo-5-phenylisoxazole-3-carboxylate (358 mg, 1.27 mmol) and tributyl(1-ethoxyvinyl)tin (0.858 mL, 2.54 mmol) in dioxane (5 mL) was heated at 100 °C for 24 h. To the reaction mixture was added 1 N aqueous hydrochloric acid (2.54 mL, 2.54 mmol), and the mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with ethyl acetate (100 mL), washed with water (30 mL), washed with a saturated aqueous solution of sodium bicarbonate (30 mL), and washed with brine (30 mL). The mixture was concentrated to ∼5 mL, potassium fluoride (0.059 mL, 2.54 mmol) in 2 mL of water was added, and the mixture was stirred for 10 min. The solid was filtered and washed with ethyl acetate, and the filtrate was washed with water (10 mL), washed with brine (10 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by flash silica gel chromatography (hexanes/ethyl acetate, 10:1) afforded methyl 4-acetyl-5-phenylisoxazole-3-carboxylate (<b>24</b>, 105 mg). HPLC <i>t</i><sub>R</sub> = 3.69 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 246.1. Found: 246<sup>+</sup>.</div><div class="NLM_p">Methyl 4-acetyl-5-phenylisoxazole-3-carboxylate (105 mg, 0.428 mmol) was added to a mixture of ethanol (5.00 μL) and deoxofluor (513 μL, 2.78 mmol), and the reaction mixture was heated to 85 °C for 6 h. The reaction mixture was quenched with 20 mL of a saturated aqueous solution of sodium bicarbonate while maintaining the temperature between 0 and 5 °C. The mixture was extracted with ethyl acetate (30 mL), and the organic phase was washed with water (15 mL), washed with brine (15 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by flash silica gel chromatography (hexanes/ethyl acetate, 9:1) afforded methyl 4-(1,1-difluoroethyl)-5-phenylisoxazole-3-carboxylate (63 mg, 0.236 mmol, 55%). HPLC <i>t</i><sub>R</sub> = 3.13 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>F<sub>2</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 268.1. Found: 268<sup>+</sup>.</div><div class="NLM_p">A solution of methyl 4-(1,1-difluoroethyl)-5-phenylisoxazole-3-carboxylate (62 mg, 0.232 mmol) and 1 N aqueous sodium hydroxide (11.1 mg, 0.278 mmol) in methanol (1 mL) was stirred at 23 °C for 1 h. The reaction mixture was concentrated under reduced pressure to give 4-(1,1-difluoroethyl)-5-phenylisoxazole-3-carboxylic acid, sodium salt (<b>25</b>, 59 mg, 0.232 mmol, >99%). HPLC <i>t</i><sub>R</sub> = 2.39 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>9</sub>F<sub>2</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 254.1. Found: 254<sup>+</sup>.</div><div class="NLM_p">To a solution of 4-(1,1-difluoroethyl)-5-phenylisoxazole-3-carboxylic acid (58.7 mg, 0.232 mmol), HOBt (64.0 mg, 0.418 mmol), and diisopropylethylamine (0.162 mL, 0.928 mmol) in acetonitrile (2 mL) were added <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (105 mg, 0.545 mmol) and <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 70.8 mg, 0.232 mmol). The reaction mixture was stirred at 80 °C for 2 h and then concentrated. The residue was diluted with ethyl acetate (3 mL), washed with a saturated aqueous solution of sodium bicarbonate (1 mL), washed with water (1 mL), washed with brine (1 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by reverse phase preparative HPLC gave <i>tert</i>-butyl 1-(4-(5-(4-(1,1-difluoroethyl)-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4-(1,1-difluoroethyl)-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylatein dichloromethane (0.5 mL) and trifluoroacetic acid (0.5 mL) was stirred at room temperature for 30 min. Concentration under reduced pressure afforded 1-(4-(5-(4-(1,1-difluoroethyl)-5-phenylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5l</b>, 19 mg, 0.041 mmol, 18% over two steps). HPLC purity 99.0%; <i>t</i><sub>R</sub> = 7.40 min (method A); 99.0%; <i>t</i><sub>R</sub> = 8.12 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>20</sub>F<sub>2</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 467.2. Found: 467<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ ppm 2.24 (t, <i>J</i> = 18.56 Hz, 3H) 3.64–3.73 (m, 1H), 4.35–4.39 (m, 4H), 4.52 (s, 2H), 7.58–7.67 (m, 3H), 7.70 (d, <i>J</i> = 8.25 Hz, 2H), 7.76 (d, <i>J</i> = 7.15 Hz, 2H), and 8.29 (d, <i>J</i> = 8.25 Hz, 2H).</div></div><div id="sec5_4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-(4-(5-(5-Isobutyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5m</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a solution of 4-methylpent-1-yne (0.588 mL, 5.00 mmol) in tetrahydrofuran at −78 °C was added butyllithium, 2.5 M in hexanes (2.20 mL, 5.50 mmol). After stirring for 15 min at −78 °C, the reaction mixture was allowed to warm to room temperature. 1-Iodopropane (0.488 mL, 5.00 mmol) was added, and the reaction mixture was stirred at room temperature for 3 days. The reaction mixture was quenched with water (50 mL), and the resulting mixture was transferred to a separatory funnel. The mixture was extracted with ether (75 mL), and the organic layer was washed with brine (50 mL), dried over anhydrous magnesium sulfate, and concentrated to afford 2-methyloct-4-yne (555 mg, 4.47 mmol, 89%) as a light yellow liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 0.91–0.99 (m, 9 H), 1.45–1.53 (m, 2 H), 1.70–1.81 (m, 1 H), 2.03 (dt, <i>J</i> = 6.5, 2.4 Hz, 2 H), 2.12 (tt, <i>J</i> = 7.0, 2.4 Hz, 2 H).</div><div class="NLM_p">A mixture of 2-methyloct-4-yne (248 mg, 2.00 mmol), dimethyl 2-nitromalonate (567 mg, 3.20 mmol), and 1-butyl-3-methylimidazolium hexafluorophosphate (0.041 mL, 0.020 mmol) in toluene (4 mL) was heated to 170 °C under microwave conditions for 1 h. After cooling to room temperature, the reaction mixture was partitioned between ethyl acetate (50 mL) and water (50 mL), and the organic layer was collected, washed with brine, dried over magnesium sulfate, and concentrated to afford an orange oil that was chromatographed on a 24 g ISCO silica gel cartridge (0–5% ethyl acetate/hexane). The pure fractions were concentrated under reduced pressure to afford a 1:1 mixture of methyl 5-isobutyl-4-propylisoxazole-3-carboxylate and methyl 4-isobutyl-5-propylisoxazole-3-carboxylate (164 mg, 0.728 mmol, 36%) as a light yellow oil. These isomers were not readily separable by normal or reverse phase chromatography, and this material was used without further purification in the next step.</div><div class="NLM_p">To a mixture of methyl 5-isobutyl-4-propylisoxazole-3-carboxylate and methyl 4-isobutyl-5-propylisoxazole-3-carboxylate (164 mg, 0.728 mmol) in methanol (8 mL) and water (2 mL) was added lithium hydroxide, monohydrate (15.3 mg, 0.364 mmol), and the mixture was allowed to stir overnight at room temperature. An additional amount of lithium hydroxide, monohydrate (15.3 mg, 0.364 mmol) was added, and the reaction mixture was stirred at room temperature for 2 h. The methanol was removed under reduced pressure, and the remaining aqueous layer was acidified to pH ≈ 1 with 1 N aqueous hydrochloric acid. The mixture was extracted with ethyl acetate (20 mL), and the organic layer was washed with brine (20 mL), dried over anhydrous sodium sulfate, and concentrated to afford 144 mg (0.682 mmol, 94% yield) of the product mixture which was approximately a 1:1 mixture of 5-isobutyl-4-propylisoxazole-3-carboxylic acid and 4-isobutyl-5-propylisoxazole-3-carboxylic acid as a light yellow oil. (Compounds were not readily separable by normal or reverse phase chromatography and were used without further purification in the next step.) HPLC <i>t</i><sub>R</sub> = 1.72 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>17</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 212.1. Found: 212.2.</div><div class="NLM_p">A mixture of 5-isobutyl-4-propylisoxazole-3-carboxylic acid and 4-isobutyl-5-propylisoxazole-3-carboxylic acid (42.3 mg, 0.2 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 61.1 mg, 0.200 mmol), HOBt (38.3 mg, 0.250 mmol), diisopropylethylamine (0.070 mL, 0.400 mmol), and <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (47.9 mg, 0.250 mmol) in dimethylformamide (1 mL) was stirred at room temperature for 18 h. Additional dimethylformamide (1 mL) was added, and the reaction mixture was warmed to 50 °C and stirred for 8 h. The reaction mixture was partitioned between ethyl acetate (30 mL) and a saturated sodium bicarbonate solution (30 mL), and the organic layer was washed with water (2 × 30 mL), washed with brine (30 mL), and dried over anhydrous magnesium sulfate. Concentration followed by purification by flash silica gel chromatography (0–100% ethyl acetate/hexane) afforded a mixture of <i>tert</i>-butyl-1-(4-(5-(5-isobutyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (32 mg, 0.067 mmol, 66%) and <i>tert</i>-butyl 1-(4-(5-(4-isobutyl-5-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (32 mg, 0.067 mmol, 67% yield) as a colorless oil. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>36</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 481.3. Found: 481.3.</div><div class="NLM_p">The mixture was separated on a Berger Prep SFC MGIII unit on a Chiralpak AD-H 30 cm × 3 cm i.d., 5 μm column, eluting with 70/30 CO<sub>2</sub>/(MeOH, 0.1% diethylamine) and a flow rate of 88 mL/min, monitored at 220 nm. The fractions from the second peak to elute were concentrated to afford <i>tert</i>-butyl 1-(4-(5-(5-isobutyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (24 mg, 50%) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 0.95–1.01 (m, 9 H), 1.44 (s, 9 H), 1.57–1.65 (m, 2 H), 2.10–2.19 (m, 1 H), 2.67 (d, <i>J</i> = 7.4 Hz, 2 H), 2.69–2.73 (m, 2 H), 3.22–3.30 (m, 3 H), 3.50–3.56 (m, 2 H), 3.67 (s, 2 H), 7.42 (d, <i>J</i> = 8.1 Hz, 2 H), 8.10 (d, <i>J</i> = 8.1 Hz, 2 H).</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(5-isobutyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (23 mg, 0.048 mmol) in trifluoroacetic acid (0.5 mL) was allowed to stand at room temperature for 2.5 h. The solvent was removed under reduced pressure, and the residue was triturated with ether and dried to afford 1-(4-(5-(5-isobutyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid, trifluoroacetic acid salt (24 mg, 0.044 mmol, 92%) as a light yellow glassy solid. HPLC purity 99.5%; <i>t</i><sub>R</sub> = 9.44 min (method A); 99.6%; <i>t</i><sub>R</sub> = 9.80 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 425.2. Found: 425.2. <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 1.01 (m, 9 H), 1.60–1.71 (m, 2 H), 2.14 (m, 1 H), 2.77 (m, 4 H), 3.62–3.73 (m, 1 H), 4.30–4.40 (m, 4 H), 4.51 (s, 2 H), 7.68 (d, <i>J</i> = 7.8 Hz, 2 H), 8.24 (d, <i>J</i> = 7.8 Hz, 2 H).</div></div><div id="sec5_4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(4-(5-(5-Isobutyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>5n</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">A mixture of methyl 5-isobutylisoxazole-3-carboxylate (<b>18</b>, 0.923 g, 5.04 mmol) and <i>N</i>-iodosuccinimide (1.25 g, 5.54 mmol) in trifluoroacetic acid (25 mL) was stirred at room temperature overnight. The trifluoroacetic acid was removed under reduced pressure, and the residue was diluted with dichloromethane (100 mL), washed with a saturated aqueous solution of sodium bicarbonate (2 × 25 mL), washed with a 2.5% aqueous solution of sodium bisulfite (25 mL), and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using a 5% mixture of ethyl acetate in hexane afforded methyl 4-iodo-5-isobutylisoxazole-3-carboxylate (<b>19</b>, 1.21 g, 3.91 mmol, 78%) as a pale yellow oil. HPLC <i>t</i><sub>R</sub> = 2.40 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>11</sub>F<sub>2</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 310.0. Found: 310.1.</div><div class="NLM_p">To a solution of methyl 4-iodo-5-isobutylisoxazole-3-carboxylate (<b>19</b>, 1.21 g, 3.91 mmol), copper(I) iodide (0.149 g, 0.783 mmol), and HMPA (2.59 mL) in <i>N</i>,<i>N</i>-dimethylformamide (19 mL) was added methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (1.993 mL, 15.66 mmol) over 1 min. The reaction mixture was immediately immersed in an oil bath at 75 °C and was stirred overnight. The clear, orange reaction mixture was cooled to room temperature and diluted with ether (100 mL), washed with a saturated aqueous solution of ammonium chloride (2 × 100 mL), washed with a 10% aqueous solution of lithium chloride (2 × 50 mL), and washed with brine (50 mL). The aqueous layer was back-extracted with ether (100 mL + 50 mL), and the combined organic layers were dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using a 5% mixture of ethyl acetate in hexane provided methyl 5-isobutyl-4-(trifluoromethyl)isoxazole-3-carboxylate (<b>20</b>, 0.819 g, 3.26 mmol, 83%) as a clear, colorless oil. HPLC <i>t</i><sub>R</sub> = 2.52 min (method C). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 0.99 (s, 3H), 1.00 (s, 3H), 2.09–2.20 (m, 1H), 2.86 (dd, <i>J</i> = 7.21, 1.11 Hz, 2H), and 4.01 (s, 3H).</div><div class="NLM_p">A mixture of methyl 5-isobutyl-4-(trifluoromethyl)isoxazole-3-carboxylate (<b>20</b>, 0.816 g, 3.25 mmol) and lithium hydroxide hydrate (0.136 g, 3.25 mmol) in methanol (18 mL) and water (9.00 mL) was stirred at room temperature overnight. The reaction mixture was concentrated under reduced pressure, and the residue was dissolved in 1 N aqueous hydrochloric acid and extracted with ether. The organic layer was collected and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 5-isobutyl-4-(trifluoromethyl)isoxazole-3-carboxylic acid (<b>21</b>, 0.746 g, 3.15 mmol, 97%) as an off-white solid. HPLC <i>t</i><sub>R</sub> = 2.00 min (method C). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.91 (s, 3H), 0.93 (s, 3H), 1.97–2.09 (m, 1H), and 2.89 (d, <i>J</i> = 7.28 Hz, 2H).</div><div class="NLM_p">To a mixture of 3-isobutyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid (<b>21</b>, 0.200 g, 0.843 mmol) and pyridine (0.082 mL, 1.01 mmol) in dichloromethane (8 mL) at room temperature was added 2,4,6-trifluoro-1,3,5-triazine (cyanuric fluoride) (0.085 mL, 1.01 mmol). The reaction mixture was stirred at room temperature overnight. The heterogeneous reaction was diluted with dichloromethane, washed with an ice-cold solution of 0.5 N aqueous hydrochloric acid (2×), and the organic layer was collected. The aqueous layer was back-extracted with dichloromethane, and the combined organic layers were dried over anhydrous sodium sulfate and concentrated to afford 3-isobutyl-4-(trifluoromethyl)isoxazole-5-carbonyl fluoride (0.130 g, 0.544 mmol, 65%) as a yellow solid. HPLC <i>t</i><sub>R</sub> = 2.51 min, corresponding to the methyl ester (method C).</div><div class="NLM_p">A mixture of 5-isobutyl-4-(trifluoromethyl)isoxazole-3-carbonyl fluoride (0.130 g, 0.544 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 0.166 g, 0.544 mmol), and Hunig’s base (0.123 mL, 0.707 mmol) in acetonitrile (2 mL) was stirred at room temperature for 2 days. HPLC analysis indicated that there was ∼7% of the uncyclized intermediate remaining. The reaction mixture was gently heated with a heat gun for ∼15 min, resulting in further cyclization. The homogeneous mixture was diluted with dichloromethane and washed with a saturated aqueous solution of sodium bicarbonate. The aqueous layer was extracted with dichloromethane, and the organic layers were combined and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using a 1% mixture of methanol in dichloromethane afforded <i>tert</i>-butyl 1-(4-(5-(5-isobutyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.219 g, 0.432 mmol, 80%) as a clear, viscous yellow oil. HPLC <i>t</i><sub>R</sub> = 3.03 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>29</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 507.2. Found: 507.4.</div><div class="NLM_p">A mixture of <i>tert</i>-butyl 1-(4-(5-(5-isobutyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.219 g, 0.432 mmol) and trifluoroacetic acid (2.496 mL, 32.4 mmol) was stirred at room temperature for 45 min. The trifluoroacetic acid was removed under reduced pressure, and the residue was suspended in ∼6 mL of water with sonication. The product gummed up and did not disperse. The pH was adjusted to ∼4.5 with 1 N aqueous sodium hydroxide, and the product still remained largely clumped on the bottom. Dichloromethane (∼8 mL) was added, and the mixture was stirred vigorously overnight. The organic layer was collected, dried over anhydrous sodium sulfate, and concentrated. The oily residue was dissolved in methanol and left standing overnight. The methanol solution was passed through a Whatman 0.45 μm PTFE with GMF syringe filter and concentrated to give the product (0.195 g, 0.424 mmol, 98%) as a pale, yellow oil.</div><div class="NLM_p last">A portion of the compound was purified by flash silica gel chromatography using a mixture of methanol, dichloromethane, and ammonium hydroxide (10:90:0 to 20:80:1). The desired fractions were concentrated, diluted with dichloromethane and water, and the pH was adjusted to 4.5 with 1.0 N aqueous hydrochloric acid. After shaking, the resulting emulsion was left to settle for 30 min. The organic layer was collected, and the aqueous layer/emulsion was back-extracted with dichloromethane (2×). The cloudy organic layer was dried over anhydrous sodium sulfate and concentrated to give a white solid residue which was redissolved in dichloromethane and filtered through a Whatman 0.45 μm PTFE with GMF syringe filter and concentrated to give the product as a white solid (118 mg). The solid was suspended in methanol with sonication and concentrated (2×). After the third resuspension, the solid was collected by vacuum filtration to give 1-(4-(5-(5-isobutyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>5n</b>, 0.011 g) as a white solid. HPLC purity 99.2%; <i>t</i><sub>R</sub> = 7.51 min (method A); 99.4%; <i>t</i><sub>R</sub> = 8.44 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 451.2. Found: 451.1. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.02 (s, 3H), 1.03 (s, 3H), 2.15–2.25 (m, 1H), 2.93 (d, <i>J</i> = 7.21 Hz, 2H), 3.39 (br s, 1H), 3.93 (br s, 2H), 4.15 (br s, 4H), 7.55 (d, <i>J</i> = 7.77 Hz, 2H), and 8.14 (d, <i>J</i> = 7.77 Hz, 2H).</div></div><div id="sec5_4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(4-(5-(3-Phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>6a</b>)</h3><div class="NLM_p">To a homogeneous mixture of 3-phenylisoxazole-5-carboxylic acid (0.200 g, 1.06 mmol) and pyridine (0.103 mL, 1.27 mmol) in dichloromethane (10 mL) at room temperature was added 2,4,6-trifluoro-1,3,5-triazine (0.11 mL, 1.27 mmol). The reaction mixture was stirred at room temperature overnight. The heterogeneous reaction mixture was diluted with dichloromethane (25 mL), washed with an ice-cold aqueous solution of 0.5 N aqueous hydrochloric acid (2 × 10 mL), and the organic layer was collected. The aqueous layer was back-extracted with dichloromethane (25 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated to afford 3-phenylisoxazole-5-carbonyl fluoride (0.193 g, 1.01 mmol, 95%) as a white solid.</div><div class="NLM_p">A mixture of 3-phenylisoxazole-5-carbonyl fluoride (0.193 g, 1.010 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 0.308 g, 1.01 mmol), and Hunig’s base (0.229 mL, 1.31 mmol) in acetonitrile (2.0 mL) was stirred at room temperature for 30 min. The solidified reaction mixture was immersed in an oil bath at 60 °C, stirred for 5 h, and then stirred at room temperature overnight. The solidified reaction mixture was diluted with dichloromethane (30 mL) and washed with a saturated aqueous solution of sodium bicarbonate (10 mL). The aqueous layer was extracted with dichloromethane (30 mL), and the organic layers were combined and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded a tan solid which was triturated with methanol with sonication and filtered under reduced pressure to give <i>tert-</i>butyl 1-(4-(5-(3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate as a white solid (0.276 g, 0.602 mmol, 60%). HPLC <i>t</i><sub>R</sub> = 2.68 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 459.2. Found: 459.2.</div><div class="NLM_p last">A mixture of <i>tert</i>-butyl 1-(4-(5-(3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (0.276 g, 0.602 mmol) and trifluoroacetic acid (3.29 mL, 42.7 mmol) was stirred at room temperature for 1.0 h. The solvent was removed under reduced pressure, and the residue was suspended in water with sonication. To the resulting white suspension was added a 1 N aqueous solution of sodium hydroxide portionwise until the pH was ∼9 with sonication. The pH was then adjusted to ∼5 with 1 N aqueous hydrochloric acid, and the suspension was sonicated for 20 min. The solid was collected by vacuum filtration (a significant amount passed through the filter), washed with water several times, and dried under reduced pressure overnight. The solid was suspended in methanol and sonicated for 20 min. During the sonication, the solution became very thick. The product was collected by vacuum filtration, washed with methanol, and dried under reduced pressure to give 1-(4-(5-(3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>6a</b>, 0.112 g, 0.272 mmol, 45%) as a white solid. HPLC purity 98.4%; <i>t</i><sub>R</sub> = 6.74 min (method A); 97.7%; <i>t</i><sub>R</sub> = 8.02 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 403.1. Found: 403.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.55–3.66 (m, 1H), 4.11–4.22 (m, 4H), 4.41–4.48 (m, 2H), 7.56–7.62 (m, 3H), 7.67–7.73 (m, 2H), 8.03–8.08 (m, 2H), 8.14–8.21 (m, 2H), 8.32–8.37 (m, 1H), 10.26–10.72 (m, 1H), and 12.95–13.32 (m, 1H).</div></div><div id="sec5_4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(4-(5-(4-Methyl-3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>6b</b>)</h3><div class="NLM_p">To a solution of methyl 4-methyl-3-phenylisoxazole-5-carboxylate (100 mg, 0.460 mmol) in methanol (4 mL) and water (0.8 mL) at room temperature was added lithium hydroxide, monohydrate (19.3 mg, 0.460 mmol), and the reaction mixture was stirred at room temperature for 1 h. The volatiles were removed under reduced pressure, and the residue was coevaporated from ethyl acetate/heptane several times to afford lithium 4-methyl-3-phenylisoxazole-5-carboxylate (96 mg, 0.502 mmol, 100%) as a white foamy solid. HPLC <i>t</i><sub>R</sub> = 1.45 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>9</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 204.1. Found: 204.1.</div><div class="NLM_p">A mixture of lithium 4-methyl-3-phenylisoxazole-5-carboxylate (21 mg, 0.100 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 30.5 mg, 0.1 mmol), HOBt (24.50 mg, 0.160 mmol), <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (45.0 mg, 0.235 mmol), and Hunig’s base (0.070 mL, 0.400 mmol) in dimethylfomamide (1 mL) was allowed to stir at room temperature for 3 days. The reaction mixture was warmed to 60 °C for 4.5 h and was then partitioned between ethyl acetate (30 mL) and a saturated aqueous solution of sodium bicarbonate (30 mL). The organic layer was washed with water (2 × 30 mL), washed with brine (20 mL), and dried over anhydrous magnesium sulfate. Concentration followed by purification by flash silica gel chromatography (0–70% ethyl acetate/hexane) afforded <i>tert</i>-butyl 1-(4-(5-(4-methyl-3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (28 mg, 0.059 mmol, 59%) as a colorless solid. HPLC <i>t</i><sub>R</sub> = 3.16 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 473.2. Found: 473.1.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(4-methyl-3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (28 mg, 0.059 mmol) in trifluoroacetic acid (0.75 mL) was allowed to stand at room temperature for 1 h. Concentration followed by purification by reverse phase preparative HPLC afforded 1-(4-(5-(4-methyl-3-phenylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid, trifluoroacetic acid salt (<b>6b</b>, 25 mg, 0.047 mmol, 80%) as a white solid. HPLC purity 99.2%; <i>t</i><sub>R</sub> = 8.15 min (method A); 98.8%; <i>t</i><sub>R</sub> = 8.82 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 417.2. Found: 417.1. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.31 (d, <i>J</i> = 8.0 Hz, 2H), 7.77 (dd, <i>J</i> = 6.5, 2.8 Hz, 2H), 7.70 (d, <i>J</i> = 8.3 Hz, 2H) 7.64 (m, 3H), 4.54 (s, 2H), 4.43–4.34 (m, 4H), 3.76–3.68 (m, 1H), 2.63 (s, 3H).</div></div><div id="sec5_4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(4-(5-(3-Phenyl-4-propylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>6c</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a suspension of sodium hydride, 60% (0.800 g, 20.0 mmol) in tetrahydrofuran (40 mL), cooled in an adiabatic cooling bath, was added portionwise over 15 min triethyl phosphonoacetate (4.00 mL, 20 mmol). The reaction mixture was allowed to stir at room temperature for 45 min. Bromine (1.03 mL, 20.0 mmol) was added dropwise over 15 min. The resulting suspension was warmed to 40 °C, stirred for 10 min, and then at room temperature for 1 h. The reaction mixture was cooled to 10 °C, sodium hydride (60%, 0.800 g, 20.0 mmol) was added in one portion, and the reaction mixture was allowed to warm to room temperature and stir for 45 min. Butyraldehyde (1.80 mL, 20.0 mmol) was then added over 2 min, and the reaction mixture was stirred for 18 h. The reaction mixture was partitioned between ether (200 mL) and water (100 mL). The organic layer was washed with a saturated aqueous solution of sodium bicarbonate (150 mL), washed with water (100 mL), washed with brine (100 mL), and dried over anhydrous magnesium sulfate. Concentration followed by purification by flash silica gel chromatography (0–5% ethyl acetate/hexane) gave ethyl 2-bromohex-2-enoate (3.61 g, 16.3 mmol, 82%) as a colorless liquid. HPLC <i>t</i><sub>R</sub> = 1.81 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>13</sub>BrO<sub>2</sub> [M + H]<sup>+</sup> 221.1 and 223.1. Found: 221.1 and 223.1. (Note: The product is a 3:1 mixture of olefin isomers.)</div><div class="NLM_p">To a solution of <i>N</i>-hydroxybenzimidoyl chloride (770 mg, 4.95 mmol) and ethyl 2-bromohex-2-enoate (1.09 g, 4.95 mmol) in dichloromethane (15 mL) was added triethylamine (2.07 mL, 14.9 mmol) over 5 min. The reaction mixture was stirred overnight at room temperature and was then partitioned between ether (100 mL) and water (100 mL). The organic layer was washed with brine (100 mL) and dried over anhydrous magnesium sulfate. Concentration followed by purification by flash silica gel chromatography (0–1% ethyl acetate/hexane) afforded ethyl 3-phenyl-4-propylisoxazole-5-carboxylate (34 mg, 0.131 mmol, 3%) as a colorless oil. HPLC <i>t</i><sub>R</sub> = 1.91 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 260.1. Found: 260.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 0.90 (t, <i>J</i> = 7.4 Hz, 3H), 1.45 (t, <i>J</i> = 7.2 Hz, 3H), 1.53 (m, 2H), 2.80 (m, 2H), 4.46 (q, <i>J</i> = 7.2 Hz, 2H), 7.45 (m, 1H), 7.50 (m, 2H), 7.59 (m, 2H).</div><div class="NLM_p">To a mixture of ethyl 3-phenyl-4-propylisoxazole-5-carboxylate (27 mg, 0.104 mmol) in methanol (0.8 mL) and water (0.2 mL) was added lithium hydroxide, monohydrate (4.37 mg, 0.104 mmol), and the reaction mixture was stirred at room temperature overnight. The solvent was removed under reduced pressure to afford 3-phenyl-4-propylisoxazole-5-carboxylic acid, lithium salt (24 mg, 0.101 mmol, 97%) as a colorless oil, which was used without further purification. HPLC <i>t</i><sub>R</sub> = 1.66 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>13</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 232.1. Found: 232.2.</div><div class="NLM_p">A mixture of <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 30.5 mg, 0.1 mmol), HOBt (16.85 mg, 0.110 mmol), diisopropylethylamine (0.044 mL, 0.250 mmol), and <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (23.0 mg, 0.120 mmol) was stirred in dimethylformamide (1 mL) at room temperature for 18 h. Additional <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (23.0 mg, 0.120 mmol) was added, and the reaction mixture was stirred at 60 °C for 5 h. The reaction mixture was partitioned between ethyl acetate (30 mL) and a saturated aqueous solution of sodium bicarbonate (30 mL). The organic layer was washed with water (2 × 25 mL), washed with brine (25 mL), and dried over anhydrous sodium sulfate. Concentration followed by purification by flash silica gel chromatography (0–50% ethyl acetate/hexane) afforded <i>tert</i>-butyl 1-(4-(5-(3-phenyl-4-propylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (22 mg, 0.044 mmol, 44%) as a colorless oil. HPLC <i>t</i><sub>R</sub> = 1.84 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 501.3. Found: 501.2.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl 1-(4-(5-(3-phenyl-4-propylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (22 mg, 0.044 mmol) in trifluoroacetic acid (0.5 mL) was allowed to stand at room temerature for 2.5 h. The solvent was removed under reduced pressure, and the residue was triturated with ether and dried to afford 1-(4-(5-(3-phenyl-4-propylisoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid, trifluoroacetic acid salt (<b>6c</b>, 16 mg, 0.028 mmol, 63%) as an off-white solid. HPLC purity 97.4%; <i>t</i><sub>R</sub> = 8.97 min (method A); 96.7%; <i>t</i><sub>R</sub> = 9.61 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 445.2. Found: 445.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 0.97 (t, <i>J</i> = 7.4 Hz, 3H), 1.66 (m, 2H), 3.09 (t, <i>J</i> = 7.8 Hz, 2H), 3.71 (m, 1H), 4.39 (m, 4H), 4.54 (s, 2H), 7.61 (m, 3H), 7.72 (m, 4H), and 8.31 (d, J= 8.3 Hz, 2H).</div></div><div id="sec5_4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(4-(5-(3-Phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>6d</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a solution of diisopropylamine (24.7 mL, 176 mmol) in ether (100 mL) at −78 °C was added a 10 M solution of butyllithium in ether (17.6 mL, 176 mmol) over 5 min. After 10 min at −78 °C, 2-bromo-3,3,3-trifluoroprop-1-ene (14.0 g, 80 mmol) was added to the pale yellow solution. After an additional 10 min, paraformaldehyde (2.40 g, 80 mmol) was added, the dry ice bath was removed, and the reaction mixture was stirred at room temperature overnight. As the reaction mixture approached room temperature, it became dark in color. The reaction was quenched with a 1 N aqueous solution of hydrochloric acid (100 mL), diluted with ether (500 mL), washed with a 1 N aqueous solution of hydrochloric acid (2 × 100 mL), washed with brine 100 mL, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded a dark liquid which was distilled under low vacuum (∼50 Torr, ∼50 °C) to give 4,4,4-trifluorobut-2-yn-1-ol (<b>32</b>, 7.10 g, 57.2 mmol, 72%) as a pale yellow liquid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 2.31 (br s, 1H) and 4.38–4.42 (m, 2H).</div><div class="NLM_p">To a pale yellow, homogeneous mixture of <i>N</i>-hydroxybenzimidoyl chloride (5.50 g, 35.4 mmol)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and 4,4,4-trifluorobut-2-yn-1-ol (<b>32</b>, 5.46 g, 39.6 mmol) in dichloroethane (85 mL) in a 250 mL round-bottom flask at 70 °C was added triethylamine (9.85 mL, 70.7 mmol) in 22 mL of dichloroethane over 2.5 h via an addition funnel (the first ∼50% over 2 h and the remaining 50% over 0.5 h). After the addition, the reaction mixture was complete based on HPLC analysis (total time at 70 °C was 3 h). The reaction mixture was diluted with dichloromethane (100 mL), washed with water (100 mL), and the organic layer was collected. The aqueous layer was extracted with dichloromethane (2 × 50 mL), and the combined organic layers were dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure. Analysis indicated that the product mixture was composed of a 9:1 mixture of the desired regioisomer, (3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)methanol (<b>33</b>), and the undesired regioisomer, (3-phenyl-5-(trifluoromethyl)isoxazol-4-yl)methanol (<b>34</b>). The mixture was purified by silica gel chromatography using a mixture of ethyl acetate and hexane (1% to pack and load, 5% to 9% to 12%) to afford (3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)methanol (<b>33</b>, 5.34 g, 22.0 mmol, 62%) as a pale yellow oil. HPLC <i>t</i><sub>R</sub> = 1.91 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>F<sub>3</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 244.1. Found: 244.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 2.21 (br s, 1H), 4.97 (s, 2H), 7.47–7.56 (m, 3H), and 7.65 (d, <i>J</i> = 6.60 Hz, 2H).</div><div class="NLM_p">To a solution of (3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)methanol (<b>33</b>, 5.24 g, 21.6 mmol) in acetone (75 mL) at room temperature (immersed in a water bath) was slowly added Jones’ reagent (43.8 mL, 53.9 mmol) via addition funnel over 1.5 h. The dark reaction mixture was stirred at room temperature overnight. HPLC analysis indicated that the reaction was 93% complete. An additional 0.5 equiv (9 mL) of the Jones’ reagent was added. After 1 h, the reaction was 95% complete. After an additional 3 h, the reaction was 96% complete. An additional 0.5 equiv (9 mL) of the Jones’ reagent was added. The reaction mixture was stirred for an additional 2.5 h and was determined to be 97% complete. Isopropyl alcohol (6 mL) was added, and the mixture was stirred for 90 min, resulting in a dark green precipitate. The mixture was diluted with ether (600 mL), washed with a 2% aqueous solution of sodium hydrogen sulfite (5 × 100 mL), and the organic layer was collected. The aqueous layer was back-extracted with ether (2 × 100 mL). The combined organic layers were washed with water (100 mL), washed with a saturated aqueous solution of brine (100 mL), and dried over anhydrous sodium sulfate. The aqueous layer was back-extracted with ether (100 mL), and the organic layer was added to the previous organic layers. The solution was concentrated under reduced pressure to give 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid as an off-white solid. The solid was diluted with dichloromethane (200 mL), washed with a 2% aqueous solution of sodium hydrogen sulfite, washed with brine, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid (3.84 g, 14.9 mmol, 70%) as a pale yellow solid.</div><div class="NLM_p">The sodium hydrogen sulfite aqueous layer still contained a significant amount of product. The brine layer contained no additional product and was discarded. The aqueous layer was saturated with sodium chloride, the pH was adjusted to ∼3.5, and the solution was extracted with ether (3 × 100 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated to afford additional 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid (1.12 g, 4.36 mmol, 20%) as a white solid.</div><div class="NLM_p">The products were combined to give 4.96 g (<b>35</b>, 90% yield) of 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid. HPLC <i>t</i><sub>R</sub> = 1.60 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>6</sub>F<sub>3</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 258.0. Found: 258.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.55–7.63 (m, 5H).</div><div class="NLM_p">A mixture of (3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)methanol (<b>33</b>, 2.1 g, 8.64 mmol), TEMPO (0.094 g, 0.604 mmol), and a sodium phosphate buffer (0.67 M) (32.2 mL, 21.59 mmol) was heated to 35 °C. A solution of sodium phosphate buffer (40 mL, pH ≈ 6.5), consisting of a 1:1 solution of NaH<sub>2</sub>PO<sub>4</sub> (20 mL, 0.67M) and Na<sub>2</sub>HPO<sub>4</sub> (20 mL, 0.67M), was prepared in acetonitrile (30 mL) prior to use. Solutions of sodium chlorite (3.91 g, 34.5 mmol) in water (4.5 mL) and bleach (4.3 mL, 6% wt.) were added simultaneously over 40 min. The reaction was monitored by HPLC, and after 2 h, ∼30% of the starting material remained. After 6 h, 10% remained. Additional bleach (100 μL) was added, and the reaction mixture was left at room temperature overnight.</div><div class="NLM_p">Additional bleach (100 μL) was added, and the resulting mixture was allowed to stir at 35 °C for an additional 2 h. HPLC indicated complete conversion. The reaction was quenched by the slow addition of a solution of sodium sulfite (2.07 mL, 43.2 mmol) in water (90 mL) at 0 °C, resulting in the disappearance of the brown reaction color. The solvent was removed under reduced pressure, and the remaining aqueous residue was extracted with ethyl acetate (3 × 40 mL). The organic layers were combined, washed with water (8 mL), washed with brine (8 mL), and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid (<b>35</b>, 2.2 g, 8.55 mmol, 99% yield) as a pale yellow solid.</div><div class="NLM_p">To a mixture of 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic acid (<b>35</b>, 3.00 g, 11.7 mmol) and pyridine (1.13 mL, 14.0 mmol) in dichloromethane (100 mL) at room temperature was added 2,4,6-trifluoro-1,3,5-triazine (cyanuric fluoride) (1.18 mL, 14.0 mmol). The reaction mixture was stirred at room temperature overnight, diluted with dichloromethane (300 mL), washed with an ice-cold solution of 0.5 N aqueous hydrochloric acid (2 × 100 mL), and the organic layer was collected. The aqueous layer was back-extracted with dichloromethane (200 mL), and the combined organic layers were dried with anhydrous sodium sulfate and concentrated to afford 3-phenyl-4-(trifluoromethyl)isoxazole-5-carbonyl fluoride (<b>36</b>, 2.91 g, 11.2 mmol, 96%) as a yellow, viscous oil. The product was found to react readily with methanol and during analysis was characterized as the methyl ester, which had an HPLC <i>t</i><sub>R</sub> = 2.56 min (method C); LCMS (ESI) [M + H]<sup>+</sup> 272.3 (methyl ester).</div><div class="NLM_p">A suspension of 3-phenyl-4-(trifluoromethyl)isoxazole-5-carbonyl fluoride (<b>36</b>, 2.91 g, 11.2 mmol), <i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 3.43 g, 11.2 mmol), and Hunig’s base (2.55 mL, 14.6 mmol) in acetonitrile (20 mL) was stirred at room temperature over the weekend. The completely solidified reaction mixture was diluted with dichloromethane and washed with a saturated aqueous solution of sodium bicarbonate (150 mL). The organic layer was collected, and the aqueous layer was extracted with dichloromethane (2 × 100 mL). The combined organic layers were dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded a tan solid which was purified by flash silica gel chromatography using a mixture of ethyl acetate in hexane (0–50%) to afford <i>tert</i>-butyl 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (4.60 g, 78%) as a white solid. The material was suspended in methanol (∼75 mL) and was sonicated for 5 min. The methanol was removed under reduced pressure, and the residue was resuspended in methanol (∼50 mL) with sonication. Vacuum filtration and drying afforded <i>tert</i>-butyl 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (<b>37</b>, 4.04 g, 7.67 mmol, 68%) as a white solid. The methanol filtrate was concentrated to afford additional <i>tert</i>-butyl 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (<b>33</b>, 570 mg, 10%) as a slightly off-white solid. HPLC <i>t</i><sub>R</sub> = 3.12 min (method C); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 527.2. Found: 527.1. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.47 (s, 9H) 3.28–3.37 (m, 3H), 3.60 (br s, 2H), 3.74 (br s, 2H), 7.49 (d, <i>J</i> = 7.70 Hz, 2H), 7.53–7.62 (m, 3H), 7.69 (d, <i>J</i> = 7.15 Hz, 2H), and 8.16 (d, <i>J</i> = 7.70 Hz, 2H).</div><div class="NLM_p">A mixture of <i>tert</i>-butyl 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (<b>37</b>, 6.12 g, 11.6 mmol) and trifluoroacetic acid (50.1 mL, 651 mmol) was stirred at room temperature for 1.5 h. The solvent was removed under reduced pressure, and the oily residue was diluted with water (100 mL) and sonicated for 5 min. The resulting suspension was stirred for an additional 10 min until a consistent white suspension was observed. A 1 N aqueous solution of sodium hydroxide was added portionwise until the pH was ∼4.5 (42 mL of 1 N aqueous sodium hydroxide). Over time, the pH drifted back down to 3–4, and additional 1 N aqueous sodium hydroxide had to be added. The suspension was stirred overnight at room temperature. Several drops of 1 N aqueous sodium hydroxide were added to readjust the pH to 4.5, and after 60 min, the pH appeared to be stable. The solid was collected by vacuum filtration, washed with water several times, and dried under reduced pressure for 5 h. The solid was then suspended in methanol (110 mL) in a 150 mL round-bottom flask and sonicated for 15 min. During the sonication, the solution became very thick. An additional 25 mL of methanol was added, and the suspension was stirred overnight.</div><div class="NLM_p last">The product was collected by vacuum filtration, washed with methanol (∼50 mL), and dried under reduced pressure. The solid was transferred to a 250 mL round-bottom flask, resuspended in methanol (115 mL), sonicated for 5 min, and stirred for 60 min. The solid was collected by vacuum filtration, washed with methanol (∼50 mL), and dried over well under reduced pressure to give 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid (<b>6d</b>, 5.06 g, 10.7 mmol, 92%) as a crystalline, white solid. HPLC purity 99.8%; <i>t</i><sub>R</sub> = 7.62 min (method A); 99.9%; <i>t</i><sub>R</sub> = 8.45 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 445.2. Found: 471.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.20–3.46 (m, 5H), 3.66 (s, 2H), 7.53 (d, <i>J</i> = 8.25 Hz, 2H), 7.60–7.70 (m, 5H), and 8.06 (d, <i>J</i> = 7.70 Hz, 2H). Anal. Calcd for C<sub>23</sub>H<sub>17</sub>N<sub>4</sub>O<sub>4</sub>F<sub>3</sub>, 0.44% water: C, 58.42; H, 3.70; N, 11.83. Found: C, 58.52; H, 3.43; N, 11.86.</div></div><div id="sec5_4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>tert</i>-Butyl 1-(4-(<i>N</i>′-Hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>)<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></h3><div class="NLM_p">To a solution of azetidine-3-carboxylic acid (88 g, 0.871 mol) and sodium bicarbonate (161 g, 1.92 mol) in water (1.75 L) at room temperature was added a solution of benzyl 2,5-dioxopyrrolidin-1-ylcarbonate (239 g, 0.959 mol) in tetrahydrofuran (3.5 L). The reaction mixture was stirred at room temperature overnight. The solvent was removed under reduced pressure, and the aqueous layer was washed with ethyl acetate (2 × 500 mL). The aqueous layer was acidified with a 1.0 N aqueous hydrochloric acid solution and was then extracted with ethyl acetate (3 × 750 mL). The organic layer was washed with water, washed with brine, and dried over anhydrous sodium sulfate. Concentration under reduced pressure afforded 1-(benzyloxycarbonyl)azetidine-3-carboxylic acid as colorless oil (<b>7</b>, 202 g, 99% yield). HPLC <i>t</i><sub>R</sub> = 2.27 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>13</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 236.1. Found: 236.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.39–3.49 (m, 1H), 4.22 (d, <i>J</i> = 7.28 Hz, 4H), 5.11 (s, 2H), and 7.29–7.39 (m, 5H).</div><div class="NLM_p">To a solution of 1-(benzyloxycarbonyl)azetidine-3-carboxylic acid (<b>7</b>, 200 g, 0.851 mol) in dichloromethane (6.0 L) at 0 °C was added <i>tert</i>-butanol (158 g, 2.13 mol), DMAP (52.0 g, 0.425 mol), and <i>N</i>1-((ethylimino)methylene)-<i>N</i>3,<i>N</i>3-dimethylpropane-1,3-diamine hydrochloride (163 g, 0.853 mol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was concentrated, and the residue was dissolved in ethyl acetate. The organic layer washed with 10% aqueous citric acid, washed with 10% aqueous sodium bicarbonate solution, and washed with brine. Subsequent drying over anhydrous sodium sulfate followed by concentration under reduced pressure afforded 1-benzyl-3-<i>tert</i>-butyl azetidine-1,3-dicarboxylate (200 g, 81% yield) as a colorless oil. HPLC <i>t</i><sub>R</sub> = 3.27 min (method D); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 292.2. Found: 292.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.46 (s, 9H), 3.24–3.33 (m, 1H), 4.14 (d, <i>J</i> = 7.53 Hz, 4H), 5.10 (s, 2H), and 7.30–7.39 (m, 5H).</div><div class="NLM_p">A mixture of 1-benzyl-3-<i>tert</i>-butyl azetidine-1,3-dicarboxylate (140 g, 0.480 mol) and 10% palladium on carbon (28.0 g) in ethyl acetate (1.40 L) was placed in an autoclave under 3.0 kg/cm<sup>2</sup> of hydrogen pressure overnight. The reaction mixture was filtered through Celite, and the Celite bed was washed with ethyl acetate. Acetic acid (28.9 g, 0.480 mol) was added to the filtrate, and it was concentrated under reduced pressure maintaining the temperature below 50 °C to give <i>tert</i>-butyl azetidine-3-carboxylate acetic acid salt (<b>8</b>, 96 g, 92% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.47 (s, 9H), 2.02 (s, 3H), 3.52–3.63 (m, 1H), and 4.00–4.10 (m, 4H).</div><div class="NLM_p">To a solution of <i>tert</i>-butyl azetidine-3-carboxylate acetic acid salt (<b>8</b>, 92.0 g, 0.423 mol) in methanol (1.0 L) at room temperature was added 4-formylbenzonitrile (50.8 g, 0.381 mol). The reaction mixture was cooled to 0 °C, and sodium cyanoborohydride (28.8 g, 0.458 mol) was added portionwise. The reaction mixture was allowed to warm to room temperature, and stirring continued overnight. After the reaction mixture was concentrated under reduced pressure, the residue was diluted with a 10% aqueous sodium bicarbonate solution and extracted with ethyl acetate. The organic layer was collected, washed with brine, and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using 20% ethyl acetate in petroleum ether afforded <i>tert</i>-butyl 1-(4-cyanobenzyl)azetidine-3-carboxylate (<b>9</b>, 89%). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 273.2. Found: 273.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.46 (s, 9H), 3.22–3.31 (m, 3H), 3.48–3.56 (m, 2H), 3.66 (s, 2H), 7.39 (d, <i>J</i> = 8.28 Hz, 2H), and 7.60 (d, <i>J</i> = 8.28 Hz, 2H).</div><div class="NLM_p last">To <i>tert</i>-butyl 1-(4-cyanobenzyl)azetidine-3-carboxylate (<b>9</b>, 89.0 g, 0.326 mol) in <i>tert</i>-butanol (1.30 L) were added sodium bicarbonate (109.8 g, 1.31 mol) and hydroxylamine hydrochloride (45.5 g, 0.654 mol). The reaction was heated at reflux for 7 h and then cooled to room temperature and stirred overnight. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was collected, washed with water, washed with brine, then dried over anhydrous sodium sulfate. Concentration followed by purification by flash silica gel chromatography using 2.5% methanol in chloroform containing 0.2% triethylamine as eluent afforded (<i>Z</i>)-<i>tert</i>-butyl 1-(4-(<i>N</i>′-hydroxycarbamimidoyl)benzyl)azetidine-3-carboxylate (<b>10</b>, 64 g, 0.210 mol, 55% yield over 2 steps). HPLC <i>t</i><sub>R</sub> = 7.03 min (method B); LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 306.2. Found: 306.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.45 (s, 9H), 3.23–3.30 (m, 3H), 3.49–3.57 (m, 2H), 3.63 (s, 2H), 4.85 (s, 2H), 7.31 (d, <i>J</i> = 8.28 Hz, 2H), and 7.57 (d, <i>J</i> = 8.28 Hz, 2H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Receptor [<sup>35</sup>S] GTPγS Binding Assays</h3><div class="NLM_p last">Compounds were loaded in a 384 Falcon v-bottom plate (0.5 μL/well in a 3-fold dilution). Membranes prepared from S1P<sub>1</sub>/CHO cells or EDG3-Ga15-bla HEK293T cells were added to the compound plate (40 μL/well, final protein 3 μg/well) with multidrop liquid handler (Thermo Scientific, Waltham, MA). [<sup>35</sup>S]GTP (1250 Ci/mmol, PerkinElmer) was diluted in assay buffer: 20 mM HEPES, pH 7.5, 10 mM MgCl<sub>2</sub>, 150 mM NaCl, 1 mM EGTA, 1 mM DTT, 10 μM GDP, 0.1% fatty acid free BSA, and 10 μg/mL saponin to 0.4 nM. 40 μL of the [<sup>35</sup>S] GTP solution was added to the compound plate with a final concentration of 0.2 nM. The reaction was kept at room temperature for 45 min. At the end of incubation, all the mixtures in the compound plate were transferred to 384-well FB filter plates via GPCR robot system. The filter plate was washed with water 4 times by using the modified manifold Embla plate washer and dried at 60 °C for 45 min. 30 μL of MicroScint 20 scintillation fluid was added to each well for counting at Packard TopCount. EC<sub>50</sub> is defined as the agonist concentration that corresponds to 50% of the <i>Y</i><sub>max</sub> (maximal response) obtained for each individual compound tested.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> S1P-1 Internalization and Recycling Assay (High Content Based)</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> hS1P-1 Internalization Assay</h4><div class="NLM_p last">For quantification of S1P-1 expression using a high content system, GFP was fused to hS1P-1 at its C-terminus and a stable CHO cell line expressing hS1P-1/GFP was established. Cells were suspended in assay medium (F12 medium with 5% charcoal–dextran treated FBS, 20 mM HEPES, and 1× Pen/Strep) at 7.5 × 10<sup>4</sup> cells/mL and plated into 384-well plates (in 20 μL, 1500 cells/well final) with a multidrop liquid handler (Thermo Scientific, Waltham, MA). Cell plates were incubated at 37 °C for 48 h. Titrated S1P and compounds of interest were dispensed into the cell plates (concentration range from 100 μM to 0.005 μM), and the plates were further incubated at 37 °C for 50 min. Cells were fixed by adding 10 μL of fixation buffer (7.4% v/v formaldehyde containing 15 μM Draq5 in DPBS) directly onto the assay medium and incubated for 15 min at rt followed by two washes with DPBS. This was followed by the addition of 50 μL of DPBS to the cell layer, and the plates were sealed with a transparent plate seal (PerkinElmer no. 6005185). Imaging was carried out using the Evotec Opera high content confocal system (PerkinElmer, Boston, MA) equipped with three diode lasers, Peltier cooled CCD camera detector, and a Nipkow spinning disk. Cell images were quantified using a membrane fluorescent scoring algorithm. Data were analyzed using a customized HTS data analysis software package. EC<sub>50</sub> values were determined using XL-Fit software program.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> hS1P-1 Recycling Assay</h4><div class="NLM_p">After a 50 min stimulation with compounds to drive internalization, cells were washed 8 times with 100 μL of DPBS followed by the addition of F12 medium containing 2.5% charcoal–dextran treated serum to each well. Cells were incubated at 37 °C for different time points (1, 4, 8, and 16 h). Cell plates were then fixed, stained, and scanned as described in the internalization assay protocol.</div><div class="NLM_p">In both receptor internalization and receptor recycling assays, the buffer control is considered as 100% S1P-1/GFP present on the cell membrane; 1 μM <b>3</b> (reference compound) is used as the reference for 100% S1P-1/GFP internalized.</div><div class="NLM_p last">All procedures involving animals were reviewed and approved by the Institutional Animal Care Use Committee.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Blood Lymphocyte Reduction Assay (BLR) in Rat</h3><div class="NLM_p last">Lewis rats were dosed orally with test article (as a solution or suspension in the vehicle) or vehicle alone (polyethylene glycol 300, “PEG300”). Blood was drawn at 4 h and 24 h by retro-orbital bleeding. Blood lymphocyte counts were determined on an ADVIA 120 hematology analyzer (Siemens Healthcare Diagnostics). The results were measured as a reduction in the percentage of circulating lymphocytes as compared to the vehicle treated group at the 4 and 24 h measurement. The results represent the average results of all animals within each treatment group (<i>n</i> = 3–4).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Rat Adjuvant Induced Arthritis Assay (AA)</h3><div class="NLM_p last">Male Lewis rats (200–225 g; Harlan, <i>n</i> = 8 treatment group) were immunized at the base of the tail with 100 μL of 10 mg/mL freshly ground <i>Mycobacterium butyricum</i> (Difco Laboratories) in incomplete Freund’s adjuvant (Sigma). Animals were dosed once daily with the test article (as a solution or suspension in the vehicle) or vehicle alone (PEG300) starting from the day of immunization. The volumes of their hind paws were measured in a water displacement plethysmometer (Ugo Basile, Italy). The baseline paw measurements were taken before onset of the disease (between day 7 and day 10). The paw measurements were then taken three times a week until the end of the study on day 20.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Mouse Experimental Autoimmune Encephalomyelitis Assay (EAE)</h3><div class="NLM_p last">Mice (C57BL/6 female, 6–8 weeks of age, Charles River, <i>n</i> = 10–12 treatment group) were immunized subcutaneously with 150 μg of MOG<sub>35–55</sub> peptide emulsified 1:1 with incomplete Freund’s adjuvant (Sigma) supplemented with 150 μg <i>Mycobacterium tuberculosis</i> H37RA (Difco Laboratories). 400 ng of pertussis toxin (CalBiochem) was injected intraperitoneally on the day of immunization and 2 days later. Animals were dosed once daily with the test article (as a solution or suspension in the vehicle) or vehicle alone (PEG300) starting from 1 day after immunization. Clinical scoring and body weight were taken 3 times per week until the end of the study on day 24. Clinical scoring system was the following: 0.5, partial tail weakness; 1, limp tail or waddling gait with tail tonicity; 1.5, waddling gait with partial tail weakness; 2, waddling gait with limp tail (ataxia); 2.5, ataxia with partial limb paralysis; 3, full paralysis of one limb; 3.5, full paralysis of one limb with partial paralysis of a second limb; 4, full paralysis of two limbs; 4.5, moribund; 5, death.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e6889-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00089">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00089" class="ext-link">10.1021/acs.jmedchem.6b00089</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00089/suppl_file/jm6b00089_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00089/suppl_file/jm6b00089_si_001.csv">jm6b00089_si_001.csv (1.85 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00089" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott H. Watterson</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a6979756e6e346d7b6e6e7f686975745a78776934797577"><span class="__cf_email__" data-cfemail="5c2f3f332828722b3d2828392e2f33321c3e312f723f3331">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junqing Guo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve H. Spergel</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles M. Langevine</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert V. Moquin</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ding Ren Shen</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Yarde</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ellen Cvijic</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dana Banas</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Liu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne J. Suchard</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathleen Gillooly</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy Taylor</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Rex-Rabe</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Shuster</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim W. McIntyre</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georgia Cornelius</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia D’Arienzo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Marino</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praveen Balimane</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bethanne Warrack</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luisa Salter-Cid</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murray McKinnon</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Percy H. Carter</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William J. Pitts</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Xie</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alaric J. Dyckman</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research
and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i50" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i50"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i51" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i51"> Abbreviations Used</h2><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr><tr><td class="NLM_term">S1P<sub>1–5</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptors 1–5</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine 5′-<i>O</i>-[γ-thio]triphosphate</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple schlerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e3181cbf825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1097%2FWNF.0b013e3181cbf825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+schlerosis&doi=10.1097%2FWNF.0b013e3181cbf825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e3181cbf825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e3181cbf825%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520schlerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FWNF.0b013e3181cbf825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-348&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span><span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lifCR-ngP8fYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pappu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regard, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1126/science.1139221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1126%2Fscience.1139221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=17363629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVeku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=295-298&author=R.+Pappuauthor=S.+R.+Schwabauthor=I.+Cornelissenauthor=J.+P.+Pereiraauthor=J.+B.+Regardauthor=Y.+Xuauthor=E.+Camererauthor=Y.-W.+Zhengauthor=Y.+Huangauthor=J.+G.+Cysterauthor=S.+R.+Coughlin&title=Promotion+of+lymphocyte+egress+into+blood+and+lymph+by+distinct+sources+of+sphingosine-1-phosphate&doi=10.1126%2Fscience.1139221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate</span></div><div class="casAuthors">Pappu, Rajita; Schwab, Susan R.; Cornelissen, Ivo; Pereira, Joao P.; Regard, Jean B.; Xu, Ying; Camerer, Eric; Zheng, Yao-Wu; Huang, Yong; Cyster, Jason G.; Coughlin, Shaun R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5822</span>),
    <span class="NLM_cas:pages">295-298</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Lymphocytes require sphingosine-1-phosphate (S1P) receptor-1 to exit lymphoid organs, but the source(s) of extracellular S1P and whether S1P directly promotes egress are unknown.  By using mice in which the two kinases that generate S1P were conditionally ablated, we find that plasma S1P is mainly hematopoietic in origin, with erythrocytes a major contributor, whereas lymph S1P is from a distinct radiation-resistant source.  Lymphocyte egress from thymus and secondary lymphoid organs was markedly reduced in kinase-deficient mice.  Restoration of S1P to plasma rescued egress to blood but not lymph, and the rescue required lymphocyte expression of S1P-receptor-1.  Thus, sep. sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs.  Disruption of compartmentalized S1P signaling is a plausible mechanism by which S1P-receptor-1 agonists function as immunosuppressives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMH4WVYwTIX7Vg90H21EOLACvtfcHk0lhGBriKShHCSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVeku70%253D&md5=6c658296c3b1d34543c193987092506b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1139221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1139221%26sid%3Dliteratum%253Aachs%26aulast%3DPappu%26aufirst%3DR.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCornelissen%26aufirst%3DI.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DRegard%26aufirst%3DJ.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DY.-W.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DPromotion%2520of%2520lymphocyte%2520egress%2520into%2520blood%2520and%2520lymph%2520by%2520distinct%2520sources%2520of%2520sphingosine-1-phosphate%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D295%26epage%3D298%26doi%3D10.1126%2Fscience.1139221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1038/nature02284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fnature02284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=14737169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1&doi=10.1038%2Fnature02284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span></div><div class="casAuthors">Matloubian, Mehrdad; Lo, Charles G.; Cinamon, Guy; Lesneski, Matthew J.; Xu, Ying; Brinkmann, Volker; Allende, Maria L.; Proia, Richard L.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">6972</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adaptive immunity depends on T-cell exit from the thymus and T and B cells traveling between secondary lymphoid organs to survey for antigens.  After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown.  An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate (S1P) receptors.  However, the role of S1P receptors in normal immune cell trafficking is unclear.  Here we show that in mice whose hematopoietic cells lack a single S1P receptor (S1P1; also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus.  Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph.  Adoptive cell transfer expts. establish an intrinsic requirement for S1P1 in T and B cells for lymphoid organ egress.  Furthermore, S1P1-dependent chemotactic responsiveness is strongly upregulated in T-cell development before exit from the thymus, whereas S1P1 is downregulated during peripheral lymphocyte activation, and this is assocd. with retention in lymphoid organs.  We find that FTY720 treatment downregulates S1P1, creating a temporary pharmacol. S1P1-null state in lymphocytes, providing an explanation for the mechanism of FTY720-induced lymphocyte sequestration.  These findings establish that S1P1 is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mWA73kFtwbVg90H21EOLACvtfcHk0lhGBriKShHCSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D&md5=0dd84e9cca37ec30894497ff4477d0d8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature02284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02284%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360%26doi%3D10.1038%2Fnature02284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, J.</span><span> </span><span class="NLM_article-title">The vascular S1P gradient: cellular sources and biological significance</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2008.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.bbalip.2008.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=18674637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=477-482&author=T.+Hlaauthor=K.+Venkataramanauthor=J.+Michaud&title=The+vascular+S1P+gradient%3A+cellular+sources+and+biological+significance&doi=10.1016%2Fj.bbalip.2008.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The vascular S1P gradient-Cellular sources and biological significance</span></div><div class="casAuthors">Hla, Timothy; Venkataraman, Krishnan; Michaud, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P), a product of sphingomyelin metab., is enriched in the circulatory system whereas it is estd. to be much lower in interstitial fluids of tissues.  This concn. gradient, termed the vascular S1P gradient appears to form as a result of substrate availability and the action of metabolic enzymes.  S1P levels in blood and lymph are estd. to be in the μM range.  In the immune system, the S1P gradient is needed as a spatial cue for lymphocyte and hematopoietic cell trafficking.  During inflammatory reactions in which enhanced vascular permeability occurs, a burst of S1P becomes available to its receptors in the extravascular compartment, which likely contributes to the tissue reactions.  Thus, the presence of the vascular S1P gradient is thought to contribute to physiol. and pathol. conditions.  From an evolutionary perspective, S1P receptors may have co-evolved with the advent of a closed vascular system and the trafficking paradigms for hematopoietic cells to navigate in and out of the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosbyXvTWrRf7Vg90H21EOLACvtfcHk0lhGBriKShHCSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrF&md5=a9c4420dff6764f71060b18149669767</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DVenkataraman%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DJ.%26atitle%3DThe%2520vascular%2520S1P%2520gradient%253A%2520cellular%2520sources%2520and%2520biological%2520significance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D477%26epage%3D482%26doi%3D10.1016%2Fj.bbalip.2008.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Finding a way out: lymphocyte egress from lymphoid organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span><span class="refDoi"> DOI: 10.1038/ni1545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fni1545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=18026082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1295-1301&author=S.+R.+Schwabauthor=J.+G.+Cyster&title=Finding+a+way+out%3A+lymphocyte+egress+from+lymphoid+organs&doi=10.1038%2Fni1545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a way out: lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Schwab, Susan R.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1301</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function.  The discovery that a small-mol. inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs.  S1P exists in higher concns. in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit.  Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes.  In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites.  We relate this model to work examg. the effects of S1P receptor agonists on endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWY-Rk111SmLVg90H21EOLACvtfcHk0li5L2PX_STEIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J&md5=ccf7ef06130d3ebd218707ac92618f36</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fni1545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1545%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DFinding%2520a%2520way%2520out%253A%2520lymphocyte%2520egress%2520from%2520lymphoid%2520organs%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1295%26epage%3D1301%26doi%3D10.1038%2Fni1545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1038/nri1650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fnri1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=15999095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=560-570&author=H.+Rosenauthor=E.+J.+Goetzl&title=Sphingosine+1-phosphate+and+its+receptors%3A+an+autocrine+and+paracrine+network&doi=10.1038%2Fnri1650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span></div><div class="casAuthors">Rosen, Hugh; Goetzl, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a biol. active lysophospholipid that transmits signals through a family of G-protein-coupled receptors to control cellular differentiation and survival, as well as the vital functions of several types of immune cell.  In this Review article, the authors discuss recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles.  In an autocrine manner, through interactions with different G-protein-coupled receptors, S1P also enhances optimal mast-cell migration and release of pro-inflammatory mediators in allergic reactions.  S1P-S1P-receptor regulatory systems might therefore be novel targets for the therapy of diverse immunol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-Zo0R14YILVg90H21EOLACvtfcHk0li5L2PX_STEIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D&md5=b680f6c9e29d407579ab7f056209d853</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnri1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1650%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520its%2520receptors%253A%2520an%2520autocrine%2520and%2520paracrine%2520network%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D560%26epage%3D570%26doi%3D10.1038%2Fnri1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the sphingosine 1-phosphate receptor, S1P<sub>1</sub>, on T-cells controls thymic emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span><span class="refDoi"> DOI: 10.1074/jbc.M314291200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1074%2Fjbc.M314291200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+sphingosine+1-phosphate+receptor%2C+S1P1%2C+on+T-cells+controls+thymic+emigration&doi=10.1074%2Fjbc.M314291200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314291200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314291200%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520controls%2520thymic%2520emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401%26doi%3D10.1074%2Fjbc.M314291200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pham, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">S1P<sub>1</sub> receptor singling overrides retention mediated by Gαi-coupled receptors to promote T-cell egress</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1016/j.immuni.2007.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.immuni.2007.11.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=122-133&author=T.+H.+Phamauthor=T.+Okadaauthor=M.+Matloubianauthor=C.+G.+Loauthor=J.+G.+Cyster&title=S1P1+receptor+singling+overrides+retention+mediated+by+G%CE%B1i-coupled+receptors+to+promote+T-cell+egress&doi=10.1016%2Fj.immuni.2007.11.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2007.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2007.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DPham%26aufirst%3DT.%2BH.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DS1P1%2520receptor%2520singling%2520overrides%2520retention%2520mediated%2520by%2520G%25CE%25B1i-coupled%2520receptors%2520to%2520promote%2520T-cell%2520egress%26jtitle%3DImmunity%26date%3D2008%26volume%3D28%26spage%3D122%26epage%3D133%26doi%3D10.1016%2Fj.immuni.2007.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><div class="note"><p class="first last">and references therein</p></div><span class="refDoi"> DOI: 10.1038/nrd3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis&doi=10.1038%2Fnrd3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lj7eZlvuLicYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897%26doi%3D10.1038%2Fnrd3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">A mechanistically novel, first oral therapy for multiple sclerosis: The development of fingolimod (FTY720, Gilenya)</span> <span class="citation_source-journal">Discovery Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=213-228&author=J.+Chunauthor=V.+Brinkmann&title=A+mechanistically+novel%2C+first+oral+therapy+for+multiple+sclerosis%3A+The+development+of+fingolimod+%28FTY720%2C+Gilenya%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DA%2520mechanistically%2520novel%252C%2520first%2520oral%2520therapy%2520for%2520multiple%2520sclerosis%253A%2520The%2520development%2520of%2520fingolimod%2520%2528FTY720%252C%2520Gilenya%2529%26jtitle%3DDiscovery%2520Med.%26date%3D2011%26volume%3D12%26spage%3D213%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e3181cbf825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1097%2FWNF.0b013e3181cbf825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.-P.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+sclerosis&doi=10.1097%2FWNF.0b013e3181cbf825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e3181cbf825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e3181cbf825%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FWNF.0b013e3181cbf825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pelletier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafler, D. A.</span><span> </span><span class="NLM_article-title">Fingolimod for multiple sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.1056/NEJMct1101691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1056%2FNEJMct1101691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=22276823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1artLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=339-347&author=D.+Pelletierauthor=D.+A.+Hafler&title=Fingolimod+for+multiple+sclerosis&doi=10.1056%2FNEJMct1101691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod for multiple sclerosis</span></div><div class="casAuthors">Pelletier, Daniel; Hafler, David A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">339-347</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A 37-yr-old man with multiple sclerosis was evaluated for consideration of oral immunotherapy. Six years earlier, he had reported acute monocular visual disturbance.  The diagnosis of multiple sclerosis was subsequently confirmed by means of examn. of cerebrospinal fluid, which revealed an increased IgG index and oligoclonal banding, and by abnormal results on magnetic resonance imaging (MRI).  There was no family history of multiple sclerosis.  Daily injections of glatiramer acetate were initiated at the time of diagnosis, but two consecutive annual brain MRI scans revealed substantial disease activity.  He was then switched to interferon beta therapy, but this treatment was discontinued after the patient had two episodes of acute neurol. worsening.  Monthly natalizumab therapy was then considered, but a test for JC virus antibodies was pos.  Neurol. examn. showed disk pallor and visual acuity of 20/40 in the right eye, partial internuclear ophthalmoplegia, wide-based gait, and posterior column deficits in both legs.  The patient was referred to a specialist in multiple sclerosis for consideration of oral fingolimod therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7E7D-NWq_7LVg90H21EOLACvtfcHk0lj7eZlvuLicYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1artLc%253D&md5=6e217009d6b857582cab89b7629ba4e5</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1056%2FNEJMct1101691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMct1101691%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DD.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26atitle%3DFingolimod%2520for%2520multiple%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D339%26epage%3D347%26doi%3D10.1056%2FNEJMct1101691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span> </span><span class="NLM_article-title">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span><span class="refDoi"> DOI: 10.1056/NEJMoa052643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1056%2FNEJMoa052643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=16971719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1124-1140&author=L.+Kapposauthor=J.+Antelauthor=G.+Comiauthor=X.+Montalbanauthor=P.+O%E2%80%99Connorauthor=C.+H.+Polmanauthor=T.+Haasauthor=A.+A.+Kornauthor=G.+Karlssonauthor=E.+W.+Radue&title=Oral+fingolimod+%28FTY720%29+for+relapsing+multiple+sclerosis&doi=10.1056%2FNEJMoa052643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1140</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis.  We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 mo with magnetic resonance imaging (MRI) and clin. evaluations (core study, months 0 to 6).  The primary end point was the total no. of gadolinium-enhanced lesions recorded on T1-weighted MRI at monthly intervals for 6 mo.  In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses.  A total of 255 patients completed the core study.  The median total no. of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P < 0.001) and 5.0 mg of fingolimod (3 lesions, P = 0.006) than with placebo (5 lesions).  The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P = 0.009) and 0.36 in the group given 5.0 mg of fingolimod (P = 0.01).  For the 227 patients who completed the extension study, the no. of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod.  Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea.  Clin. asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group).  One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group.  Fingolimod was also assocd. with an initial redn. in the heart rate and a modest decrease in the forced expiratory vol. in 1 s.  In this proof-of-concept study, fingolimod reduced the no. of lesions detected on MRI and clin. disease activity in patients with multiple sclerosis.  Evaluation in larger, longer-term studies is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4MSvDIuvV7Vg90H21EOLACvtfcHk0lg7ygjRZ-qG5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D&md5=2a84e8f5fb92091782406da9dcbc1453</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052643%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DAntel%26aufirst%3DJ.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DHaas%26aufirst%3DT.%26aulast%3DKorn%26aufirst%3DA.%2BA.%26aulast%3DKarlsson%26aufirst%3DG.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26atitle%3DOral%2520fingolimod%2520%2528FTY720%2529%2520for%2520relapsing%2520multiple%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1124%26epage%3D1140%26doi%3D10.1056%2FNEJMoa052643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1124/jpet.103.062828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes&doi=10.1124%2Fjpet.103.062828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lg7ygjRZ-qG5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768%26doi%3D10.1124%2Fjpet.103.062828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6173</span><span class="refDoi"> DOI: 10.1021/jm0503244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6169-6173&author=Z.+Liauthor=W.+Chenauthor=J.+J.+Haleauthor=C.+L.+Lynchauthor=S.+G.+Millsauthor=T.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=S.+A.+Parentauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=E.+J.+Quackenbushauthor=L.+A.+Wickhamauthor=H.+Vargasauthor=R.+M.+Evansauthor=H.+Rosenauthor=S.+Mandala&title=Discovery+of+Potent+3%2C5-Diphenyl-1%2C2%2C4-oxadiazole+Sphingosine-1-phosphate-1+%28S1P1%29+Receptor+Agonists+with+Exceptional+Selectivity+against+S1P2+and+S1P3&doi=10.1021%2Fjm0503244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm0503244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503244%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DT.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DE.%2BJ.%26aulast%3DWickham%26aufirst%3DL.%2BA.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Potent%25203%252C5-Diphenyl-1%252C2%252C4-oxadiazole%2520Sphingosine-1-phosphate-1%2520%2528S1P1%2529%2520Receptor%2520Agonists%2520with%2520Exceptional%2520Selectivity%2520against%2520S1P2%2520and%2520S1P3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6169%26epage%3D6173%26doi%3D10.1021%2Fjm0503244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+Crumbauthor=M.+Saltzmanauthor=M.+Rosenbergauthor=E.+Wallstrom&title=The+selective+sphingosine+1-phosphate+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate&doi=10.1111%2Fj.1476-5381.2012.02061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely, P.; Nuesslein-Hildesheim, B.; Guerini, D.; Brinkmann, V.; Traebert, M.; Bruns, C.; Pan, S.; Gray, N. S.; Hinterding, K.; Cooke, N. G.; Groenewegen, A.; Vitaliti, A.; Sing, T.; Luttringer, O.; Yang, J.; Gardin, A.; Wang, N.; Crumb, W. J., Jr.; Saltzman, M.; Rosenberg, M.; Wallstrom, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors.  S1P1 receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclin. and human data.  Exptl. Approach BAF312 was tested in a rat exptl. autoimmune encephalomyelitis (EAE) model.  Electrophysiol. recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  Key Results BAF312 effectively suppressed EAE in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4+ T cells, Tnaive, Tcentral memory and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P3 receptors (assocd. with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  Conclusion and Implications This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42VfW58NMyLVg90H21EOLACvtfcHk0lhDjZPsPl3IVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE&md5=0034be62fb68b10abefff50f0220be2a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSaltzman%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DThe%2520selective%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047%26doi%3D10.1111%2Fj.1476-5381.2012.02061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brossard, P.; Hofmann, S.; Cavallaro, M.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Entry-into-Humans Study with ACT-128800, a Selective S1P<sub>1</sub> Receptor Agonist: Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics</span>. Presented at ASCPT 2009, Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Washington DC, U.S., March 18–21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>PII-87;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Brossard&author=S.+Hofmann&author=M.+Cavallaro&author=A.+Halabi&author=J.+Dingemanse&title=Entry-into-Humans+Study+with+ACT-128800%2C+a+Selective+S1P1+Receptor+Agonist%3A+Tolerability%2C+Safety%2C+Pharmacokinetics%2C+and+Pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEntry-into-Humans%2520Study%2520with%2520ACT-128800%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%253A%2520Tolerability%252C%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11a1"><span>Clin. Pharmcol. Ther.<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">S63</span><span class="NLM_x">–</span> <span class="NLM_lpage">S64</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clin.+Pharmcol.+Ther.+2009%2C+85%2C+S63%E2%80%93S64."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DClin.%2520Pharmcol.%2520Ther.%26date%3D2009%26volume%3D85%26spage%3DS63%26epage%3DS64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P<sub>1</sub>/S1P<sub>5</sub> Receptor Modulator BAF312 Indicates That S1P<sub>1</sub> Rather Than S1P<sub>3</sub> Mediates Transient Heart Rate Reduction in Humans</span>. Presented at the 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Düsseldorf, Germany,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>P437.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P<sub>1</sub>/S1P<sub>5</sub> Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P<sub>1</sub> in Mediating a Transient Heart Rate Reduction</span>. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Discovery and Development of Sphingosine-1-Phosphate-1 Receptor Agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><div class="note"><p class="first last">and references therein</p></div><span class="refDoi"> DOI: 10.1016/B978-0-12-396492-2.00013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2FB978-0-12-396492-2.00013-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+Advances+in+the+Discovery+and+Development+of+Sphingosine-1-Phosphate-1+Receptor+Agonists&doi=10.1016%2FB978-0-12-396492-2.00013-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00013-8%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Sphingosine-1-Phosphate-1%2520Receptor%2520Agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1016%2FB978-0-12-396492-2.00013-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of new trycyclic indoles as potent modulators of the S1P<sub>1</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.bmcl.2014.11.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=659-663&author=D.+J.+Buzardauthor=O.+Schraderauthor=X.+Zhuauthor=J.+Lehmannauthor=B.+Johnsonauthor=M.+Kasemauthor=S.-H.+Kimauthor=A.+Kawasakiauthor=L.+Lopezauthor=J.+Moodyauthor=S.+Hanauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=J.+Thatteauthor=J.+Gatlinauthor=R.+M.+Jones&title=Design+and+synthesis+of+new+trycyclic+indoles+as+potent+modulators+of+the+S1P1+receptor&doi=10.1016%2Fj.bmcl.2014.11.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.089%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DSchrader%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520trycyclic%2520indoles%2520as%2520potent%2520modulators%2520of%2520the%2520S1P1%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D659%26epage%3D663%26doi%3D10.1016%2Fj.bmcl.2014.11.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acids as S1P<sub>1</sub> functional agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1334</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/ml500422m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500422m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1334-1339&author=D.+J.+Buzardauthor=L.+Lopezauthor=J.+Moodyauthor=A.+Kawasakiauthor=T.+O.+Schraderauthor=M.+Kasemauthor=B.+Johnsonauthor=X.+Zhuauthor=L.+Thoresenauthor=S.+H.+Kimauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+Krishnanauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=W.+Chenauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=I.+Gaidarovauthor=T.+Anthonyauthor=M.+Leauthor=D.+J.+Unettauthor=S.+Stirnauthor=A.+Blackburnauthor=D.+P.+Behanauthor=R.+M.+Jones&title=%287-Benzyloxy-2%2C3-dihydro-1H-pyrrolo%5B1%2C2-a%5Dindol-1-yl%29acetic+acids+as+S1P1+functional+agonists&doi=10.1021%2Fml500422m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fml500422m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500422m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%2BO.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3D%25287-Benzyloxy-2%252C3-dihydro-1H-pyrrolo%255B1%252C2-a%255Dindol-1-yl%2529acetic%2520acids%2520as%2520S1P1%2520functional%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1334%26epage%3D1339%26doi%3D10.1021%2Fml500422m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Skidmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cridland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">Optimization of Sphingosine-1-phosphate receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamics profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10424</span><span class="NLM_x">–</span> <span class="NLM_lpage">10442</span><span class="refDoi"> DOI: 10.1021/jm5010336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10424-10442&author=J.+Skidmoreauthor=J.+Heerauthor=C.+N.+Johnsonauthor=D.+Nortonauthor=S.+Redshawauthor=J.+Sweetingauthor=D.+Hurstauthor=A.+Cridlandauthor=D.+Veseyauthor=I.+Wallauthor=M.+Ahmedauthor=D.+Riversauthor=J.+Myattauthor=G.+Giblinauthor=K.+Philpottauthor=U.+Kumarauthor=A.+Stevensauthor=R.+A.+Bitauthor=A.+Haynesauthor=S.+Taylorauthor=R.+Watsonauthor=J.+Witheringtonauthor=E.+Demontauthor=T.+D.+Heightman&title=Optimization+of+Sphingosine-1-phosphate+receptor+agonists%3A+effects+of+acidic%2C+basic%2C+and+zwitterionic+chemotypes+on+pharmacokinetic+and+pharmacodynamics+profiles&doi=10.1021%2Fjm5010336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Fjm5010336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010336%26sid%3Dliteratum%253Aachs%26aulast%3DSkidmore%26aufirst%3DJ.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DSweeting%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DD.%26aulast%3DCridland%26aufirst%3DA.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWall%26aufirst%3DI.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DRivers%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DGiblin%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DOptimization%2520of%2520Sphingosine-1-phosphate%2520receptor%2520agonists%253A%2520effects%2520of%2520acidic%252C%2520basic%252C%2520and%2520zwitterionic%2520chemotypes%2520on%2520pharmacokinetic%2520and%2520pharmacodynamics%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10424%26epage%3D10442%26doi%3D10.1021%2Fjm5010336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists–Part 3: From thiophenes to pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1021/jm4014696</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014696" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=110-130&author=M.+H.+Bolliauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=C.+Kohlauthor=J.+Grimontauthor=P.+Hessauthor=C.+Lescopauthor=B.+Mathysauthor=C.+Mullerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=G.+Schmidtauthor=J.+Seifertauthor=B.+Steinerauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists%E2%80%93Part+3%3A+From+thiophenes+to+pyridines&doi=10.1021%2Fjm4014696"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Fjm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014696%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DGrimont%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSeifert%26aufirst%3DJ.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%25E2%2580%2593Part%25203%253A%2520From%2520thiophenes%2520to%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D110%26epage%3D130%26doi%3D10.1021%2Fjm4014696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists – Part 2: From bicylco[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1021/jm401456d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401456d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=78-97&author=M.+H.+Bolliauthor=J.+Velkerauthor=C.+Mullerauthor=B.+Mathysauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=S.+Meyerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=B.+Steiner&title=Novel+S1P1+receptor+agonists+%E2%80%93+Part+2%3A+From+bicylco%5B3.1.0%5Dhexane-fused+thiophenes+to+isobutyl+substituted+thiophenes&doi=10.1021%2Fjm401456d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1021%2Fjm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520%25E2%2580%2593%2520Part%25202%253A%2520From%2520bicylco%255B3.1.0%255Dhexane-fused%2520thiophenes%2520to%2520isobutyl%2520substituted%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D78%26epage%3D97%26doi%3D10.1021%2Fjm401456d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span> </span><span class="NLM_article-title">Discovery of oxazole and triazole derivatives as potent and selective S1P<sub>1</sub> agonists through pharmacophore-guided design</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.ejmech.2014.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=1-15&author=Y.+Tianauthor=J.+Jinauthor=X.+Wangauthor=J.+Huauthor=Q.+Xiaoauthor=W.+Zhouauthor=X.+Chenauthor=D.+Yin&title=Discovery+of+oxazole+and+triazole+derivatives+as+potent+and+selective+S1P1+agonists+through+pharmacophore-guided+design&doi=10.1016%2Fj.ejmech.2014.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520oxazole%2520and%2520triazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520S1P1%2520agonists%2520through%2520pharmacophore-guided%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.ejmech.2014.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill-Drzewi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueneva-Boucheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, R. M.</span><span> </span><span class="NLM_article-title">Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4807</span><span class="NLM_x">–</span> <span class="NLM_lpage">4811</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.bmcl.2014.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4807-4811&author=J.+C.+Horanauthor=S.+Sanyalauthor=Y.+Choiauthor=M.+Hill-Drzewiauthor=L.+Patnaudeauthor=S.+Andersonauthor=S.+Fogalauthor=C.+Maoauthor=B.+N.+Cookauthor=K.+Gueneva-Bouchevaauthor=M.+B.+Fisherauthor=E.+Hickeyauthor=E.+Packauthor=L.+C.+Bannenauthor=D.+S.+Chanauthor=M.+B.+Macauthor=S.+M.+Ngauthor=Y.+Wangauthor=W.+Xuauthor=L.+K.+Modisauthor=R.+M.+Lemieux&title=Piperazinyl-oxadiazoles+as+selective+sphingosine-1-phosphate+receptor+agonists&doi=10.1016%2Fj.bmcl.2014.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DFogal%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DGueneva-Boucheva%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DBannen%26aufirst%3DL.%2BC.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DMac%26aufirst%3DM.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DPiperazinyl-oxadiazoles%2520as%2520selective%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4807%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2014.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span><span class="refDoi"> DOI: 10.1021/jm0492507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists&doi=10.1021%2Fjm0492507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665%26doi%3D10.1021%2Fjm0492507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Dyckman, A. J.; Li, L.; Watterson, S. H.; Das, J.; Li, T.; Banas, D.; Cvijic, M. E.; Liu, R.; Suchard, S.; Shen, D. R.; Yarde, M.; Gillooly, K.; McIntyre, K.; Shuster, D.; Taylor, T.; Yang, X.; Cornelius, G.; D’Arienzo, C.; Marino, A.; Balimane, P.; Salter-Cid, L.; McKinnon, M.; Barrish, J. C.; Carter, P. H.; Pitts, W. J.; Xie, J.</span><span> </span><span class="NLM_article-title">Identification of potent and selective pyrazole based agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>)</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 244th National Meeting and Exposition of the American Chemical Society, Philadelphia, PA, U.S., August 19–23, 2012; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>MEDI-72.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+J.+Dyckman&author=L.+Li&author=S.+H.+Watterson&author=J.+Das&author=T.+Li&author=D.+Banas&author=M.+E.+Cvijic&author=R.+Liu&author=S.+Suchard&author=D.+R.+Shen&author=M.+Yarde&author=K.+Gillooly&author=K.+McIntyre&author=D.+Shuster&author=T.+Taylor&author=X.+Yang&author=G.+Cornelius&author=C.+D%E2%80%99Arienzo&author=A.+Marino&author=P.+Balimane&author=L.+Salter-Cid&author=M.+McKinnon&author=J.+C.+Barrish&author=P.+H.+Carter&author=W.+J.+Pitts&author=J.+Xie&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520pyrazole%2520based%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watterson, S. H.; Guo, J.; Spergel, S. H.; Langevine, C. M.; Moquin, R. V.; Kempson, J.; Shen, D. R.; Yarde, M.; Cvijic, M. E.; Banas, D.; Liu, R.; Suchard, S. J.; Gillooly, K.; Taylor, T.; RexRabe, S.; Shuster, D. J.; McIntyre, K. W.; Cornelius, G.; Darienzo, C.; Marino, A.; Balimane, P.; Saltercid, L.; McKinnon, M.; Barrish, J. C.; Carter, P. C.; Pitts, W. J.; Xie, J.; Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Potent and selective agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>): The discovery and SAR of a novel isoxazole based series</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 241st National Meeting and Exposition of the American Chemical Society, Anaheim, CA, U.S., March 27–31, 2011; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>MEDI-96.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+H.+Watterson&author=J.+Guo&author=S.+H.+Spergel&author=C.+M.+Langevine&author=R.+V.+Moquin&author=J.+Kempson&author=D.+R.+Shen&author=M.+Yarde&author=M.+E.+Cvijic&author=D.+Banas&author=R.+Liu&author=S.+J.+Suchard&author=K.+Gillooly&author=T.+Taylor&author=S.+RexRabe&author=D.+J.+Shuster&author=K.+W.+McIntyre&author=G.+Cornelius&author=C.+Darienzo&author=A.+Marino&author=P.+Balimane&author=L.+Saltercid&author=M.+McKinnon&author=J.+C.+Barrish&author=P.+C.+Carter&author=W.+J.+Pitts&author=J.+Xie&author=A.+J.+Dyckman&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26atitle%3DPotent%2520and%2520selective%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%253A%2520The%2520discovery%2520and%2520SAR%2520of%2520a%2520novel%2520isoxazole%2520based%2520series%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watterson, S. H.; Dyckman, A. J.; Pitts, W. J.; Spergel, S. H.</span><span> </span><span class="NLM_article-title">Substituted isoxazole derivatives as S1P agonists in the treatment of autoimmune and inflammatory diseases and their preparation</span>. WO 2010085581,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+H.+Watterson&author=A.+J.+Dyckman&author=W.+J.+Pitts&author=S.+H.+Spergel&title=Substituted+isoxazole+derivatives+as+S1P+agonists+in+the+treatment+of+autoimmune+and+inflammatory+diseases+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26atitle%3DSubstituted%2520isoxazole%2520derivatives%2520as%2520S1P%2520agonists%2520in%2520the%2520treatment%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%2520and%2520their%2520preparation%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b.2"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">232588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2010%2C+153%2C+232588"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b.2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2010%26volume%3D153%26spage%3D232588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b.3"><span>(U.S. Patent 8354398,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28U.S.+Patent+8354398%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b.3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Liu, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, R. K.</span><span> </span><span class="NLM_article-title">A particularly convenient preparation of benzohydroximinoyl chlorides (nitrile oxide precursors)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span><span class="refDoi"> DOI: 10.1021/jo01307a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01307a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADyaL3cXlsV2qsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=3916-1918&author=K.-C.+Liuauthor=B.+R.+Sheltonauthor=R.+K.+Howe&title=A+particularly+convenient+preparation+of+benzohydroximinoyl+chlorides+%28nitrile+oxide+precursors%29&doi=10.1021%2Fjo01307a039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A particularly convenient preparation of benzohydroximinoyl chlorides (nitrile oxide precursors)</span></div><div class="casAuthors">Liu, Kou-Chang; Shelton, Becky R.; Howe, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3916-18</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Reaction of RC6H4CH:NOH with N-chlorosuccinimide in DMF gave RC6H4CCl:NOH (R = 2-MeO, 3-Cl, 2-F3C, etc.) in 75-96% yields.  Ring chlorination does not occur with mesitaldehyde oxime or 2-methoxybenzaldehyde oxime.  Only with the very strongly ring activated 2,4-dimethoxybenzaldehyde oxime does ring chlorination occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgo8rs7VXWVLVg90H21EOLACvtfcHk0lg4y5JWl2TIaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlsV2qsbo%253D&md5=6047d84ce7c2466ff9fa0800dbe6f313</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo01307a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01307a039%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.-C.%26aulast%3DShelton%26aufirst%3DB.%2BR.%26aulast%3DHowe%26aufirst%3DR.%2BK.%26atitle%3DA%2520particularly%2520convenient%2520preparation%2520of%2520benzohydroximinoyl%2520chlorides%2520%2528nitrile%2520oxide%2520precursors%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D3916%26epage%3D1918%26doi%3D10.1021%2Fjo01307a039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hamper, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leschinsky, K. L.</span><span> </span><span class="NLM_article-title">Reaction of benzohydroximinoyl chlorides and β-trifluoromethyl)-acetylenic esters: Synthesis of regioisomeric (trifluoromethyl)-isoxazolecarboxylate esters and oxime addition products</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1002/jhet.5570400404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1002%2Fjhet.5570400404" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=575-583&author=B.+C.+Hamperauthor=K.+L.+Leschinsky&title=Reaction+of+benzohydroximinoyl+chlorides+and+%CE%B2-trifluoromethyl%29-acetylenic+esters%3A+Synthesis+of+regioisomeric+%28trifluoromethyl%29-isoxazolecarboxylate+esters+and+oxime+addition+products&doi=10.1002%2Fjhet.5570400404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570400404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570400404%26sid%3Dliteratum%253Aachs%26aulast%3DHamper%26aufirst%3DB.%2BC.%26aulast%3DLeschinsky%26aufirst%3DK.%2BL.%26atitle%3DReaction%2520of%2520benzohydroximinoyl%2520chlorides%2520and%2520%25CE%25B2-trifluoromethyl%2529-acetylenic%2520esters%253A%2520Synthesis%2520of%2520regioisomeric%2520%2528trifluoromethyl%2529-isoxazolecarboxylate%2520esters%2520and%2520oxime%2520addition%2520products%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2003%26volume%3D40%26spage%3D575%26epage%3D583%26doi%3D10.1002%2Fjhet.5570400404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jiang, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, F.-L.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of both enantiomers of <i>anti</i>-4,4,4-trifluorothreonine and 2-amino-4,4,4-trifluorobutanoic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7544</span><span class="NLM_x">–</span> <span class="NLM_lpage">7547</span><span class="refDoi"> DOI: 10.1021/jo0344384</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0344384" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFamtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=7544-7547&author=Z.-H.+Jiangauthor=Y.-Y.+Qinauthor=F.-L.+Qing&title=Asymmetric+synthesis+of+both+enantiomers+of+anti-4%2C4%2C4-trifluorothreonine+and+2-amino-4%2C4%2C4-trifluorobutanoic+acid&doi=10.1021%2Fjo0344384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Both Enantiomers of anti-4,4,4-Trifluorothreonine and 2-Amino-4,4,4-trifluorobutanoic Acid</span></div><div class="casAuthors">Jiang, Zhong-Xing; Qin, Ying-Ying; Qing, Feng-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7544-7547</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A short and efficient enantioselective synthesis of both enantiomers of anti-4,4,4-trifluorothreonine and 2-amino-4,4,4-trifluorobutanoic acid was successfully developed.  Trifluoromethylation of (E)-BrCH:CHCH2OCH2Ph provided key intermediate (E)-F3CCH:CHCH2OCH2Ph in good yield.  The sequence then involved Sharpless asym. dihydroxylation, nucleophilic opening of cyclic sulfate with NaN3, palladium-catalyzed selective hydrogenation, and oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHDpKu5PxHQbVg90H21EOLACvtfcHk0lic_FKhqqrC3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFamtr4%253D&md5=fd26bec46cdeecb8cdc9c93c64ea44e2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo0344384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0344384%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-H.%26aulast%3DQin%26aufirst%3DY.-Y.%26aulast%3DQing%26aufirst%3DF.-L.%26atitle%3DAsymmetric%2520synthesis%2520of%2520both%2520enantiomers%2520of%2520anti-4%252C4%252C4-trifluorothreonine%2520and%25202-amino-4%252C4%252C4-trifluorobutanoic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D7544%26epage%3D7547%26doi%3D10.1021%2Fjo0344384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bendele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAbee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlipala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, M.</span><span> </span><span class="NLM_article-title">Animal models of arthritis: relevance to human disease</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1177/019262339902700125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1177%2F019262339902700125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10367688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=134-142&author=A.+Bendeleauthor=J.+McCombauthor=T.+Gouldauthor=T.+McAbeeauthor=G.+Sennelloauthor=E.+Chlipalaauthor=M.+Guy&title=Animal+models+of+arthritis%3A+relevance+to+human+disease&doi=10.1177%2F019262339902700125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of arthritis: relevance to human disease</span></div><div class="casAuthors">Bendele A; McComb J; Gould T; McAbee T; Sennello G; Chlipala E; Guy M</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-42</span>
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    </div><div class="casAbstract">Animal models of arthritis are used to evaluate potential antiarthritis drugs for clinical use.  Therefore capacity of the model to predict efficacy in human disease is one of the most important criteria in model selection.  Animal models of rheumatoid arthritis (RA) with a proven track record of predictability include rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis, and antigen-induced arthritis in several species.  Agents currently in clinical use (or trials) that are active in these models include corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide, interleukin-1 receptor antagonist, and soluble tumor necrosis factor receptors.  For some of these agents, the models also predict that toxicities seen at higher doses for prolonged periods would preclude dosing in humans at levels that might provide disease-modifying effects.  Animal models of osteoarthritis (OA) include mouse and guinea pig spontaneous OA, meniscectomy and ligament transection in guinea pigs, meniscectomy in rabbits, and meniscectomy and cruciate transection in dogs.  None of these models have a proven track record of predictability in human disease because there are no agents that have been proven to provide anything other than symptomatic relief in human OA.  Efficacy data and features of the various models of RA and OA are discussed with emphasis on their proven relevance to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl_Wv0PotC6OkdrW1FkXG-fW6udTcc2ebI_rWncXlYVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D&md5=1b6484ca61fd10dbb07f090d376730a4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F019262339902700125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F019262339902700125%26sid%3Dliteratum%253Aachs%26aulast%3DBendele%26aufirst%3DA.%26aulast%3DMcComb%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMcAbee%26aufirst%3DT.%26aulast%3DSennello%26aufirst%3DG.%26aulast%3DChlipala%26aufirst%3DE.%26aulast%3DGuy%26aufirst%3DM.%26atitle%3DAnimal%2520models%2520of%2520arthritis%253A%2520relevance%2520to%2520human%2520disease%26jtitle%3DToxicol.%2520Pathol.%26date%3D1999%26volume%3D27%26spage%3D134%26epage%3D142%26doi%3D10.1177%2F019262339902700125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11a1','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e','cit13f','cit13g'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16b.2','cit16b.3'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Clare
F. Vickers, Ana P. G. Silva, Ajanta Chakraborty, Paulina Fernandez, Natalia Kurepina, Charis Saville, Yandi Naranjo, Miquel Pons, Laura S. Schnettger, Maximiliano G. Gutierrez, Steven Park, Barry N. Kreiswith, David S. Perlin, Eric J. Thomas, Jennifer S. Cavet, <span class="NLM_string-name hlFld-ContribAuthor">Lydia Tabernero</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8337-8352. <a href="https://doi.org/10.1021/acs.jmedchem.8b00832" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00832%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BMptpB%252BInhibitors%252BThat%252BReduce%252BMultidrug-Resistant%252BMycobacterium%252Btuberculosis%252BSurvival%252Band%252BInfection%252BBurden%252Bin%252BVivo%26aulast%3DVickers%26aufirst%3DClare%2BF.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01062018%26date%3D10092018%26date%3D28082018%26volume%3D61%26issue%3D18%26spage%3D8337%26epage%3D8352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Yun  Xiao</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Anurag S.  Srivastava</span>, <span class="hlFld-ContribAuthor ">Soo S.  Ko</span>, <span class="hlFld-ContribAuthor ">Yanlei  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Cherney</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Guo</span>, <span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Dauh-Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Duraisamy  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Piramanayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Ding-Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen V.  Balimane</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Dana M.  Banas</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia J.  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Bethanne M.  Warrack</span>, <span class="hlFld-ContribAuthor ">Lois  Lehman-McKeeman</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, and <span class="hlFld-ContribAuthor ">T. G. Murali  Dhar</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9837-9854. <a href="https://doi.org/10.1021/acs.jmedchem.6b01099" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01099%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTricyclic%252BAgonists%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BEmploying%252BLigand-Based%252BDrug%252BDesign%26aulast%3DXiao%26aufirst%3DHai-Yun%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25072016%26date%3D20102016%26date%3D10112016%26date%3D11102016%26volume%3D59%26issue%3D21%26spage%3D9837%26epage%3D9854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Lauren  Haque</span>, <span class="hlFld-ContribAuthor ">Parag  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Tebben</span>, <span class="hlFld-ContribAuthor ">Michael A.  Galella</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Virna  Borowski</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Bethanne  Warrack</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Julia P.  Li</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, and <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6248-6264. <a href="https://doi.org/10.1021/acs.jmedchem.6b00373" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252Bof%252Ba%252BSeries%252Bof%252BEthanolamine-Based%252BDirect-Acting%252BAgonists%252Bof%252BSphingosine-1-phosphate%252B%252528S1P1%252529%26aulast%3DGilmore%26aufirst%3DJohn%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29032016%26date%3D01072016%26date%3D14072016%26date%3D16062016%26volume%3D59%26issue%3D13%26spage%3D6248%26epage%3D6264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoping  Hou</span>, <span class="hlFld-ContribAuthor ">Juliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, and <span class="hlFld-ContribAuthor ">Huiping  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">An Efficient Scale-Up Synthesis of BMS-520, a Potent and Selective Isoxazole-Containing S1P1 Receptor Agonist. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (5)
                                     , 989-995. <a href="https://doi.org/10.1021/acs.oprd.6b00112" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00112%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DAn%252BEfficient%252BScale-Up%252BSynthesis%252Bof%252BBMS-520%25252C%252Ba%252BPotent%252Band%252BSelective%252BIsoxazole-Containing%252BS1P1%252BReceptor%252BAgonist%26aulast%3DHou%26aufirst%3DXiaoping%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D31032016%26date%3D11052016%26date%3D20052016%26date%3D05052016%26volume%3D20%26issue%3D5%26spage%3D989%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yangyang  Ma</span>, <span class="hlFld-ContribAuthor ">Yuanjin  Chen</span>, <span class="hlFld-ContribAuthor ">Chenhao  Lou</span>, <span class="hlFld-ContribAuthor ">Zhiping  Li</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO‐Mediated [4+1] Cycloaddition of β,β‐Dihalo Peroxides with Sodium Azide toward Isoxazoles. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (7)
                                     , 1018-1021. <a href="https://doi.org/10.1002/ajoc.202000153" title="DOI URL">https://doi.org/10.1002/ajoc.202000153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000153%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDABCO%2525E2%252580%252590Mediated%252B%25255B4%25252B1%25255D%252BCycloaddition%252Bof%252B%2525CE%2525B2%25252C%2525CE%2525B2%2525E2%252580%252590Dihalo%252BPeroxides%252Bwith%252BSodium%252BAzide%252Btoward%252BIsoxazoles%26aulast%3DMa%26aufirst%3DYangyang%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D7%26spage%3D1018%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiuhang Henry  Yip</span>, <span class="hlFld-ContribAuthor ">Dauh‐Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">James  Kempson</span>, <span class="hlFld-ContribAuthor ">Andres  Hernandez</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Dawn  Sun</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>. </span><span class="cited-content_cbyCitation_article-title">Large‐scale chiral supercritical fluid chromatography of a key intermediate in the synthesis of two S1P
              1
              final active pharmaceutical ingredients. </span><span class="cited-content_cbyCitation_journal-name">SEPARATION SCIENCE PLUS</span><span> <strong>2019,</strong> <em>2 </em>
                                    (9)
                                     , 343-352. <a href="https://doi.org/10.1002/sscp.201900047" title="DOI URL">https://doi.org/10.1002/sscp.201900047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/sscp.201900047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsscp.201900047%26sid%3Dliteratum%253Aachs%26jtitle%3DSEPARATION%2520SCIENCE%2520PLUS%26atitle%3DLarge%2525E2%252580%252590scale%252Bchiral%252Bsupercritical%252Bfluid%252Bchromatography%252Bof%252Ba%252Bkey%252Bintermediate%252Bin%252Bthe%252Bsynthesis%252Bof%252Btwo%252BS1P%252B1%252Bfinal%252Bactive%252Bpharmaceutical%252Bingredients%26aulast%3DYip%26aufirst%3DShiuhang%2BHenry%26date%3D2019%26date%3D2019%26volume%3D2%26issue%3D9%26spage%3D343%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Song</span>, <span class="hlFld-ContribAuthor ">Wei-Fen  Kang</span>, <span class="hlFld-ContribAuthor ">Hui  Cui</span>, <span class="hlFld-ContribAuthor ">Qian-Nan  Mu</span>, <span class="hlFld-ContribAuthor ">Yan-Yu  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient route to highly functionalized benzene derivatives by rhodium-catalyzed dimerization of diynes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2018,</strong> <em>72 </em>
                                    (6)
                                     , 1363-1368. <a href="https://doi.org/10.1007/s11696-018-0391-0" title="DOI URL">https://doi.org/10.1007/s11696-018-0391-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-018-0391-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-018-0391-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DAn%252Befficient%252Broute%252Bto%252Bhighly%252Bfunctionalized%252Bbenzene%252Bderivatives%252Bby%252Brhodium-catalyzed%252Bdimerization%252Bof%252Bdiynes%26aulast%3DXu%26aufirst%3DFen%26date%3D2018%26date%3D2018%26volume%3D72%26issue%3D6%26spage%3D1363%26epage%3D1368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neetu  Agrawal</span>, <span class="hlFld-ContribAuthor ">Pradeep  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">The synthetic and therapeutic expedition of isoxazole and its analogs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2018,</strong> <em>27 </em>
                                    (5)
                                     , 1309-1344. <a href="https://doi.org/10.1007/s00044-018-2152-6" title="DOI URL">https://doi.org/10.1007/s00044-018-2152-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-018-2152-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-018-2152-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DThe%252Bsynthetic%252Band%252Btherapeutic%252Bexpedition%252Bof%252Bisoxazole%252Band%252Bits%252Banalogs%26aulast%3DAgrawal%26aufirst%3DNeetu%26date%3D2018%26date%3D2018%26volume%3D27%26issue%3D5%26spage%3D1309%26epage%3D1344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelika  Sysak</span>, <span class="hlFld-ContribAuthor ">Bożena  Obmińska-Mrukowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Isoxazole ring as a useful scaffold in a search for new therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>137 </em>, 292-309. <a href="https://doi.org/10.1016/j.ejmech.2017.06.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIsoxazole%252Bring%252Bas%252Ba%252Buseful%252Bscaffold%252Bin%252Ba%252Bsearch%252Bfor%252Bnew%252Btherapeutic%252Bagents%26aulast%3DSysak%26aufirst%3DAngelika%26date%3D2017%26volume%3D137%26spage%3D292%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Nikodemiak</span>, <span class="hlFld-ContribAuthor ">Ulrich  Koert</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Catalyzed Synthesis of Functionalized 1,2,4-Oxadiazoles from Silyl Nitronates and Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (10)
                                     , 1708-1716. <a href="https://doi.org/10.1002/adsc.201601378" title="DOI URL">https://doi.org/10.1002/adsc.201601378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201601378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201601378%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMetal-Catalyzed%252BSynthesis%252Bof%252BFunctionalized%252B1%25252C2%25252C4-Oxadiazoles%252Bfrom%252BSilyl%252BNitronates%252Band%252BNitriles%26aulast%3DNikodemiak%26aufirst%3DPaul%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D10%26spage%3D1708%26epage%3D1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wooyoung  Hur</span>, <span class="hlFld-ContribAuthor ">Hugh  Rosen</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">A benzo[ b ]thiophene-based selective type 4 S1P receptor agonist. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (1)
                                     , 1-5. <a href="https://doi.org/10.1016/j.bmcl.2016.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bbenzo%25255B%252Bb%252B%25255Dthiophene-based%252Bselective%252Btype%252B4%252BS1P%252Breceptor%252Bagonist%26aulast%3DHur%26aufirst%3DWooyoung%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junqing  Guo</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Steven H.  Spergel</span>, <span class="hlFld-ContribAuthor ">James  Kempson</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Dana  Banas</span>, <span class="hlFld-ContribAuthor ">Richard  Liu</span>, <span class="hlFld-ContribAuthor ">Suzanne J.  Suchard</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Sandra  Rex-Rabe</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (10)
                                     , 2470-2474. <a href="https://doi.org/10.1016/j.bmcl.2016.03.105" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.105%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252Bsynthesis%252Bof%252Bpotent%252Band%252Bselective%252Bpyridyl-isoxazole%252Bbased%252Bagonists%252Bof%252Bsphingosine-1-phosphate%252B1%252B%252528S1P1%252529%26aulast%3DGuo%26aufirst%3DJunqing%26date%3D2016%26volume%3D26%26issue%3D10%26spage%3D2470%26epage%3D2474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of sphingosine and sphingosine 1-phospate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of fingolimod (<b>1</b>) and fingolimod-P (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Discovery of isoxazole based agonists of S1P<sub>1</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Isoxazoles <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuOH, DMAP, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 81%; (b) 10% Pd/C, EtOAc, 92%; (c) 4-cyanobenzaldehyde, Na(CN)BH<sub>3</sub>; MeOH, 89%; (d) HONH<sub>2</sub>–HCl; NaHCO<sub>3</sub>, <i>t</i>-BuOH, 55%; (e) <b>13</b>, <b>25</b>, or <b>29</b>, EDCI, HOBt, DMF, 53–86%; (f) TFA.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Isoxazole-3-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-butyl-3-methyl-1<i>H</i>-imidazol-3-ium hexafluorophosphate, toluene, microwave, 170 °C; (b) mesitylene, 150 °C; (c) LiOH–H<sub>2</sub>O, MeOH/H<sub>2</sub>O; (d) 1 N aqueous NaOH, MeOH, microwave, 100 °C.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 4-Trifluoromethylisoxazole-3-carboxylic Acids</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Isoxazole-3-carboxylic Acid <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, 5% fuming HNO<sub>3</sub> in AcOH; (b) tributyl(1-ethoxyvinyl)tin, dioxane, 100 °C; (c) deoxofluor, ethanol, 85 °C; (d) 1 N aq NaOH, methanol.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Isoxazole-5-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, <10%; (b) LiOH, MeOH/H<sub>2</sub>O, 95–100%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Preparation of 3-Phenyl-4-(trifluoromethyl)isoxazole-5-carboxylic Acid <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of 4,4,4-Trifluorobut-2-yn-1-ol<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>-BuLi, DIPA, Et<sub>2</sub>O; (b) <i>n</i>-BuLi, Et<sub>2</sub>O; (c) paraformaldehyde, 70%.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0016.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. An Improved Synthesis of Isoxazole <b>6d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) cyanuric fluoride, >95%; (b) Hunig’s base, MeCN, 80%; (c) TFA, neutralization, >90%.</p></p></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Quantification of S1P<sub>1</sub> on the cell membrane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0006.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Paw swelling of <b>6d</b> (0.03, 0.1, 0.5, and 3.0 mg/kg) and <b>1</b> (0.3 mg/kg) vs vehicle in a rat adjuvant arthritis model. (B) Paw histology of <b>6d</b> (0.03, 0.1, 0.5, and 3.0 mg/kg) and <b>1</b> (0.3 mg/kg) vs vehicle in a rat adjuvant arthritis model: rats (<i>n</i> = 8–10/group) were administered <b>6d</b> and <b>1</b> po/q.d. starting on day 0 at the time of immunization; vehicle, PEG300; (∗) <i>p</i> < 0.05 compared to vehicle treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/medium/jm-2016-00089z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0007.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Efficacy of <b>6d</b> (0.0, 0.2, and 2.0 mg/kg) and <b>1</b> (1.0 mg/kg) vs vehicle in a mouse experimental autoimmune encephalomyelitis model (EAE). (B) Spinal cord histology of <b>6d</b> (0.0, 0.2, and 2.0 mg/kg) and <b>1</b> (1.0 mg/kg) vs vehicle in a mouse experimental autoimmune encephalomyelitis model (EAE): mice (<i>n</i> = 10/group) were administered <b>6d</b> and <b>1</b> po/q.d. starting on day 0 at the time of immunization with MOG-peptide (myelin oligodendrocyte glycoprotein); vehicle, PEG300; (∗) <i>p</i> < 0.05 compared to vehicle treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-6/acs.jmedchem.6b00089/20160318/images/large/jm-2016-00089z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00089&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple schlerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e3181cbf825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1097%2FWNF.0b013e3181cbf825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+schlerosis&doi=10.1097%2FWNF.0b013e3181cbf825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e3181cbf825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e3181cbf825%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520schlerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FWNF.0b013e3181cbf825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-348&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span><span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lhh1B7WYg7pcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pappu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regard, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1126/science.1139221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1126%2Fscience.1139221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=17363629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVeku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=295-298&author=R.+Pappuauthor=S.+R.+Schwabauthor=I.+Cornelissenauthor=J.+P.+Pereiraauthor=J.+B.+Regardauthor=Y.+Xuauthor=E.+Camererauthor=Y.-W.+Zhengauthor=Y.+Huangauthor=J.+G.+Cysterauthor=S.+R.+Coughlin&title=Promotion+of+lymphocyte+egress+into+blood+and+lymph+by+distinct+sources+of+sphingosine-1-phosphate&doi=10.1126%2Fscience.1139221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate</span></div><div class="casAuthors">Pappu, Rajita; Schwab, Susan R.; Cornelissen, Ivo; Pereira, Joao P.; Regard, Jean B.; Xu, Ying; Camerer, Eric; Zheng, Yao-Wu; Huang, Yong; Cyster, Jason G.; Coughlin, Shaun R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5822</span>),
    <span class="NLM_cas:pages">295-298</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Lymphocytes require sphingosine-1-phosphate (S1P) receptor-1 to exit lymphoid organs, but the source(s) of extracellular S1P and whether S1P directly promotes egress are unknown.  By using mice in which the two kinases that generate S1P were conditionally ablated, we find that plasma S1P is mainly hematopoietic in origin, with erythrocytes a major contributor, whereas lymph S1P is from a distinct radiation-resistant source.  Lymphocyte egress from thymus and secondary lymphoid organs was markedly reduced in kinase-deficient mice.  Restoration of S1P to plasma rescued egress to blood but not lymph, and the rescue required lymphocyte expression of S1P-receptor-1.  Thus, sep. sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs.  Disruption of compartmentalized S1P signaling is a plausible mechanism by which S1P-receptor-1 agonists function as immunosuppressives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMH4WVYwTIX7Vg90H21EOLACvtfcHk0lhh1B7WYg7pcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVeku70%253D&md5=6c658296c3b1d34543c193987092506b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1139221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1139221%26sid%3Dliteratum%253Aachs%26aulast%3DPappu%26aufirst%3DR.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCornelissen%26aufirst%3DI.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DRegard%26aufirst%3DJ.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DY.-W.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DPromotion%2520of%2520lymphocyte%2520egress%2520into%2520blood%2520and%2520lymph%2520by%2520distinct%2520sources%2520of%2520sphingosine-1-phosphate%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D295%26epage%3D298%26doi%3D10.1126%2Fscience.1139221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1038/nature02284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fnature02284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=14737169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1&doi=10.1038%2Fnature02284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span></div><div class="casAuthors">Matloubian, Mehrdad; Lo, Charles G.; Cinamon, Guy; Lesneski, Matthew J.; Xu, Ying; Brinkmann, Volker; Allende, Maria L.; Proia, Richard L.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">6972</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adaptive immunity depends on T-cell exit from the thymus and T and B cells traveling between secondary lymphoid organs to survey for antigens.  After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown.  An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate (S1P) receptors.  However, the role of S1P receptors in normal immune cell trafficking is unclear.  Here we show that in mice whose hematopoietic cells lack a single S1P receptor (S1P1; also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus.  Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph.  Adoptive cell transfer expts. establish an intrinsic requirement for S1P1 in T and B cells for lymphoid organ egress.  Furthermore, S1P1-dependent chemotactic responsiveness is strongly upregulated in T-cell development before exit from the thymus, whereas S1P1 is downregulated during peripheral lymphocyte activation, and this is assocd. with retention in lymphoid organs.  We find that FTY720 treatment downregulates S1P1, creating a temporary pharmacol. S1P1-null state in lymphocytes, providing an explanation for the mechanism of FTY720-induced lymphocyte sequestration.  These findings establish that S1P1 is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mWA73kFtwbVg90H21EOLACvtfcHk0lj9OFU-kXFGSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCguw%253D%253D&md5=0dd84e9cca37ec30894497ff4477d0d8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature02284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02284%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360%26doi%3D10.1038%2Fnature02284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, J.</span><span> </span><span class="NLM_article-title">The vascular S1P gradient: cellular sources and biological significance</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2008.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.bbalip.2008.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=18674637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=477-482&author=T.+Hlaauthor=K.+Venkataramanauthor=J.+Michaud&title=The+vascular+S1P+gradient%3A+cellular+sources+and+biological+significance&doi=10.1016%2Fj.bbalip.2008.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The vascular S1P gradient-Cellular sources and biological significance</span></div><div class="casAuthors">Hla, Timothy; Venkataraman, Krishnan; Michaud, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1781</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P), a product of sphingomyelin metab., is enriched in the circulatory system whereas it is estd. to be much lower in interstitial fluids of tissues.  This concn. gradient, termed the vascular S1P gradient appears to form as a result of substrate availability and the action of metabolic enzymes.  S1P levels in blood and lymph are estd. to be in the μM range.  In the immune system, the S1P gradient is needed as a spatial cue for lymphocyte and hematopoietic cell trafficking.  During inflammatory reactions in which enhanced vascular permeability occurs, a burst of S1P becomes available to its receptors in the extravascular compartment, which likely contributes to the tissue reactions.  Thus, the presence of the vascular S1P gradient is thought to contribute to physiol. and pathol. conditions.  From an evolutionary perspective, S1P receptors may have co-evolved with the advent of a closed vascular system and the trafficking paradigms for hematopoietic cells to navigate in and out of the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosbyXvTWrRf7Vg90H21EOLACvtfcHk0lj9OFU-kXFGSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKjtbrF&md5=a9c4420dff6764f71060b18149669767</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2008.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2008.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DVenkataraman%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DJ.%26atitle%3DThe%2520vascular%2520S1P%2520gradient%253A%2520cellular%2520sources%2520and%2520biological%2520significance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2008%26volume%3D1781%26spage%3D477%26epage%3D482%26doi%3D10.1016%2Fj.bbalip.2008.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Finding a way out: lymphocyte egress from lymphoid organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span><span class="refDoi"> DOI: 10.1038/ni1545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fni1545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=18026082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1295-1301&author=S.+R.+Schwabauthor=J.+G.+Cyster&title=Finding+a+way+out%3A+lymphocyte+egress+from+lymphoid+organs&doi=10.1038%2Fni1545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a way out: lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Schwab, Susan R.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1301</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function.  The discovery that a small-mol. inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs.  S1P exists in higher concns. in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit.  Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes.  In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites.  We relate this model to work examg. the effects of S1P receptor agonists on endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWY-Rk111SmLVg90H21EOLACvtfcHk0lj9OFU-kXFGSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J&md5=ccf7ef06130d3ebd218707ac92618f36</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fni1545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1545%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DFinding%2520a%2520way%2520out%253A%2520lymphocyte%2520egress%2520from%2520lymphoid%2520organs%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1295%26epage%3D1301%26doi%3D10.1038%2Fni1545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1038/nri1650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fnri1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=15999095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=560-570&author=H.+Rosenauthor=E.+J.+Goetzl&title=Sphingosine+1-phosphate+and+its+receptors%3A+an+autocrine+and+paracrine+network&doi=10.1038%2Fnri1650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span></div><div class="casAuthors">Rosen, Hugh; Goetzl, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a biol. active lysophospholipid that transmits signals through a family of G-protein-coupled receptors to control cellular differentiation and survival, as well as the vital functions of several types of immune cell.  In this Review article, the authors discuss recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles.  In an autocrine manner, through interactions with different G-protein-coupled receptors, S1P also enhances optimal mast-cell migration and release of pro-inflammatory mediators in allergic reactions.  S1P-S1P-receptor regulatory systems might therefore be novel targets for the therapy of diverse immunol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-Zo0R14YILVg90H21EOLACvtfcHk0lhKqs7dRhAAxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D&md5=b680f6c9e29d407579ab7f056209d853</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnri1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1650%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520its%2520receptors%253A%2520an%2520autocrine%2520and%2520paracrine%2520network%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D560%26epage%3D570%26doi%3D10.1038%2Fnri1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the sphingosine 1-phosphate receptor, S1P<sub>1</sub>, on T-cells controls thymic emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span><span class="refDoi"> DOI: 10.1074/jbc.M314291200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1074%2Fjbc.M314291200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+sphingosine+1-phosphate+receptor%2C+S1P1%2C+on+T-cells+controls+thymic+emigration&doi=10.1074%2Fjbc.M314291200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314291200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314291200%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520controls%2520thymic%2520emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401%26doi%3D10.1074%2Fjbc.M314291200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pham, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">S1P<sub>1</sub> receptor singling overrides retention mediated by Gαi-coupled receptors to promote T-cell egress</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span><span class="refDoi"> DOI: 10.1016/j.immuni.2007.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.immuni.2007.11.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=122-133&author=T.+H.+Phamauthor=T.+Okadaauthor=M.+Matloubianauthor=C.+G.+Loauthor=J.+G.+Cyster&title=S1P1+receptor+singling+overrides+retention+mediated+by+G%CE%B1i-coupled+receptors+to+promote+T-cell+egress&doi=10.1016%2Fj.immuni.2007.11.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2007.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2007.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DPham%26aufirst%3DT.%2BH.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DS1P1%2520receptor%2520singling%2520overrides%2520retention%2520mediated%2520by%2520G%25CE%25B1i-coupled%2520receptors%2520to%2520promote%2520T-cell%2520egress%26jtitle%3DImmunity%26date%3D2008%26volume%3D28%26spage%3D122%26epage%3D133%26doi%3D10.1016%2Fj.immuni.2007.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><div class="note"><p class="first last">and references therein</p></div><span class="refDoi"> DOI: 10.1038/nrd3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis&doi=10.1038%2Fnrd3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lhKqs7dRhAAxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897%26doi%3D10.1038%2Fnrd3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">A mechanistically novel, first oral therapy for multiple sclerosis: The development of fingolimod (FTY720, Gilenya)</span> <span class="citation_source-journal">Discovery Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=213-228&author=J.+Chunauthor=V.+Brinkmann&title=A+mechanistically+novel%2C+first+oral+therapy+for+multiple+sclerosis%3A+The+development+of+fingolimod+%28FTY720%2C+Gilenya%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DA%2520mechanistically%2520novel%252C%2520first%2520oral%2520therapy%2520for%2520multiple%2520sclerosis%253A%2520The%2520development%2520of%2520fingolimod%2520%2528FTY720%252C%2520Gilenya%2529%26jtitle%3DDiscovery%2520Med.%26date%3D2011%26volume%3D12%26spage%3D213%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e3181cbf825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1097%2FWNF.0b013e3181cbf825" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.-P.+Hartung&title=Mechanism+of+action+of+oral+fingolimod+%28FTY720%29+in+multiple+sclerosis&doi=10.1097%2FWNF.0b013e3181cbf825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e3181cbf825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e3181cbf825%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DMechanism%2520of%2520action%2520of%2520oral%2520fingolimod%2520%2528FTY720%2529%2520in%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FWNF.0b013e3181cbf825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pelletier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafler, D. A.</span><span> </span><span class="NLM_article-title">Fingolimod for multiple sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.1056/NEJMct1101691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1056%2FNEJMct1101691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=22276823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1artLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=339-347&author=D.+Pelletierauthor=D.+A.+Hafler&title=Fingolimod+for+multiple+sclerosis&doi=10.1056%2FNEJMct1101691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod for multiple sclerosis</span></div><div class="casAuthors">Pelletier, Daniel; Hafler, David A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">339-347</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A 37-yr-old man with multiple sclerosis was evaluated for consideration of oral immunotherapy. Six years earlier, he had reported acute monocular visual disturbance.  The diagnosis of multiple sclerosis was subsequently confirmed by means of examn. of cerebrospinal fluid, which revealed an increased IgG index and oligoclonal banding, and by abnormal results on magnetic resonance imaging (MRI).  There was no family history of multiple sclerosis.  Daily injections of glatiramer acetate were initiated at the time of diagnosis, but two consecutive annual brain MRI scans revealed substantial disease activity.  He was then switched to interferon beta therapy, but this treatment was discontinued after the patient had two episodes of acute neurol. worsening.  Monthly natalizumab therapy was then considered, but a test for JC virus antibodies was pos.  Neurol. examn. showed disk pallor and visual acuity of 20/40 in the right eye, partial internuclear ophthalmoplegia, wide-based gait, and posterior column deficits in both legs.  The patient was referred to a specialist in multiple sclerosis for consideration of oral fingolimod therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7E7D-NWq_7LVg90H21EOLACvtfcHk0lg6gHg0gsZirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1artLc%253D&md5=6e217009d6b857582cab89b7629ba4e5</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1056%2FNEJMct1101691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMct1101691%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DD.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26atitle%3DFingolimod%2520for%2520multiple%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D339%26epage%3D347%26doi%3D10.1056%2FNEJMct1101691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span> </span><span class="NLM_article-title">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span><span class="refDoi"> DOI: 10.1056/NEJMoa052643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1056%2FNEJMoa052643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=16971719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1124-1140&author=L.+Kapposauthor=J.+Antelauthor=G.+Comiauthor=X.+Montalbanauthor=P.+O%E2%80%99Connorauthor=C.+H.+Polmanauthor=T.+Haasauthor=A.+A.+Kornauthor=G.+Karlssonauthor=E.+W.+Radue&title=Oral+fingolimod+%28FTY720%29+for+relapsing+multiple+sclerosis&doi=10.1056%2FNEJMoa052643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1140</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis.  We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 mo with magnetic resonance imaging (MRI) and clin. evaluations (core study, months 0 to 6).  The primary end point was the total no. of gadolinium-enhanced lesions recorded on T1-weighted MRI at monthly intervals for 6 mo.  In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses.  A total of 255 patients completed the core study.  The median total no. of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P < 0.001) and 5.0 mg of fingolimod (3 lesions, P = 0.006) than with placebo (5 lesions).  The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P = 0.009) and 0.36 in the group given 5.0 mg of fingolimod (P = 0.01).  For the 227 patients who completed the extension study, the no. of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod.  Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea.  Clin. asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group).  One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group.  Fingolimod was also assocd. with an initial redn. in the heart rate and a modest decrease in the forced expiratory vol. in 1 s.  In this proof-of-concept study, fingolimod reduced the no. of lesions detected on MRI and clin. disease activity in patients with multiple sclerosis.  Evaluation in larger, longer-term studies is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4MSvDIuvV7Vg90H21EOLACvtfcHk0lg6gHg0gsZirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D&md5=2a84e8f5fb92091782406da9dcbc1453</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052643%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DAntel%26aufirst%3DJ.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DHaas%26aufirst%3DT.%26aulast%3DKorn%26aufirst%3DA.%2BA.%26aulast%3DKarlsson%26aufirst%3DG.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26atitle%3DOral%2520fingolimod%2520%2528FTY720%2529%2520for%2520relapsing%2520multiple%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1124%26epage%3D1140%26doi%3D10.1056%2FNEJMoa052643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1124/jpet.103.062828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes&doi=10.1124%2Fjpet.103.062828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lg6gHg0gsZirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768%26doi%3D10.1124%2Fjpet.103.062828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6173</span><span class="refDoi"> DOI: 10.1021/jm0503244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6169-6173&author=Z.+Liauthor=W.+Chenauthor=J.+J.+Haleauthor=C.+L.+Lynchauthor=S.+G.+Millsauthor=T.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=S.+A.+Parentauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=E.+J.+Quackenbushauthor=L.+A.+Wickhamauthor=H.+Vargasauthor=R.+M.+Evansauthor=H.+Rosenauthor=S.+Mandala&title=Discovery+of+Potent+3%2C5-Diphenyl-1%2C2%2C4-oxadiazole+Sphingosine-1-phosphate-1+%28S1P1%29+Receptor+Agonists+with+Exceptional+Selectivity+against+S1P2+and+S1P3&doi=10.1021%2Fjm0503244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm0503244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503244%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DT.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DE.%2BJ.%26aulast%3DWickham%26aufirst%3DL.%2BA.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Potent%25203%252C5-Diphenyl-1%252C2%252C4-oxadiazole%2520Sphingosine-1-phosphate-1%2520%2528S1P1%2529%2520Receptor%2520Agonists%2520with%2520Exceptional%2520Selectivity%2520against%2520S1P2%2520and%2520S1P3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6169%26epage%3D6173%26doi%3D10.1021%2Fjm0503244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+Crumbauthor=M.+Saltzmanauthor=M.+Rosenbergauthor=E.+Wallstrom&title=The+selective+sphingosine+1-phosphate+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate&doi=10.1111%2Fj.1476-5381.2012.02061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely, P.; Nuesslein-Hildesheim, B.; Guerini, D.; Brinkmann, V.; Traebert, M.; Bruns, C.; Pan, S.; Gray, N. S.; Hinterding, K.; Cooke, N. G.; Groenewegen, A.; Vitaliti, A.; Sing, T.; Luttringer, O.; Yang, J.; Gardin, A.; Wang, N.; Crumb, W. J., Jr.; Saltzman, M.; Rosenberg, M.; Wallstrom, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors.  S1P1 receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclin. and human data.  Exptl. Approach BAF312 was tested in a rat exptl. autoimmune encephalomyelitis (EAE) model.  Electrophysiol. recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  Key Results BAF312 effectively suppressed EAE in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4+ T cells, Tnaive, Tcentral memory and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P3 receptors (assocd. with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  Conclusion and Implications This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42VfW58NMyLVg90H21EOLACvtfcHk0lhPrwl4neHwJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE&md5=0034be62fb68b10abefff50f0220be2a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSaltzman%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DThe%2520selective%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047%26doi%3D10.1111%2Fj.1476-5381.2012.02061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brossard, P.; Hofmann, S.; Cavallaro, M.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Entry-into-Humans Study with ACT-128800, a Selective S1P<sub>1</sub> Receptor Agonist: Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics</span>. Presented at ASCPT 2009, Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Washington DC, U.S., March 18–21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>PII-87;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Brossard&author=S.+Hofmann&author=M.+Cavallaro&author=A.+Halabi&author=J.+Dingemanse&title=Entry-into-Humans+Study+with+ACT-128800%2C+a+Selective+S1P1+Receptor+Agonist%3A+Tolerability%2C+Safety%2C+Pharmacokinetics%2C+and+Pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEntry-into-Humans%2520Study%2520with%2520ACT-128800%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%253A%2520Tolerability%252C%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11a1"><span>Clin. Pharmcol. Ther.<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">S63</span><span class="NLM_x">–</span> <span class="NLM_lpage">S64</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clin.+Pharmcol.+Ther.+2009%2C+85%2C+S63%E2%80%93S64."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DClin.%2520Pharmcol.%2520Ther.%26date%3D2009%26volume%3D85%26spage%3DS63%26epage%3DS64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P<sub>1</sub>/S1P<sub>5</sub> Receptor Modulator BAF312 Indicates That S1P<sub>1</sub> Rather Than S1P<sub>3</sub> Mediates Transient Heart Rate Reduction in Humans</span>. Presented at the 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Düsseldorf, Germany,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>P437.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P<sub>1</sub>/S1P<sub>5</sub> Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P<sub>1</sub> in Mediating a Transient Heart Rate Reduction</span>. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Discovery and Development of Sphingosine-1-Phosphate-1 Receptor Agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><div class="note"><p class="first last">and references therein</p></div><span class="refDoi"> DOI: 10.1016/B978-0-12-396492-2.00013-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2FB978-0-12-396492-2.00013-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+Advances+in+the+Discovery+and+Development+of+Sphingosine-1-Phosphate-1+Receptor+Agonists&doi=10.1016%2FB978-0-12-396492-2.00013-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396492-2.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396492-2.00013-8%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Sphingosine-1-Phosphate-1%2520Receptor%2520Agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1016%2FB978-0-12-396492-2.00013-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Design and synthesis of new trycyclic indoles as potent modulators of the S1P<sub>1</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.bmcl.2014.11.089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=659-663&author=D.+J.+Buzardauthor=O.+Schraderauthor=X.+Zhuauthor=J.+Lehmannauthor=B.+Johnsonauthor=M.+Kasemauthor=S.-H.+Kimauthor=A.+Kawasakiauthor=L.+Lopezauthor=J.+Moodyauthor=S.+Hanauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=J.+Thatteauthor=J.+Gatlinauthor=R.+M.+Jones&title=Design+and+synthesis+of+new+trycyclic+indoles+as+potent+modulators+of+the+S1P1+receptor&doi=10.1016%2Fj.bmcl.2014.11.089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.089%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DSchrader%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520new%2520trycyclic%2520indoles%2520as%2520potent%2520modulators%2520of%2520the%2520S1P1%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D659%26epage%3D663%26doi%3D10.1016%2Fj.bmcl.2014.11.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acids as S1P<sub>1</sub> functional agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1334</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/ml500422m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500422m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1334-1339&author=D.+J.+Buzardauthor=L.+Lopezauthor=J.+Moodyauthor=A.+Kawasakiauthor=T.+O.+Schraderauthor=M.+Kasemauthor=B.+Johnsonauthor=X.+Zhuauthor=L.+Thoresenauthor=S.+H.+Kimauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+Krishnanauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=W.+Chenauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=I.+Gaidarovauthor=T.+Anthonyauthor=M.+Leauthor=D.+J.+Unettauthor=S.+Stirnauthor=A.+Blackburnauthor=D.+P.+Behanauthor=R.+M.+Jones&title=%287-Benzyloxy-2%2C3-dihydro-1H-pyrrolo%5B1%2C2-a%5Dindol-1-yl%29acetic+acids+as+S1P1+functional+agonists&doi=10.1021%2Fml500422m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fml500422m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500422m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%2BO.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3D%25287-Benzyloxy-2%252C3-dihydro-1H-pyrrolo%255B1%252C2-a%255Dindol-1-yl%2529acetic%2520acids%2520as%2520S1P1%2520functional%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1334%26epage%3D1339%26doi%3D10.1021%2Fml500422m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Skidmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cridland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">Optimization of Sphingosine-1-phosphate receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamics profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10424</span><span class="NLM_x">–</span> <span class="NLM_lpage">10442</span><span class="refDoi"> DOI: 10.1021/jm5010336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10424-10442&author=J.+Skidmoreauthor=J.+Heerauthor=C.+N.+Johnsonauthor=D.+Nortonauthor=S.+Redshawauthor=J.+Sweetingauthor=D.+Hurstauthor=A.+Cridlandauthor=D.+Veseyauthor=I.+Wallauthor=M.+Ahmedauthor=D.+Riversauthor=J.+Myattauthor=G.+Giblinauthor=K.+Philpottauthor=U.+Kumarauthor=A.+Stevensauthor=R.+A.+Bitauthor=A.+Haynesauthor=S.+Taylorauthor=R.+Watsonauthor=J.+Witheringtonauthor=E.+Demontauthor=T.+D.+Heightman&title=Optimization+of+Sphingosine-1-phosphate+receptor+agonists%3A+effects+of+acidic%2C+basic%2C+and+zwitterionic+chemotypes+on+pharmacokinetic+and+pharmacodynamics+profiles&doi=10.1021%2Fjm5010336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Fjm5010336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010336%26sid%3Dliteratum%253Aachs%26aulast%3DSkidmore%26aufirst%3DJ.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DNorton%26aufirst%3DD.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DSweeting%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DD.%26aulast%3DCridland%26aufirst%3DA.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWall%26aufirst%3DI.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DRivers%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DGiblin%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3DOptimization%2520of%2520Sphingosine-1-phosphate%2520receptor%2520agonists%253A%2520effects%2520of%2520acidic%252C%2520basic%252C%2520and%2520zwitterionic%2520chemotypes%2520on%2520pharmacokinetic%2520and%2520pharmacodynamics%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10424%26epage%3D10442%26doi%3D10.1021%2Fjm5010336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists–Part 3: From thiophenes to pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1021/jm4014696</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4014696" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=110-130&author=M.+H.+Bolliauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=C.+Kohlauthor=J.+Grimontauthor=P.+Hessauthor=C.+Lescopauthor=B.+Mathysauthor=C.+Mullerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=G.+Schmidtauthor=J.+Seifertauthor=B.+Steinerauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists%E2%80%93Part+3%3A+From+thiophenes+to+pyridines&doi=10.1021%2Fjm4014696"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Fjm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014696%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DGrimont%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSeifert%26aufirst%3DJ.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%25E2%2580%2593Part%25203%253A%2520From%2520thiophenes%2520to%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D110%26epage%3D130%26doi%3D10.1021%2Fjm4014696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists – Part 2: From bicylco[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span><span class="refDoi"> DOI: 10.1021/jm401456d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401456d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=78-97&author=M.+H.+Bolliauthor=J.+Velkerauthor=C.+Mullerauthor=B.+Mathysauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=S.+Meyerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=B.+Steiner&title=Novel+S1P1+receptor+agonists+%E2%80%93+Part+2%3A+From+bicylco%5B3.1.0%5Dhexane-fused+thiophenes+to+isobutyl+substituted+thiophenes&doi=10.1021%2Fjm401456d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1021%2Fjm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520%25E2%2580%2593%2520Part%25202%253A%2520From%2520bicylco%255B3.1.0%255Dhexane-fused%2520thiophenes%2520to%2520isobutyl%2520substituted%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D78%26epage%3D97%26doi%3D10.1021%2Fjm401456d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D.</span><span> </span><span class="NLM_article-title">Discovery of oxazole and triazole derivatives as potent and selective S1P<sub>1</sub> agonists through pharmacophore-guided design</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.ejmech.2014.07.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=1-15&author=Y.+Tianauthor=J.+Jinauthor=X.+Wangauthor=J.+Huauthor=Q.+Xiaoauthor=W.+Zhouauthor=X.+Chenauthor=D.+Yin&title=Discovery+of+oxazole+and+triazole+derivatives+as+potent+and+selective+S1P1+agonists+through+pharmacophore-guided+design&doi=10.1016%2Fj.ejmech.2014.07.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520oxazole%2520and%2520triazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520S1P1%2520agonists%2520through%2520pharmacophore-guided%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.ejmech.2014.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill-Drzewi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueneva-Boucheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, R. M.</span><span> </span><span class="NLM_article-title">Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4807</span><span class="NLM_x">–</span> <span class="NLM_lpage">4811</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1016%2Fj.bmcl.2014.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4807-4811&author=J.+C.+Horanauthor=S.+Sanyalauthor=Y.+Choiauthor=M.+Hill-Drzewiauthor=L.+Patnaudeauthor=S.+Andersonauthor=S.+Fogalauthor=C.+Maoauthor=B.+N.+Cookauthor=K.+Gueneva-Bouchevaauthor=M.+B.+Fisherauthor=E.+Hickeyauthor=E.+Packauthor=L.+C.+Bannenauthor=D.+S.+Chanauthor=M.+B.+Macauthor=S.+M.+Ngauthor=Y.+Wangauthor=W.+Xuauthor=L.+K.+Modisauthor=R.+M.+Lemieux&title=Piperazinyl-oxadiazoles+as+selective+sphingosine-1-phosphate+receptor+agonists&doi=10.1016%2Fj.bmcl.2014.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DFogal%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DB.%2BN.%26aulast%3DGueneva-Boucheva%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DBannen%26aufirst%3DL.%2BC.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DMac%26aufirst%3DM.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DLemieux%26aufirst%3DR.%2BM.%26atitle%3DPiperazinyl-oxadiazoles%2520as%2520selective%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4807%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2014.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span><span class="refDoi"> DOI: 10.1021/jm0492507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists&doi=10.1021%2Fjm0492507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665%26doi%3D10.1021%2Fjm0492507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Dyckman, A. J.; Li, L.; Watterson, S. H.; Das, J.; Li, T.; Banas, D.; Cvijic, M. E.; Liu, R.; Suchard, S.; Shen, D. R.; Yarde, M.; Gillooly, K.; McIntyre, K.; Shuster, D.; Taylor, T.; Yang, X.; Cornelius, G.; D’Arienzo, C.; Marino, A.; Balimane, P.; Salter-Cid, L.; McKinnon, M.; Barrish, J. C.; Carter, P. H.; Pitts, W. J.; Xie, J.</span><span> </span><span class="NLM_article-title">Identification of potent and selective pyrazole based agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>)</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 244th National Meeting and Exposition of the American Chemical Society, Philadelphia, PA, U.S., August 19–23, 2012; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>MEDI-72.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+J.+Dyckman&author=L.+Li&author=S.+H.+Watterson&author=J.+Das&author=T.+Li&author=D.+Banas&author=M.+E.+Cvijic&author=R.+Liu&author=S.+Suchard&author=D.+R.+Shen&author=M.+Yarde&author=K.+Gillooly&author=K.+McIntyre&author=D.+Shuster&author=T.+Taylor&author=X.+Yang&author=G.+Cornelius&author=C.+D%E2%80%99Arienzo&author=A.+Marino&author=P.+Balimane&author=L.+Salter-Cid&author=M.+McKinnon&author=J.+C.+Barrish&author=P.+H.+Carter&author=W.+J.+Pitts&author=J.+Xie&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520pyrazole%2520based%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watterson, S. H.; Guo, J.; Spergel, S. H.; Langevine, C. M.; Moquin, R. V.; Kempson, J.; Shen, D. R.; Yarde, M.; Cvijic, M. E.; Banas, D.; Liu, R.; Suchard, S. J.; Gillooly, K.; Taylor, T.; RexRabe, S.; Shuster, D. J.; McIntyre, K. W.; Cornelius, G.; Darienzo, C.; Marino, A.; Balimane, P.; Saltercid, L.; McKinnon, M.; Barrish, J. C.; Carter, P. C.; Pitts, W. J.; Xie, J.; Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Potent and selective agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>): The discovery and SAR of a novel isoxazole based series</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 241st National Meeting and Exposition of the American Chemical Society, Anaheim, CA, U.S., March 27–31, 2011; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>MEDI-96.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+H.+Watterson&author=J.+Guo&author=S.+H.+Spergel&author=C.+M.+Langevine&author=R.+V.+Moquin&author=J.+Kempson&author=D.+R.+Shen&author=M.+Yarde&author=M.+E.+Cvijic&author=D.+Banas&author=R.+Liu&author=S.+J.+Suchard&author=K.+Gillooly&author=T.+Taylor&author=S.+RexRabe&author=D.+J.+Shuster&author=K.+W.+McIntyre&author=G.+Cornelius&author=C.+Darienzo&author=A.+Marino&author=P.+Balimane&author=L.+Saltercid&author=M.+McKinnon&author=J.+C.+Barrish&author=P.+C.+Carter&author=W.+J.+Pitts&author=J.+Xie&author=A.+J.+Dyckman&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26atitle%3DPotent%2520and%2520selective%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%253A%2520The%2520discovery%2520and%2520SAR%2520of%2520a%2520novel%2520isoxazole%2520based%2520series%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watterson, S. H.; Dyckman, A. J.; Pitts, W. J.; Spergel, S. H.</span><span> </span><span class="NLM_article-title">Substituted isoxazole derivatives as S1P agonists in the treatment of autoimmune and inflammatory diseases and their preparation</span>. WO 2010085581,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+H.+Watterson&author=A.+J.+Dyckman&author=W.+J.+Pitts&author=S.+H.+Spergel&title=Substituted+isoxazole+derivatives+as+S1P+agonists+in+the+treatment+of+autoimmune+and+inflammatory+diseases+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26atitle%3DSubstituted%2520isoxazole%2520derivatives%2520as%2520S1P%2520agonists%2520in%2520the%2520treatment%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%2520and%2520their%2520preparation%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b.2"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">232588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2010%2C+153%2C+232588"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b.2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2010%26volume%3D153%26spage%3D232588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b.3"><span>(U.S. Patent 8354398,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28U.S.+Patent+8354398%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b.3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Liu, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, R. K.</span><span> </span><span class="NLM_article-title">A particularly convenient preparation of benzohydroximinoyl chlorides (nitrile oxide precursors)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1918</span><span class="refDoi"> DOI: 10.1021/jo01307a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01307a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADyaL3cXlsV2qsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=3916-1918&author=K.-C.+Liuauthor=B.+R.+Sheltonauthor=R.+K.+Howe&title=A+particularly+convenient+preparation+of+benzohydroximinoyl+chlorides+%28nitrile+oxide+precursors%29&doi=10.1021%2Fjo01307a039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A particularly convenient preparation of benzohydroximinoyl chlorides (nitrile oxide precursors)</span></div><div class="casAuthors">Liu, Kou-Chang; Shelton, Becky R.; Howe, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3916-18</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Reaction of RC6H4CH:NOH with N-chlorosuccinimide in DMF gave RC6H4CCl:NOH (R = 2-MeO, 3-Cl, 2-F3C, etc.) in 75-96% yields.  Ring chlorination does not occur with mesitaldehyde oxime or 2-methoxybenzaldehyde oxime.  Only with the very strongly ring activated 2,4-dimethoxybenzaldehyde oxime does ring chlorination occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgo8rs7VXWVLVg90H21EOLACvtfcHk0ljfAIzcAKAAPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlsV2qsbo%253D&md5=6047d84ce7c2466ff9fa0800dbe6f313</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo01307a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01307a039%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.-C.%26aulast%3DShelton%26aufirst%3DB.%2BR.%26aulast%3DHowe%26aufirst%3DR.%2BK.%26atitle%3DA%2520particularly%2520convenient%2520preparation%2520of%2520benzohydroximinoyl%2520chlorides%2520%2528nitrile%2520oxide%2520precursors%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D3916%26epage%3D1918%26doi%3D10.1021%2Fjo01307a039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hamper, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leschinsky, K. L.</span><span> </span><span class="NLM_article-title">Reaction of benzohydroximinoyl chlorides and β-trifluoromethyl)-acetylenic esters: Synthesis of regioisomeric (trifluoromethyl)-isoxazolecarboxylate esters and oxime addition products</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1002/jhet.5570400404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1002%2Fjhet.5570400404" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=575-583&author=B.+C.+Hamperauthor=K.+L.+Leschinsky&title=Reaction+of+benzohydroximinoyl+chlorides+and+%CE%B2-trifluoromethyl%29-acetylenic+esters%3A+Synthesis+of+regioisomeric+%28trifluoromethyl%29-isoxazolecarboxylate+esters+and+oxime+addition+products&doi=10.1002%2Fjhet.5570400404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570400404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570400404%26sid%3Dliteratum%253Aachs%26aulast%3DHamper%26aufirst%3DB.%2BC.%26aulast%3DLeschinsky%26aufirst%3DK.%2BL.%26atitle%3DReaction%2520of%2520benzohydroximinoyl%2520chlorides%2520and%2520%25CE%25B2-trifluoromethyl%2529-acetylenic%2520esters%253A%2520Synthesis%2520of%2520regioisomeric%2520%2528trifluoromethyl%2529-isoxazolecarboxylate%2520esters%2520and%2520oxime%2520addition%2520products%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2003%26volume%3D40%26spage%3D575%26epage%3D583%26doi%3D10.1002%2Fjhet.5570400404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jiang, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, F.-L.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of both enantiomers of <i>anti</i>-4,4,4-trifluorothreonine and 2-amino-4,4,4-trifluorobutanoic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7544</span><span class="NLM_x">–</span> <span class="NLM_lpage">7547</span><span class="refDoi"> DOI: 10.1021/jo0344384</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0344384" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFamtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=7544-7547&author=Z.-H.+Jiangauthor=Y.-Y.+Qinauthor=F.-L.+Qing&title=Asymmetric+synthesis+of+both+enantiomers+of+anti-4%2C4%2C4-trifluorothreonine+and+2-amino-4%2C4%2C4-trifluorobutanoic+acid&doi=10.1021%2Fjo0344384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Both Enantiomers of anti-4,4,4-Trifluorothreonine and 2-Amino-4,4,4-trifluorobutanoic Acid</span></div><div class="casAuthors">Jiang, Zhong-Xing; Qin, Ying-Ying; Qing, Feng-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7544-7547</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A short and efficient enantioselective synthesis of both enantiomers of anti-4,4,4-trifluorothreonine and 2-amino-4,4,4-trifluorobutanoic acid was successfully developed.  Trifluoromethylation of (E)-BrCH:CHCH2OCH2Ph provided key intermediate (E)-F3CCH:CHCH2OCH2Ph in good yield.  The sequence then involved Sharpless asym. dihydroxylation, nucleophilic opening of cyclic sulfate with NaN3, palladium-catalyzed selective hydrogenation, and oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHDpKu5PxHQbVg90H21EOLACvtfcHk0lgV67lTfMgeJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFamtr4%253D&md5=fd26bec46cdeecb8cdc9c93c64ea44e2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo0344384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0344384%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.-H.%26aulast%3DQin%26aufirst%3DY.-Y.%26aulast%3DQing%26aufirst%3DF.-L.%26atitle%3DAsymmetric%2520synthesis%2520of%2520both%2520enantiomers%2520of%2520anti-4%252C4%252C4-trifluorothreonine%2520and%25202-amino-4%252C4%252C4-trifluorobutanoic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D7544%26epage%3D7547%26doi%3D10.1021%2Fjo0344384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bendele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAbee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlipala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, M.</span><span> </span><span class="NLM_article-title">Animal models of arthritis: relevance to human disease</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1177/019262339902700125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10.1177%2F019262339902700125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=10367688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;key=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=134-142&author=A.+Bendeleauthor=J.+McCombauthor=T.+Gouldauthor=T.+McAbeeauthor=G.+Sennelloauthor=E.+Chlipalaauthor=M.+Guy&title=Animal+models+of+arthritis%3A+relevance+to+human+disease&doi=10.1177%2F019262339902700125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of arthritis: relevance to human disease</span></div><div class="casAuthors">Bendele A; McComb J; Gould T; McAbee T; Sennello G; Chlipala E; Guy M</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-42</span>
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    </div><div class="casAbstract">Animal models of arthritis are used to evaluate potential antiarthritis drugs for clinical use.  Therefore capacity of the model to predict efficacy in human disease is one of the most important criteria in model selection.  Animal models of rheumatoid arthritis (RA) with a proven track record of predictability include rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis, and antigen-induced arthritis in several species.  Agents currently in clinical use (or trials) that are active in these models include corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide, interleukin-1 receptor antagonist, and soluble tumor necrosis factor receptors.  For some of these agents, the models also predict that toxicities seen at higher doses for prolonged periods would preclude dosing in humans at levels that might provide disease-modifying effects.  Animal models of osteoarthritis (OA) include mouse and guinea pig spontaneous OA, meniscectomy and ligament transection in guinea pigs, meniscectomy in rabbits, and meniscectomy and cruciate transection in dogs.  None of these models have a proven track record of predictability in human disease because there are no agents that have been proven to provide anything other than symptomatic relief in human OA.  Efficacy data and features of the various models of RA and OA are discussed with emphasis on their proven relevance to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl_Wv0PotC6OkdrW1FkXG-fW6udTcc2eaXC5V7YVhAarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D&md5=1b6484ca61fd10dbb07f090d376730a4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F019262339902700125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F019262339902700125%26sid%3Dliteratum%253Aachs%26aulast%3DBendele%26aufirst%3DA.%26aulast%3DMcComb%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMcAbee%26aufirst%3DT.%26aulast%3DSennello%26aufirst%3DG.%26aulast%3DChlipala%26aufirst%3DE.%26aulast%3DGuy%26aufirst%3DM.%26atitle%3DAnimal%2520models%2520of%2520arthritis%253A%2520relevance%2520to%2520human%2520disease%26jtitle%3DToxicol.%2520Pathol.%26date%3D1999%26volume%3D27%26spage%3D134%26epage%3D142%26doi%3D10.1177%2F019262339902700125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e6889-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i49"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00089">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24881"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00089">10.1021/acs.jmedchem.6b00089</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00089/suppl_file/jm6b00089_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00089/suppl_file/jm6b00089_si_001.csv">jm6b00089_si_001.csv (1.85 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00089&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00089%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00089" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a4d21eb95223c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
